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ABSTRACT 
After sixty years on antibiotic use in livestock production, antimicrobial resistance is 
an issue that cannot be ignored. While governments debate new regulations, evidence is 
accumulating that in-feed antibiotics are contributing to antibiotic resistance proliferation in 
intestinal microbes and potential pathogens. The mode of action for the growth benefits of 
antibiotics are not clear, but defining the intestinal bacterial communities and understanding 
the impact of antibiotics on it is an important link in developing viable alternatives to 
antibiotics. Identifying the members and functions within the bacterial communities is 
needed to identify niches within the intestinal tract. Here we evaluate the shifts in intestinal 
bacterial communities with in-feed antibiotics, which include membership and functional 
changes. Additionally, antibiotic-resistance genes increased in the intestinal communities 
after exposure to antibiotics. To evaluate localize adaptations of swine intestinal bacterial 
communities; the spatial distribution of bacterial communities was evaluated. Localized 
differences were detected and potential specialist, such mucin degraders were identified. 
Future research will need to direct therapies to mimic the beneficial effects of antibiotics on 
the host and gut bacteria while minimizing the collateral impact on health and safety. 
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CHAPTER 1 
GENERAL INTRODUCTION 
After sixty years of antibiotic use in livestock production, antimicrobial resistance is 
an issue that cannot be ignored. While governments debate new regulations, evidence is 
accumulating that in-feed antibiotics are contributing to antibiotic resistance proliferation in 
intestinal microbes and potential pathogens. The mode of action for the animal growth 
benefits of antibiotics are not clear, but defining the intestinal bacterial communities and 
understanding the impact of antibiotics on it is an important link in developing viable 
alternatives to antibiotics. Identifying the members and functions within the bacterial 
communities is needed to identify niches within the intestinal tract.  Studies have detected 
shifts in intestinal bacterial communities with in-feed antibiotics, which include species and 
functional changes. Additionally, antibiotic-resistance genes increase in the intestinal 
communities after exposure to antibiotics. Concerns about antibiotic resistance in animal and 
human pathogens have led to research searching for alternatives to in-feed antibiotics for 
growth promotion and disease suppression in livestock. Alternatives such as probiotics and 
feed additives are promising for improving efficiencies in animal production and disease 
suppression. Future research will need to direct therapies to mimic the beneficial effects of 
antibiotics on the host and gut bacteria while minimizing the collateral impact on health and 
safety.           
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Dissertation Organization 
This dissertation is organized into five chapters, including a General Introduction, 
three chapters to be submitted for publication, and a final Summary and Discussion with 
suggested directions for future studies. Chapter one is an introduction with description of the 
history and relevant studies on antibiotic use in agriculture. Chapter 2 examines the effects of 
in-feed antibiotics on swine fecal bacterial communities using a combination of 16S rRNA 
gene, metagenomic, and qPCR analysis. Chapter 3 is a manuscript to be submitted for 
publication, describes a study evaluating localized compositions of bacterial communities in 
the swine intestinal tract and the effects of in-feed antibiotics using 16S rRNA gene and 
metagenomic analysis. Chapter 4 is a description of Cloacibacillus porcorum, a novel mucin 
degrader, isolated from a pig intestine. The isolation of C. porcorum was part of a survey of 
mucin degraders along the swine intestinal tract. Chapter 5 includes general discussion and 
conclusions, and suggestions for future research. This dissertation uses the reference format 
for each chapter’s respective target journal except for chapters 1 and 5, which use the ISME 
journal format. There are four appendices; Appendix A contains the supporting material for 
Chapter 2 and Appendix B includes supporting material for Chapter 3. Appendix C is a 
manuscript describing a study on the effects of in-feed antibiotics on bacteriophage and 
bacterial populations in swine fecal microbiomes. Appendix D is a list of mucin degrading 
bacterial isolated from the swine intestinal tract, from the survey where C. porcorum 
(Chapter 4) was isolated.    
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Literature review 
The reality of the agriculture industry today includes antibiotics and antimicrobial 
resistance. Antibiotics are used to improve consistency and productivity in animals such as 
cows, pigs, chickens, turkeys, and fish, but decades of use has led some to question the long-
term safety of antibiotic usage in animal production. Numerous studies cite the emergence of 
resistance genes shortly after the introduction of an antibiotic treatment (e.g. Aarestrup and 
Wegener 1999). Despite the clear connection between antibiotic use and resistance, the 
connection between antibiotic resistance in an agricultural setting and a human medical 
setting is uncertain. Members of the agriculture industry often point to the lack of evidence of 
agricultural antibiotics causing resistance in human pathogens, noting that human use is the 
likely driver of resistance. Both sides agree that more studies are needed to understand the 
effects of antibiotics in agriculture.  
 
History of antibiotic use in agriculture 
In the early 1950’s the US and other countries were looking for a way to keep up with 
the increasing demand for food. They turned to antibiotics as a way to grow livestock 
healthier and fatter, because antibiotics were first shown to improve growth after 
chlortetracycline-containing fermentation products of Streptomyces aureofaciens, were fed to 
chickens (Jukes and Williams 1953). Governments were reaching out to farmers to teach 
them about the benefits of antibiotics in agriculture, including administering antibiotics in 
livestock feed to improve feed conversion in the animals. Antibiotics given to pigs were 
estimated to save as much as 20% of feed per pound of weight gain (Brock 1955).  
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In tandem with the growth of in-feed antibiotic practices, antibiotic resistance was 
detected in bacteria isolated from animals receiving antibiotics (Gyorgy 1954). Concerns 
were growing related to the reduced effectiveness of antibiotics over time as a growth 
promoter and to the development of resistant pathogens associated with animal and human 
disease, but ultimately benefits of reduced cost to the industry outweighed the risks (Gyorgy 
1954, NRC 1956). Despite these concerns, the US was interested in expanding the use of 
antibiotics to include agronomy and food preservation (NRC 1956). By 1954, a quarter of all 
antibiotics produced in the US were used in agriculture (NRC 1956).  
Sixty years later, the debate continues in the US and abroad. Concerns over the spread 
of antibiotic-resistance genes to human pathogens continue to drive the debate. Human 
foodborne pathogens with antimicrobial resistance, such as E. coli, Salmonella, and 
Campylobacter, have been isolated from livestock and poultry facilities (Addis et al 2011, 
Carson et al 2008, Frye et al 2011, Rao et al 2010). European nations have implemented bans 
on growth-promoting antibiotic uses while the US continues to search for a suitable policy. 
Currently, over 50% of all antibiotics sold in the US are used for agriculture, and many 
classes of antibiotics are used as growth promoters in farm animals (Lipsitch et al 2002). 
Some antibiotics used to treat disease and improve feed efficiency in animals are the same 
that are used to treat human treat disease (Lipsitch et al 2002). Some of these in-feed 
antibiotics are excreted in animals’ waste, where they can persist in the environment and be 
unintentionally transferred to crops during fertilization (Sarmah et al 2006). These concerns 
have led some to question current policies permitting antibiotic use in agriculture, and others 
to call for improved prudence in their application (Aarestrup and Wegener 1999, Levy 1978, 
Levy et al 2005) 
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Among the groups calling for prudence, the Infectious Diseases Society of America 
recommended that the U.S. government adopt policies limiting the use of antibiotics in 
agriculture because of resistance concerns (IDSA 2010). On January, 4th, 2012 the FDA 
proposed a rule limiting the “off label” use of cephalosporin drugs in animal agriculture, but 
this did little to silence the critics (FDA 2012). A law currently proposed, Preservation of 
Antibiotics for Medical Treatment Act (PAMTA, H.R. 965/S. 1211), will require the FDA to 
review the approved antibiotics for animal feed and make determination based on 
implications to human health. With no compromises expected in the near future, cost-
effective alternatives for in-feed antibiotics are needed.     
 
Bacterial diversity in the GI tract 
The basis for the increased feed efficiency in livestock receiving antibiotics is a 
debated topic, but the accepted dogma is that antibiotics are likely affecting the intestinal 
bacteria (microbiota) (Dibner and Richards 2005). However, antibiotic effects on the 
microbiota aren’t easy to measure, since the mammalian gastrointestinal (GI) tract is home to 
a diverse population of microorganisms in a relatively inaccessible environment.  As many as 
1000 species are found in the gut (Eckburg et al 2005), with approximately 800 species found 
in the swine gut (Looft et al 2012). In humans, bacterial cells are estimated to outnumber the 
host cells by a factor of ten, and bacterial genes outnumber host genes by a factor of 100 
(Savage 1977). This enormous diversity must first be defined before an antibiotic effect can 
be measured. 
Interactions between the microbiota and the host are a result of a long mutually 
beneficial co-evolution, which confers numerous benefits on the mammalian host (Ley et al 
6 
 
 
 
2008). GI microbes are important for the maintenance of host health. They have important 
protective and metabolic functions, such as assisting the host in nutrient extraction, immune 
system and epithelium development, and are a natural defense against pathogens (Zoetendal 
et al 2004). Microbial degradation products in the GI tract supply nutrients and energy to the 
host, such as vitamins, volatile fatty acids, growth factors, and under normal conditions, 
interactions are the result of a subtle balance that promotes symbiosis (Savage 1977). Studies 
using germ-free animals have shown that colonization with commensal bacteria affects the 
expression of host genes, including those associated with mucosa maturation, nutrient uptake, 
metabolism, and angiogenesis (Hooper and Gordon 2001, Hooper et al 2001). Germ free 
mice require 30% more calories than conventional mice to maintain their weight, because 
germ free animals don’t have a microbial community to help extract nutrients from food 
(Wostmann et al 1983).  Understanding the interactions between the gut microbiome and the 
host will inform decisions on antibiotic usage and improve animal health. 
 
Host mucosa and immune system 
Bacteria that colonize the GI mucosa are particularly important for animal health 
because they are in direct contact with the host (Rosebury 1962). The mucosa is a layer of 
epithelium with connective tissue and smooth muscle underneath and is responsible for 
nutrient absorption. Most interactions between commensal bacterial and the host mucosa are 
neutral or beneficial, but some interactions may lead to disorders such as Crohn's disease or 
ulcerative colitis (Joossens et al 2011).  Altered mucosal-associated bacterial communities  
have been shown to be linked to inflammatory bowel disease in humans (Campieri and 
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Gionchetti 2001, Sartor 2008), differ between the ileum to the colon (Eckburg et al 2005), 
and may even be gender specific (Aguirre de Carcer et al 2011).    
The mucosa has many microenvironments for bacterial-host interactions, in part 
because it contains many folds and villi that protrude into the interior, or lumen, of the GI 
tract and invaginations called crypts that increase the surface area for nutrient absorption. 
The mucosa is composed of many specialized cells that have digestive and protective 
functions.  Enterocytes are intestinal absorptive cells found on the villi and contain 
microvilli, which further increase the surface area of the mucosal surface for absorption. 
While increasing the surface area for digestion, these folds also facilitate interactions 
between the mucosa and the indigenous bacteria (Nataro 2005). Paneth cells are found at the 
bottom of the crypts and secrete the most of the antimicrobial peptides produced in the small 
intestine. These peptides are secreted when bacteria are detected and include α-defensins, 
lysozyme, and RegIIIγ.  In addition to this range of antimicrobial compounds, mucosally-
associated bacteria also have to deal with a gradient of oxygen that is diffusing from the 
underlying tissue, which is harmful to obligate anaerobes (Bornside et al 1976). A thick 
mucus layer is generated by columnar epithelial cells (goblet cells), serving to limit the 
contact with and penetration by the gut bacteria within the mucosa. The mucus layer also 
protects the bacteria from the host’s defenses mentioned above, thus contributing to the 
balance of the host/microbial relationship. 
The immune system is also an important factor in maintaining the balance between 
the host and its microbiota. Peyer's patches are round lymphoid follicles covered by 
specialized epithelial cells called microfold cells (M-cell). M-cells sample antigens directly 
from the lumen and deliver them to antigen-presenting cells, resulting in B-cells and memory 
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cell stimulation. Plasma cells (B cells) and T cells can be found in the follicles of Peyer’s 
patches where they encounter foreign antigens.  Intestinal microbes are important for 
lymphocyte development such as, B-cell class switching, Th17 effector T-cell development, 
and induction of T-regulatory cells (Duerkop et al 2009). The innate and adaptive immune 
systems work together to detect and influence the diverse microbial populations associated 
with the intestinal mucosa.  
 
Bacterial specialists in the GI tract 
In addition to looking at bacterial species diversity, important research focuses on 
functional subdivisions of bacteria in the gut ecosystem. Functional redundancy or niche 
specificity conferred by bacterial specialists can be shared across unrelated bacterial species 
but usually indicates important functions in the gut. Specific bacterial metabolic activities 
and fermentation end-products have been shown to benefit the host and are also targets to 
manipulate for improved efficiencies in animal production. Mammalian hosts have learned to 
tolerate many beneficial specialists, even possessing specific cellular transporters of bacterial 
fermentative products (Cresci et al 2010).  The colonic mucosal epithelium in particular 
depends on bacterially-derived nutrients diffusing from the lumen for energy (Bengmark 
2000). Other specialists benefit the host by simply occupying available niches on the mucosa, 
preventing colonization of pathogens (Poole et al 2009, Thomas et al 2011). Because of these 
interactions, bacteria that provide the host with essential nutrients or are in contact with the 
mucosa are the focus of current research.    
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Lactic acid bacteria  
An important group of gut specialists in both livestock and humans are the lactic acid 
bacteria (LAB). LAB are Gram positive, facultative anaerobes that are able to ferment sugars 
to lactic acid via fermentative pathways (Bernardeau et al 2008), and consist of over 400 
recognized species (Euzeby 1997).  Often available in dairy, fermented foods, or as a 
probiotic, LAB are known to modulate the intestinal tract to improve mucosal barrier 
function, antagonize pathogens, and reduce the severity and duration of viral diarrhea 
(Heyman 2000).  Additionally, LAB are effective at improving weight gain and minimizing 
infections in livestock, even in the absence of antibiotics (Abe et al 1995, Signorini et al 
2011). One study showed that the LAB Lactobacillus casei inhibited the ability of 
Pseudomonas aeruginosa and Listeria monocytogenes to colonize mice by stimulating the 
host immune system, thereby increasing the numbers of macrophages that prey on the 
pathogens (Driessen and De Boer 1989). Additionally, LAB may have anti-carcinogenic 
effects, reducing microbial enzymes responsible for converting procarcinogens to 
carcinogens (Gorbach and Goldin 1990). Several studies have reported a reduction in LAB 
after antibiotic treatment, which may be an unintended side-effect of antibiotic use (Allen et 
al 2011, Antonopoulos et al 2009, Hill et al 2010, Ichinohe et al 2011). As potential 
antagonists of intestinal pathogens and as producers of small molecules important for host 
health, LAB’s role in animal health is vital.      
 
Butyrate-producing bacteria 
Butyrate production by microorganisms in the gut has been shown to benefit the 
health of the host by contributing a major portion of the caloric intake in ruminants, pigs, and 
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other livestock.  Butyrate is absorbed and used by the colonic epithelium as an energy source, 
acting as a growth-promotant by stimulating epithelial cell proliferation (Sakata and von 
Engelhardt 1983, Sunkara et al 2011). Additionally, butyrate stimulates mucin synthesis 
along the intestinal mucosa, which improves the barrier against pathogens and is considered 
an indication of gut health (Brown et al 2011, Finnie et al 1995, Hatayama et al 2007). 
 
Mucin-degrading bacteria  
Adaptations for mucosal colonization are important to identify when evaluating 
bacterial roles in animal health, and one such adaptation could be mucus degradation. As 
mentioned previously, the intestinal mucosa is covered by a layer of mucus, which protects 
the underlying epithelium from damaging agents and limits microbial penetration of the 
mucosa.  Mucus is mostly water and mucin, which is the viscous part of the mucus.  Mucins 
are glycoproteins with many carbohydrate side chains connected to a main protein by O-
glycosidic links (Nataro 2005).  Most mucins are secreted (gel-forming mucins) but some 
have trans-membrane regions and are bound to the membrane of epithelial cells (membrane-
associated mucins) (Ouwehand et al 2005).  One of the major functions of mucins is to 
prevent bacterial attachment to the surface of epithelial cells by offering recognition sites 
similar to the epithelial cell surface (Nataro 2005). The mucus layer is stratified and can be 
150 µm thick. The majority of mucosally associated bacteria are able to penetrate the outer 
mucus layers but never reach the mucosal epithelium. Additionally, mucus and epithelial 
cells are constantly sloughed off to combat colonization of the mucosa. Associations of 
microbes with mucus is not well understood (Derrien et al 2008), but a diverse population of 
mucus-degrading bacteria have been identified and are associated with the mucus layer 
11 
 
 
 
(Rozee et al 1982).  Mucin-degrading activity has been linked to pathogenesis in some 
microbes (Campieri and Gionchetti 2001). Not all mucin degraders are pathogens, and 
evaluating this subpopulation for effects on animal health and potential therapeutic uses is an 
important step towards targeting alternatives for in-feed antibiotics.   
 
How antibiotics in feed lead to improved feed efficiencies 
In order to develop viable alternatives to antibiotics, we have to know how the in-feed 
antibiotics are functioning to improve feed efficiency. The mode of action for antibiotics is 
not clear, but mechanisms may include a reduction in total bacterial load, increased nutrient 
absorption by the hosts, or community modeling by favoring non-antagonistic or beneficial 
bacteria and functions (Butaye et al 2003). The most accepted dogma towards antibiotic use 
in livestock production is that antibiotics improve feed efficiency by knocking down bacterial 
load. This decreases the energy expenditure by the host because the host’s immune system is 
constantly maintaining/controlling gut microbes (Jukes and Williams 1953). Reduced 
mucosal inflammation due to a reduced bacterial load may be a specific response that reduces 
the energy cost to the host, thus leaving the surplus calories for weight gain. The hypothesis, 
therefore, is that fewer bacteria in the gut decreases the amount of energy spent on immunity, 
allowing that energy to divert into growth. Additionally, the reduced bacterial load (reduced 
bacterial metabolism) may lead to more nutrients being available for host absorption (Hardy 
2002). In addition to improving animal growth, antibiotics decrease morbidity and mortality 
due to clinical and subclinical diseases (Solomons 1978).  
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Collateral effects of in-feed antibiotics on the gut microbiota 
 
On disease susceptibility 
The benefit of improved feed efficiency by feeding antibiotics is not without a cost.  
Increased disease susceptibility may be a collateral effect of antibiotic use. For example, 
eliminating commensals with broad-spectrum antibiotics can result in a reduction of host-
produced antimicrobial molecules in the intestinal mucosa, increasing susceptibility to 
antibiotic-resistant bacteria and pathogens (Brandl et al 2008, Hill et al 2010).Treatment with 
the antibiotics streptomycin and metronidazole also leads to increased infections because 
they alter the mucus layer, thereby weakening its barrier function (Wlodarska et al 2011). 
Antibiotic treatment has also been shown to predispose mice for Salmonella infections. 
Salmonella populations increased after withdrawal from an oral antibiotic regimen because 
antibiotics perturbed the intestinal microbial ecosystem (Croswell et al 2009, Sekirov et al 
2008). The undesired collateral effects of antibiotics may not always be evident, but should 
be included in the cost-benefit analysis of agricultural antibiotics.   
 
On beneficial microbes and functions 
Numerous effects of antibiotics on the intestinal microbial membership and functions 
have been studied in recent years. Impacts on microbial community membership are 
measured using conserved phylogenetic makers (e.g. the 16S rRNA gene sequence) to make 
taxonomic assignments and compare communities. Functional studies often look at the 
functional capacity of the community (gene content –metagenome [studies –metagenomics]), 
but can include gene expression and products as well.        
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Understanding antibiotic-induced shifts in the membership (phylotypes) are an 
essential first step towards identifying which bacterial groups are of functional importance. 
In humans, the administration of ciprofloxacin affected the abundance of the majority 
bacterial taxa in the gut, resulting in decreased richness, diversity, and evenness. After a four 
week withdrawal period, the microbiota of the treated individuals resembled the pretreated 
state, but several taxa didn’t recover (Dethlefsen et al 2008). This is concerning because loss 
of specific commensal bacteria may impact host health. For example, the bacterium 
Oxalobacter formigenes is lost after antibiotic treatment in humans, and can be difficult to re-
establish. O. formigenes degrades oxalate, the accumulation of which results in the formation 
of calcium oxalate kidney stones (Duncan et al 2002). In agriculture, a study of swine given 
sub-therapeutic levels of ASP250 (chlortetracycline, sulfamethazine, and penicillin) showed 
an increase in populations of commensal E. coli and a reduction in Streptococcus spp. (Allen 
et al 2011, Looft et al 2012). The ability of the microbiota to recover after antibiotic 
treatment differs by the antibiotic regimen administered, and the impact of a failed microbial 
recovery on the host is unknown.  
Alterations in bacterial membership have important implications on the functional 
capacity of the microbiota, which in turn may confer a health advantage on the host. For 
example, particular changes in the bacterial communities, such as with obesity or antibiotic 
exposure, may be associated with improved energy harvesting capabilities of the gut 
microbiota (Ley et al 2005, Ley et al 2006, Looft et al 2012, Turnbaugh et al 2006). Changes 
in the relative abundance of Bacteroidetes and Firmicutes in obese individuals also reflects 
functional shifts towards increased energy harvesting within the microbial communities (Ley 
et al 2006, Turnbaugh et al 2006). Perhaps the growth-promoting effects in animals fed 
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antibiotics are analogous to the changes in metabolic potential of the intestinal microbiota in 
obese individuals, which could be improving feed efficiency (Looft et al 2012, Turnbaugh et 
al 2006).  
In addition to metagenomic studies, analyses of community-wide effects of 
antibiotics have included community metabolite studies (metabolome). Antunes et al. (2011) 
showed that most of the metabolites detected in the communities with exposure to antibiotics, 
shifted in abundance, when compared to the non-treated communities. Affected host 
metabolic pathways included those critical for animal physiology, including bile acid, 
eicosanoid, and steroid hormone synthesis. Functional studies are important because they 
directly address questions about what the bacteria in the community are doing and how that 
relates to host health. Functional redundancy across bacterial species may mask significant 
functional changes with antibiotic usage if only phylotype shifts are considered.  
 
The GI antibiotic resistome 
Of the functional genes to change with antibiotics, those associated with antibiotic 
resistance mechanisms would be the most intuitive because of the competitive advantage 
they confer. The antibiotic “resistome” is the total reservoir of resistance determinants in a 
microbial community (D'Costa et al 2006). An enormous diversity of antibiotic resistance 
genes have been detected in environmental and intestinal ecosystems (Allen et al 2010, 
Sommer et al 2009), and these may persist even with the absence of antibiotics (Salyers and 
Amabile-Cuevas 1997). Indeed, the microbiota of healthy humans and swine are antibiotic 
resistance reservoirs, harboring diverse and numerous resistance genes (Sommer et al 2009). 
Swine receiving sub-therapeutic (growth promoting) antibiotics (ASP250), had increases in 
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the abundance and diversity of antibiotic resistance genes, including resistance to antibiotics 
not administered (Looft et al 2012). Resistomes such as these may contribute to the 
preservation and expansion of antibiotic resistance determinants, particularly in the presence 
of antibiotic selection.  
The strong selective pressure of antibiotic use as part of livestock management is in 
part responsible for the numerous resistance genes found in livestock microbiota, but 
antibiotic resistance continues to persist even after antibiotics are no longer used. Despite an 
absence of antibiotic exposure, organically raised pigs maintain a diverse number of 
tetracycline resistance genes, many plasmid encoded (Kazimierczak et al 2009). In another 
study, chlortetracycline resistant bacteria in feral swine feces were over 1,000-fold fewer, 
when compared to organically raised pigs (Stanton et al 2011). In the absence of antibiotics, 
piglets pre-colonized with antibiotic susceptible strains of Megasphaera elsdenii lost the 
susceptible strains, in favor of the mother’s resistant M. elsdenii strains (Stanton and 
Humphrey 2011). These findings point to lasting effects that antibiotic use with livestock 
production has, and even with elimination of antibiotics and attempts to pre-colonize with 
susceptible strains, resistanct bacterial strains persists. 
One collateral effect of antibiotics is antibiotic-induced dissemination of resistance 
genes between bacteria. In some cases, antibiotics actually stimulate the transfer of resistance 
genes on mobile elements between intestinal bacteria (Salyers and Shoemaker 1992). When 
resistance genes are on plasmids, they can spread quickly, even between distantly related 
bacteria or pathogens (Gotz et al 1996, Ochman et al 2000). Mucosal inflammation can also 
lead to an increase in horizontal gene transfer between Salmonella and E. coli (Stecher et al 
2012). Antibiotic resistance genes have been identified in bacteriophages in livestock feces, 
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which may facilitate the transfer of antibiotic resistance genes to potential animal or human 
pathogens (Allen et al 2011). Several studies have demonstrated that antibiotics used in 
livestock production actually induce phage lysis of their bacterial host and facilitate gene 
transfer (Maiques et al 2006, Stanton et al 2008, Ubeda et al 2005). The potential human 
pathogens Enterococcus faecalis and E. faecium have been isolated from broiler chicken and 
turkey flocks with resistance to bacitracin, erythromycin, flavomycin, gentamicin, 
kanamycin, lincomycin, quinupristin- dalfopristin, streptomycin, tetracycline, and tylosin; 
various combinations of these resistance genes were identified on plasmids (Tremblay et al 
2011). The selective pressure of in-feed antibiotics increases the risk of pathogens with 
resistance to multiple antibiotics.   
Livestock animals may be acting as living test-tubes, facilitating gene transfers 
between human and animal isolates of related species. Methicillin-resistant Staphylococcus 
aureus has been seen in livestock since the 1970’s. Long considered a livestock pathogen, it 
is now becoming a problem for human health (Devriese et al 1972, Price et al 2012). 
Genome-wide surveys of S. aureus strains suggest that human-associated methicillin- 
susceptible S. aureus have colonized livestock, where the strains acquired resistance to 
methicillin and tetracycline (Price et al 2012). In the mouse colon, vancomycin resistance 
genes were conjugatively transferred from porcine to human Enterococcus faecium, again 
suggesting that animal-associated bacteria may serve as an antibiotic resistance reservoir for 
human bacterial species (Moubareck et al 2003). Antibiotic resistance itself doesn’t make a 
pathogen, but the transfer of resistance genes to human or animal pathogens may be more 
common than previously estimated.  
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Alternatives to in-feed antibiotics 
Concerns about antibiotic resistance make finding alternatives for the growth-
promoting and therapeutic uses of agriculture antibiotics essential. An all-out ban on 
antibiotics in agriculture may not be the best approach. In Europe after in-feed antibiotics 
were banned in livestock production, disease occurrences increased while production 
efficiencies decreased (Ferber 2003). Some have suggested that antibiotics in animal 
production should only have a role in disease treatment and that feeding prophylactically is a 
poor strategy (Hardy 2002). Viable alternatives are needed to maintain efficiency standards 
and minimize disease.  
 
Antibiotic alternatives for improved feed efficiency 
Improving the nutrient composition of animal feed and feed additives are important 
ways to improve weight gain in livestock. Prebiotics, which are substrates added to feed to 
stimulate the production of gut microbial nutrients, usually include dietary fibers and 
complex proteins (Bengmark 2000). Extensive research has been performed on certain feed 
additives, including organic acids, biomos, anhydrotetracycline, as well as improving feed 
digestibility and nutrient availability. In-feed organic acids such as lactic and formic acid 
improve pig immune response and reduce Salmonella in swine feces (Lee et al 2007, Walsh 
et al 2012, Willamil et al 2011). Folic acid is crucial for DNA and methionine metabolism 
during pregnancy and lactation in livestock (McNulty et al 1993). Fermented liquid diets 
have also been looked at as an alternative to antibiotics for growth improvements. Liquid 
feed is fermented with LAB, which can improve performance in pigs by easing the transition 
18 
 
 
 
from the sow milk to solid feed. Fermented feed is acidic, limiting food spoilage, lowering 
stomach pH, and resulting in lower pathogen survival (Missotten et al 2010).   
Augmenting the functionality of butyrate-producing bacteria in the gut is currently an 
important focal point for prebiotics. Prebiotic substrates that are efficiently converted to 
butyrate may be added to livestock diets to stimulate butyrate production. Starches resistant 
to digestion by the host have been shown to be the most powerful butyrogenic substrate in 
the intestinal tract, increasing butyrate production by up to 25% (Bird et al 2000, Brouns et al 
2002). Resistant starches could be used to affect the microbial community by stimulating 
butyrate-producing organisms. Selecting for lactate producers may also increase butyrate 
production in the gut because butyrate producers can use free lactate to produce butyrate as 
an end product (Silvi et al 1999). Prebiotic feed additives such as these stimulate particular 
gut bacteria to target functions that benefit the host, achieving similar results to antibiotics.  
 
Antibiotic alternatives for disease treatment and prevention     
Antibiotics are not the only approach for reducing potential pathogens and subclinical 
infections in animal agriculture. Methods using probiotics and prebiotics to competitively 
exclude pathogens are gaining in popularity (Hardy 2002). Bacteria that are antagonistic to 
pathogens, such as LAB, make interesting targets for reducing the pathogen load (Heyman 
2000, Mappley et al 2011). Probiotics have been effective in reducing Salmonella, E. coli, 
Clostridium perfringens, Campylobacter jejuni, and many other livestock pathogens (Chu et 
al 2011, Han et al 2011, Meng et al 2010, Santini et al 2010). Many bacterial species have 
been evaluated as potential probiotic strains for their beneficial characteristics including; 
Lactobacillus, Streptococcus, Bifidobacterium, Bacillus and yeasts (Dunne et al 2001, Guo et 
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al 2006). Several traits are important in a good probiotic strain: resistance to stomach acids 
and bile, the ability to colonize the intestine, produce essential nutrients, and antagonize 
pathogens. Bacillus species have been used in pigs with some success, resulting in an 
increased growth rate and decreased mortality (Davis et al 2008, Kyriakis et al 1999).  
A combination of these practices with other improvements may have an additive 
effect. Genetic selection of disease resistance in livestock should improve the herd health, 
negating the use of antibiotics. Additionally, environmental management could be improved. 
A reason that antibiotics are needed to combat disease is the close living confinements in 
which livestock are raised. Smaller, segregated animal groups would limit disease 
transmission. To be viable in the field, alternatives need to be effective at both performance 
and disease suppression at a cost comparable to antibiotics.             
 
Summary 
Animals have an intricate and complex relationship with the bacterial milieu in their 
guts. Intestinal microbes provide many important protective and metabolic functions, 
including the extraction of nutrients from otherwise indigestible compounds. Interactions 
along the intestinal mucosa are particularly important for animal health and simulate the host 
immune system (Ashida et al 2012). Commensal microbes even have the potential to be 
prescribed biological supplements for use as therapeutic agents (Hooper and Gordon 2001). 
The delicate balance of beneficial gut bacteria is modified by antibiotics.  It is important to 
understand the mechanisms by which antibiotics are shaping the microbiota, especially 
regarding the maintenance and acquisition of resistance genes. Knowledge of shifts in the 
microbiota during antibiotic regiments can inform strategies for alternative to antibiotics 
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while maintaining efficiencies in livestock production. There is significant potential for pre- 
and probiotics as alternatives for antibiotics.  
  
Future directions with host-bacterial interactions in the gut 
Host-microbe relationships that benefit the host will continue to be the focus of future 
research improving animal health and production. Understanding intestinal bacterial diversity 
and niches occupied by commensals will inform studies targeting specific groups. New 
molecular technologies have improved our ability to deeply sample (sequence) these 
communities, allowing researchers to test hypotheses that were previously not possible. Data 
on gene expression and the resulting products will give valuable insights into the functions 
and interactions between bacteria and the host. Host gene expression is the other side of this 
relationship, and is important when evaluating bacterial roles on animal health. In all, these 
techniques will start to fill in the details of how intestinal bacteria influence animal health, 
particularly regarding the improvement of performance in the absence of antibiotics.      
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Abstract 
Antibiotics have been administered to agricultural animals for disease treatment, 
disease prevention, and growth promotion for over 50 y. The impact of such antibiotic use on 
the treatment of human diseases is hotly debated. We raised pigs in a highly controlled 
environment, with one portion of the littermates receiving a diet containing performance-
enhancing antibiotics [chlortetracycline, sulfamethazine, and penicillin (known as ASP250)] 
and the other portion receiving the same diet but without the antibiotics. We used 
phylogenetic, metagenomic, and quantitative PCR-based approaches to address the impact of 
antibiotics on the swine gut microbiota. Bacterial phylotypes shifted after 14 d of antibiotic 
treatment, with the medicated pigs showing an increase in Proteobacteria (1–11%) compared 
with nonmedicated pigs at the same time point. This shift was driven by an increase in 
Escherichia coli populations. Analysis of the metagenomes showed that microbial functional 
genes relating to energy production and conversion were increased in the antibiotic-fed pigs. 
The results also indicate that antibiotic resistance genes increased in abundance and diversity 
in the medicated swine microbiome despite a high background of resistance genes in 
nonmedicated swine. Some enriched genes, such as aminoglycoside O-phosphotransferases, 
confer resistance to antibiotics that were not administered in this study, demonstrating the 
potential for indirect selection of resistance to classes of antibiotics not fed. The collateral 
effects of feeding subtherapeutic doses of antibiotics to agricultural animals are apparent and 
must be considered in cost-benefit analyses.  
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Introduction 
Antibiotics are the most cost-effective way to maintain or improve the health and feed 
efficiency of animals raised with conventional agricultural techniques (1, 2). In addition to 
improving feed efficiency, antibiotics are commonly given to livestock, poultry, and fish for 
disease treatment and prevention. The sum of agricultural antibiotic use reportedly accounts 
for as much as half of all antibiotics produced in the United States (3). Despite the clear 
benefits of antibiotics to agriculture, liberal antibiotic use combined with rapid and 
widespread emergence of both animal and human pathogens resistant to multiple antibiotics 
has led some to question the prudence of current antibiotic use (4, 5). Studies of 
environmental and intestinal microbial communities reveal enormous diversity of antibiotic 
resistance genes (6–8). The addition of antibiotics to feed introduces a selective pressure that 
may lead to lasting changes in livestock commensal microorganisms. Furthermore, reservoirs 
of antibiotic resistance genes have been shown to be stable in bacterial communities, even in 
the absence of antibiotics (9–12). A central concern of increased abundance of antibiotic 
resistance is the transfer of resistance to pathogens (13). As a result, the Food and Drug 
Administration recently released a draft guidance recommending restrictions on the use of 
antibiotics in animal agriculture (14). The Infectious Diseases Society of America testified 
before a Congressional subcommittee in support of such limitations (15).  
Bacteria that inhabit the gastrointestinal tract of animals are important for the 
maintenance of host health. The intestinal microbiota assists the host in nutrient extraction, 
immune system and epithelium development, and are a natural defense against pathogens 
(16). Contrary to these benefits, the gut microbiota may antagonize future disease treatment 
by facilitating the dissemination of resistance alleles across distantly related organisms. For 
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example, commensal bacteria of the human colon harbor antibiotic resistance genes and can 
transfer these genes to pathogens (17, 18). In fact, horizontal gene transfer is largely the 
cause of multidrug resistance in Gram-negative bacteria (19). With the identification of 
antibiotic resistance genes in commensal bacteria in the human food-chain (20–22), the role 
of the gut microbiota as a reservoir of resistance genes for animal and food-borne pathogens 
needs to be explored.  
Valuable insights have been gained by culture- and PCR-based approaches to study 
narrow groups of bacteria or genes, such as erythromycin resistance in swine isolates (23); 
however, the comprehensive effects of daily feeding of subtherapeutic doses of antibiotics on 
livestock microbiotas have not been studied. We therefore sought to extensively evaluate the 
effects of in-feed antibiotics on the entire gut microbiota. Phylotyping, metagenomic, and 
parallel quantitative PCR (qPCR) approaches were used to track changes in microbial 
membership and encoded functions, enabling the detection of so-called “collateral” effects of 
antibiotics (i.e., effects outside of the intended growth promotion and disease prevention). 
These collateral effects included increases in Escherichia coli populations and in the 
abundance of certain antibiotic resistance genes.  
Piglets were birthed at the National Animal Disease Center in Ames, IA, and housed 
together in highly-controlled, decontaminated rooms to avoid cross contamination among the 
medicated animals, nonmedicated animals, and other resident barn animals. Neither the 
piglets nor the sow were exposed to antibiotics before the study. This design was to ensure 
that the inoculum for the piglets would come horizontally from their mother, minimizing 
variability so that effects of antibiotic treatment could be detected. At 18 wk of age, one 
group of littermates received ASP250 feed (medicated) and the other received the same but 
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unamended feed (nonmedicated) for 3 wk. ASP250 is an antibiotic feed additive containing 
chlortetracycline, sulfamethazine, and penicillin that is commonly given to swine for the 
treatment of bacterial enteritis and for increased feed efficiency. Fecal samples were 
collected just before treatment (day 0), and after 3, 14, and 21 d of continued treatment. Day 
0 samples were used to describe the swine intestinal microbiome before antibiotic treatment 
period.  
 
Results 
 
Shifts in Community Membership with ASP250. 
We collected 133,294 sequences of the V3 region of the 16S rRNA gene from a total 
of 12 fecal samples. Data from pigs of the same treatment and sampling date were grouped to 
appraise an antibiotic effect on community membership. As reported for a mammalian 
intestinal environment (24), and recently in a swine metagenome (25), the majority of 
classifiable sequences (75–86%) belonged to the Bacteroidetes, Firmicutes, and 
Proteobacteria phyla (Supplementary table A1). Of the Bacteroidetes, the Prevotella genus 
was consistently abundant, as was shown to be a feature of the swine microbiome (25). The 
Bray-Curtis index was calculated for all sample combinations and an analysis of similarities 
(ANOSIM) was performed. A nonmetric multidimensional scaling (NMDS) plot of these 
data indicated divergence of the day 14 samples from the day 0 samples (P < 0.01), and the 
medicated microbiome diverged from the nonmedicated (P < 0.05) (Figure 2.1A), 
demonstrating changes in microbial community membership over time and with treatment.  
35 
 
 
 
 
Specific changes in the microbial community associated with ASP250 treatment 
included a decrease in the abundance of Bacteroidetes, along with members of Anaerobacter, 
Barnesiella, Papillibacter, Sporacetigenium, and Sarcina genera. Members of the 
Deinococcus-Thermus and Proteobacteria phyla increased with ASP250 treatment as well as 
Succinivibrio and Ruminococcus genera (Supplementary table A1). The increase in 
Proteobacteria abundance with in-feed ASP250 was particularly striking: from 1% of the 
population in nonmedicated animals to 11% of the population with antibiotic treatment 
(Figure 2.1B). Specifically, E. coli populations were the major difference between medicated 
and nonmedicated animals, comprising 62% of the Proteobacteria in medicated animals 
(Figure 2.1C). The increase in E. coli was confirmed in the metagenomic data (Figure 2.1D) 
and by qPCR targeting the uidA gene of E. coli (P < 0.05). A separate study using 12 pigs 
similarly treated but with analysis by culture-based techniques further established that swine 
fed ASP250 have an increased E. coli population at 14 d posttreatment, showing a 20- to 
100-fold greater E. coli abundance in medicated than nonmedicated swine (Supplementary 
figure A1).  
 
Shifts in Functional Gene Abundance with ASP250. 
DNA samples from the feces of nonmedicated and medicated pigs at days 0 and 14 
were isolated, and samples of like treatment and sampling date were pooled for 
pyrosequencing. Metagenome sequences (1,202,058 total) were analyzed in MG-RAST for 
SEED subsystems (26), and in-house for clusters of orthologous groups (COGs). All 
metagenomes showed functional stability over time by both COG and subsystem analyses 
(Supplementary figure A2). The most abundant SEED subsystem of known function was 
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carbohydrate metabolism, mirroring what was previously reported for the swine metagenome 
(25). A statistical analysis of COGs revealed shifts in microbial community functions with 
ASP250: the medicated metagenome contained 169 COGs that were significantly more 
abundant than in the nonmedicated metagenomes (Supplementary table A2). Three COGs 
(0477, permeases of the major facilitator superfamily; 1289, predicted membrane protein; 
3570, streptomycin 6-kinase) contain swine metagenomic genes that are annotated as 
resistance genes in the antibiotic resistance gene database (ARDB). Three of the COGs with 
the lowest P value (3188, 3539, and 3121) contained genes related to P pilus assembly, and 
additionally among the statistically significant COGs are transposases (0675, 1662, and 
4644).  
To identify themes among differentially represented COGs between the medicated 
and nonmedicated metagenomes, COGs of Supplementary table A2 were clustered by their 
respective COG category. Only one COG functional category, energy production and 
conversion (C), was found more frequently (P < 0.05) in the medicated metagenome than in 
the nonmedicated metagenomes (Supplementary table A3).  
 
Pervasive Antibiotic Resistance in the Absence of Antibiotic Exposure. 
The discovery that resistance-related COGs fluctuated with antibiotic treatment led to 
further scrutiny of the metagenomes by BLAST against the ARDB (27). All metagenomes, 
regardless of antibiotic treatment, harbored sequences similar to diverse antibiotic resistance 
genes representing most mechanisms of antibiotic resistance: efflux pumps, antibiotic-
modifying enzymes, and modified or protected targets of the antibiotic (Figure 2.2A). This 
analysis detected 149 different resistance genes in the day 0 metagenomes.  
37 
 
 
 
 
The finding of diverse fecal antibiotic resistance genes in the nonmedicated 
metagenomes was supported by parallel qPCR analysis. A rich array of 57 resistance genes 
was detected at least once in the swine fecal samples by qPCR. Samples from nonmedicated 
animals showed a total of 50 different resistance genes, but few were shared between 
animals: only five [ermA, ermB, mefA, tet(32), and aadA] were detected in 66% of the 
samples and none were found in more than 80% of the samples. No enrichment of these 
genes was observed in the medicated animals, even though tet(32), a ribosomal protection 
protein, is known to confer resistance to an administered antibiotic (tetracycline). Samples 
from medicated animals yielded more homogenous resistance gene diversity: 38 genes were 
detected in at least one medicated sample, 19 were detected in 66% of samples, and 10 
[mefA, ermA, ermB, tet(32), tet(O), aadA, aph(3′)-ib, bcr, acrA, and bacA] were detected in 
at least eight of nine of the samples.  
 
qPCR and Metagenomic Analyses Reveal Shifts in Resistance Gene Richness and Abundance 
in Medicated Pigs. 
Statistical analysis of the ARDB results showed 23 genes to be differentially 
represented in the medicated and nonmedicated metagenomes (Table 2.1). The 20 genes that 
were more abundant in the medicated metagenome were associated with efflux, sulfonamide 
resistance, and aminoglycoside resistance, the latter of which represents resistance to a class 
of antibiotics not present in ASP250 (Table 2.1).  
The qPCR results mirrored the metagenomic analysis, revealing six resistance-gene 
types with statistically significantly greater abundance in the medicated animals than in the 
nonmedicated animals (P < 0.05): tetracycline efflux pumps, class A β-lactamases, 
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sulfonamide resistance genes, aminoglycoside phosphotransferases, and two types of 
multidrug efflux (Figure 2.2B and Table 2.1). No statistical difference in abundance was 
found for these six resistance gene types between the medicated and nonmedicated 
microbiomes on day 0 (Figure 2.2B), suggesting that in-feed ASP250 caused the effect. 
Resistance-gene abundance increased most dramatically in the 3- and 14-d samples 
(Supplementary figure A3), indicating that antibiotic treatment induced a rapid shift in the 
abundance of resistance genes.  
ASP250 treatment increased the diversity of resistance gene types as detected by 
qPCR [Shannon indices 1.4 (medicated) and 0.8 (nonmedicated); P = 0.04]. A t test 
comparing the mean number of resistance genes in the metagenomes at day 14 to the 
corresponding nonmedicated metagenome confirms this result (P < 0.05). Additionally, the 
structure of the resistance-gene communities (β-diversity) was altered by antibiotic treatment, 
as determined by a two-way ANOSIM (P < 0.01) of Bray-Curtis measures; however, the 
comparison R-value was 0.25, indicating that the degree of separation is limited. 
Nevertheless, resistance gene diversity converges with ASP250 treatment, presumably 
because of the selective pressure of the antibiotics (Figure 2.2C). Taken together, these 
results show that feeding antibiotics increases the diversity of resistance genes within an 
individual sample and homogenizes that diversity between treated samples.  
 
Discussion 
We assessed the effect of ASP250 on the swine antibiotic resistome using phylotype, 
metagenomic, and qPCR approaches. The results show that the swine microbiome harbors 
diverse resistance genes even in the absence of selective pressure. Five genes in particular 
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were detected at high frequency in both the medicated and nonmedicated microbiomes. 
These genes could represent a core antibiotic resistome for this cohort of swine. Indeed, it 
was suggested that tet(32) is abundant in farm animals (28), and our data support that 
conclusion for swine. The constant selective pressure of 50 y of in-feed antibiotics appears to 
have established a high background level of resistance in the swine microbiome.  
Antibiotic treatment caused a detectable increase in the abundance of resistance genes 
even above the high background of resistance, and many of these were likely enriched 
because of direct interaction with the antibiotics in ASP250. For example, sulfamethazine 
presumably selected for the sulfonamide resistance genes sul2 or sul1, present in eight of the 
nine medicated samples. Additionally, class A β-lactamases were overrepresented in the 
medicated animals and confer resistance by cleaving such β-lactam antibiotics as penicillin. 
Many of the other enriched resistance genes function by exporting chemicals. Such efflux 
includes but is not limited to antibiotics and may allow bacteria that lack specific resistance 
genes to survive antibiotic pressure. Multidrug efflux is frequently associated with the 
medically alarming issue of multiple-drug resistance and can be found on mobile genetic 
elements (29). In addition to the effects on specific gene families, in-feed antibiotics 
homogenized the richness of resistance genes among individuals over time. The breadth of 
the current study enabled the visualization of this intriguing phenomenon despite the 
tremendous resistance gene heterogeneity across samples.  
One type of resistance, the aminoglycoside O-phosphotransferases, increased in 
abundance with in-feed ASP250, although it does not confer resistance to the antibiotics 
therein. This finding suggests an indirect mechanism of selection, perhaps by co-occurrence 
on mobile elements conferring resistance to ASP250 antibiotics. Ten of the 13 
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phosphotransferases identified in the medicated swine metagenome are homologous (7 of 10 
have 100% amino acid identity) with the streptomycin phosphotransferase on the pO86A1 
plasmid in E. coli O86:H- (accession number YP_788126). Resistance genes aggregate on 
plasmids in response to selective pressure (30), and pO86A1 carries at least two other 
resistance genes (accession number NC_008460). This congregation of resistance genes on 
mobile genetic elements could offer a fitness advantage to a bacterium living in the constant 
presence of antibiotics. However, this would be an undesirable collateral effect of in-feed 
antibiotics because these resistance gene clusters could be transferred to E. coli or other 
potential human pathogens in the swine gut or in the agriculture environment. Regardless of 
the mechanisms of selection, the results show that antibiotic use increased the abundance of 
resistance genes specific to and beyond the administered antibiotics from a diverse pool of 
background resistance genes in the swine microbiome, and that this increase was detectable 
even above a high background of resistance-gene diversity.  
The collateral effects of antibiotics extend beyond influencing resistance genes. 
Statistical analysis of COGs in the swine metagenomes showed that genes encoding 
virulence, gene-transfer, and energy production and conversion functions are selected by in-
feed antibiotics. Specifically overrepresented COGs included some relating to P pilus 
assembly; the P pilus has been described for attachment and virulence in E. coli (31). 
Additional COGs of interest in the medicated metagenome included transposases, which are 
known to participate in the transfer of antibiotic resistance genes (32). These functions could 
enhance the stability and spread of resistance genes in microbial communities. Additionally, 
an increase in the abundance of genes encoding energy production and conversion functions 
could be a factor in growth-promoting properties of at least some antibiotics, but further 
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experiments are required to test this. Antibiotics are thought to improve feed efficiency in 
agricultural animals primarily by decreasing the bacterial load, which is beneficial to the host 
by reducing competition for nutrients and decreasing the host's cost of responding to the 
microbes (2). Analysis of the swine metabolome after antibiotic treatment showed an effect 
on various biosynthetic pathways, including sugar, fatty acid, bile acid, and steroid hormone 
synthesis (33). COGs may therefore be useful signposts for identifying microbes and 
functions important to the performance-enhancing effects of antibiotics like ASP250.  
Changes in microbial functions result from changes in microbial membership, and 
interesting membership shifts were detected. The decrease in Bacteroidetes in the treated 
animals may relate to the growth-promoting benefits obtained from feeding swine ASP250 as 
part of their diets. Obese mice have lower levels of Bacteroidetes relative to Firmicutes in 
their feces compared with lean mice (34). The obese mice have improved energy-harvesting 
capacity, presumably because of this shift, and perhaps this shift is related to improved feed 
conversion in swine. In addition, an increase in E. coli prevalence in response to oral 
antibiotic treatment has been reported for amoxicillin, metronidazole, and bismuth (35), 
metronidazole (36), and vancomycin and imipenem (37) in the mammalian gut microbiota. 
However, amoxicillin plus the β-lactamase inhibitor clavulanic acid administered both in the 
feed and intramuscularly resulted in decreased E. coli in pigs (38), and oral ciprofloxacin 
yielded decreased Proteobacteria populations in humans during treatment (39). These results 
are an important reminder of the varying collateral effects of different antibiotics. E. coli are 
both commensal and pathogenic inhabitants of mammalian gastrointestinal tracts; an increase 
in E. coli could be beneficial or harmful, either to the host or to the food chain. Additionally, 
increased E. coli populations associated with excessive weight gain in pregnant women (40) 
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is an unfavorable result in this host but parallels a potential growth-promoting role for this 
bacterium in livestock. The cost and benefit of a given antibiotic for a desired outcome must 
therefore be carefully weighed.  
Differences among the rarer members of the microbial communities between 
treatment and control animals are less understood and invite further investigation. Of those 
that increased with treatment, members of the Deinococcus-Thermus phylum are known for 
being resistant to environmental stress; these organisms have only recently been identified in 
the human gut (41). In addition, Ruminococcus spp. are common in ruminants and are 
frequently found in the hindgut of pigs (42). Adept at degrading cellulose, an increase in 
Ruminococcus spp. after antibiotic treatment may aid in feed conversion in swine. Taken 
together, the data suggest numerous possibilities for how the swine gut microbiota might be 
involved with the improved feed efficiency afforded by certain in-feed antibiotics.  
 
Conclusions 
The results show that even a low, short-term dose of in-feed antibiotics increases the 
abundance and diversity of antibiotic resistance genes, including resistance to antibiotics not 
administered, and increases the abundance of E. coli, a potential human pathogen. 
Additionally, analysis of the metagenomes implicated functions potentially involved with 
improved feed efficiency. The study design featured environmental control in a single 
uniform inoculum source (the mother), control of the host genetics, no exposure of the sow 
or piglets to antibiotics except for the treatment, and identical diet except for the inclusion of 
ASP250 in one group. Future studies should include other in-feed antibiotics, multiple litters 
of swine with robust replication, and the identification of the antibiotic-induced mechanisms 
43 
 
 
 
 
that lead to increased feed efficiency. Implications of antibiotic resistance on human and 
animal health need to be taken into account when discussing agricultural management 
policies and evaluating alternatives to traditional antibiotics. With the use of antibiotics in 
animal agriculture at a crossroads, studies like this and others that highlight the collateral 
effects of antibiotic use are needed.  
 
Materials and Methods 
 
Swine. 
Six pigs (siblings) were used in this study and were split into two groups of three: a 
group to receive antibiotics and a group to receive no antibiotics. Animals were raised in 
accordance with National Animal Disease Center Animal Care and Use Committee 
guidelines. The rooms housing the pigs were decontaminated before the beginning of the 
study. A pregnant sow was obtained from a hog farm at which she had no prior exposure to 
antibiotics. The piglets shared a pen with the sow for 3 wk after birth; her feces were 
therefore the primary bacterial inocula for the piglets. After weaning, all pigs were fed the 
same diet (TechStart 17–25; Kent Feeds) until the start of the study, at which point the 
medicated pigs were moved to a new clean room and given the above diet but containing 
ASP250 (chlortetracycline 100 g/ton, sulfamethazine 100 g/ton, penicillin 50 g/ton). Freshly 
voided feces were collected from nonmedicated and medicated animals just before treatment 
(medicated and nonmedicated day 0) and 3, 14 and 21 d after treatment.  
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DNA Sequencing. 
Fecal DNA was isolated by bead-beating, and the V3 region of the 16S rRNA gene 
was amplified and sequenced. PCR products were sequenced on a 454 Genome Sequencer 
FLX, using the manufacturer's protocol for FLX chemistry (Roche Diagnostics). For 
sequencing the metagenome, DNA from the feces was pooled by treatment group 
(nonmedicated, medicated) for each time point (day 0, day 14). Day 14 samples were 
sequenced using FLX chemistry and day 0 samples were sequenced using Titanium 
chemistry (Roche Diagnostics).  
 
Phylotype Analysis. 
Only sequences longer than 50 bp were used for phylotype analysis (phylotyping), 
which totaled 133,294 sequences (70,667 unique sequences) from 12 fecal samples. After 
binning the samples by barcode, phylogenetic analysis and taxonomic assignments of the V3 
portion of the 16S rRNA gene were made using the Ribosomal Database project Web tools 
(43). Additional phylotype comparisons and hypothesis testing were performed with the 
software package mothur (44). Bray-Curtis similarity coefficients were calculated from 16S 
rRNA gene sequence data from individual animals at 0 and 14 d and plotted in an NMDS 
graph to show the similarity among samples. MDS plots and analysis of similarities statistical 
tests were done in PAST (45).  
 
Metagenomic Analysis. 
Sequences were dereplicated and analyzed by BLAST against the nonredundant 
database and ARDB (27). The BLAST reports were parsed to extract COG information, and 
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COG frequencies were analyzed in ShotgunFunctionalizeR (46). The ARDB was kindly 
provided by Liu and Pop (27) so that we could perform BLASTx analyses locally. In both 
analyses, differences with P < 0.05 were significant, and the significant COGs were labeled 
with their respective COG category to visualize trends. For ecological analyses, the number 
of hits was normalized to 100,000 submitted reads and analyzed using NMDS and cluster 
analyses with the Bray-Curtis similarity measurement in PAST (45).  
 
Quantitative PCR. 
Primer sets were grouped into 18 resistance types by subjecting all primer sets to the 
ARDB BLAST tool (Supplementary table A4) or by the BLAST tool in the National Center 
for Biotechnology Information when no results were obtained by the ARDB BLAST 
(Supplementary table A5). Quantitative PCR primers, reagents, and DNA samples were 
loaded into six subarrays of OpenArray plates (Applied Biosystems) (47). For each 33 nL 
qPCR reaction, 1 ng of extracted DNA was added as template. Quantitative PCR reagents 
and conditions were preformed as previously described (47). Relative gene copy numbers 
were calculated as follows: gene copy number = 10(26−Ct)/(10/3), where Ct equals the 
threshold cycle (Supplementary table A6). Amplification curves were manually inspected 
using quality control measures. The abundance of the 16S rRNA gene was determined (48), 
and E. coli was quantified by using a uidA primer set (49). Copy numbers of the uidA and 
16S rRNA genes were calculated in relation to a standard curve, which was generated by 
using 10-fold dilutions of 108 to 100 copies as template, in triplicate reactions. Those 
reactions targeting 16S rRNA and uidA were performed separately from the OpenArray 
platform.  
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Statistical Analysis of qPCR Results: Abundance and Diversity. 
All qPCR data were normalized between samples by dividing the gene copy number 
by 16S rRNA copy number and subsequently natural log-transformed to achieve normal 
distribution. A repeated-measures ANOVA model was used to determine if treatment or time 
was significantly related to the abundance of antibiotic resistance genes and Shannon 
diversity in different samples. The best covariance structure of the residuals for each 
response variable was determined and used for repeated measures ANOVA testing (SAS 
v9.2; SAS Institute). A Bonferroni adjustment was not used in the comparison of resistance 
genes or resistance gene types because of excessive reduction in power of tests; therefore, the 
reported P values were not corrected for multiple comparisons.  
Shannon diversity was calculated using PAST ver. 1.87 (45) using data normalized 
between samples (resistance gene copy number/16S rRNA gene copy number). Bray-Curtis 
coefficients were calculated for each of the samples using the natural log-transformed data 
(50). A two-way ANOSIM was calculated using these data, considering treatment and time 
as the two factors. Two-way ANOSIM analysis and NMDS plots were completed using the 
Bray-Curtis measure for β-diversity.  
 
Acknowledgments 
The authors thank Sam Humphrey, Uri Levine, and Lea Ann Hobbs for technical 
support; Vince Young for helpful conversations; the Michigan State University Crop and Soil 
Science statistical consultation center for statistical advice; and Rich Zuerner and Tom Casey 
for comments on the manuscript. The Michigan State University research was initiated under 
47 
 
 
 
 
a grant from Reservoirs of Antibiotic Resistance and was supported by Michigan State 
University's Pharmaceuticals in the Environment Initiative.  
 
Data deposition: The sequence reported in this paper has been deposited in the GenBank 
database (accession no. SRP004660).  
References: 
1.  Cromwell GL (2002) Why and how antibiotics are used in swine production. Anim  
Biotechnol 13:7–27. 
 
2.  Dibner JJ, Richards JD (2005) Antibiotic growth promoters in agriculture: History 
and mode of action. Poult Sci 84:634–643. 
 
3.  Lipsitch M, Singer RS, Levin BR (2002) Antibiotics in agriculture: When is it time to 
close the barn door? Proc Natl Acad Sci USA 99:5752–5754. 
 
4.  Levy SB (1978) Emergence of antibiotic-resistant bacteria in the intestinal flora of 
farm inhabitants. J Infect Dis 137:689–690. 
 
5.  Aarestrup FM, Wegener HC (1999) The effects of antibiotic usage in food animals on 
the development of antimicrobial resistance of importance for humans in 
Campylobacter and Escherichia coli. Microbes Infect 1:639–644. 
 
6.  Allen HK, et al. (2010) Call of the wild: Antibiotic resistance genes in natural 
environments. Nat Rev Microbiol 8:251–259. 
 
7.  Sommer MO, Dantas G, Church GM (2009) Functional characterization of the 
antibiotic resistance reservoir in the human microflora. Science 325:1128–1131. 
 
8.  Martinez JL, et al. (2009) A global view of antibiotic resistance. FEMS Microbiol 
Rev 33:44–65. 
 
9.  Götz A, et al. (1996) Detection and characterization of broad-host-range plasmids in 
environmental bacteria by PCR. Appl Environ Microbiol 62:2621–2628. 
 
10.  Salyers AA, Amábile-Cuevas CF (1997) Why are antibiotic resistance genes so 
resistant to elimination? Antimicrob Agents Chemother 41:2321–2325. 
 
11.  Stanton TB, Humphrey SB (2011) Persistence of antibiotic resistance: Evaluation of a 
probiotic approach using antibiotic-sensitive Megasphaera elsdenii strains to prevent 
48 
 
 
 
 
colonization of swine by antibiotic-resistant strains. Appl EnvironMicrobiol 77:7158–
7166. 
 
12.  Stanton TB, Humphrey SB, Stoffregen WC (2011) Chlortetracycline-resistant 
intestinal bacteria in organically raised and feral Swine. Appl Environ Microbiol 
77:7167–7170. 
 
13.  Martínez JL (2008) Antibiotics and antibiotic resistance genes in natural 
environments. Science 321:365–367. 
 
14.  US Department of Health and Human Services, Food and Drug Administration, and 
Center for Veterinary Medicine (2010) Draft guidance #209. Available at 
http://www.fda.gov/downloads/animalveterinary/guidancecomplianceenforcement/ 
guidanceforindustry/ucm216936.pdf. Accessed October 12, 2010. 
 
15.  The Infectious Diseases Society of America (2010) Antibiotic resistance: Promoting 
judicious use of medically important antibiotics in animal agriculture. Presentation 
before the House Committee on Energy and Commerce Subcommittee on Health. 
www.idsociety.org/WorkArea/DownloadAsset.aspx?id=16796. 
 
16.  Zoetendal EG, Cheng B, Koike S, Mackie RI (2004) Molecular microbial ecology of 
the gastrointestinal tract: From phylogeny to function. Curr Issues Intest Microbiol 
5:31–47. 
 
17.  Karami N, et al. (2007) Transfer of an ampicillin resistance gene between two 
Escherichia coli strains in the bowel microbiota of an infant treated with antibiotics. J 
Antimicrob Chemother 60:1142–1145. 
 
18.  Shoemaker NB, Vlamakis H, Hayes K, Salyers AA (2001) Evidence for extensive 
resistance gene transfer among Bacteroides spp. and among Bacteroides and other 
genera in the human colon. Appl Environ Microbiol 67:561–568.  
 
19.  Leverstein-van Hall MA, et al. (2002) Evidence of extensive interspecies transfer of 
integron-mediated antimicrobial resistance genes among multidrug-resistant 
Enterobacteriaceae in a clinical setting. J Infect Dis 186:49–56. 
 
20.  Barbosa TM, Scott KP, Flint HJ (1999) Evidence for recent intergeneric transfer of a 
new tetracycline resistance gene, tet(W), isolated from Butyrivibrio fibrisolvens, and 
the occurrence of tet(O) in ruminal bacteria. Environ Microbiol 1:53–64. 
 
21.  Stanton TB, Humphrey SB (2003) Isolation of tetracycline-resistant Megasphaera 
elsdenii strains with novel mosaic gene combinations of tet(O) and tet(W) from 
swine. Appl Environ Microbiol 69:3874–3882. 
 
49 
 
 
 
 
22.  Li X, Wang HH (2010) Tetracycline resistance associated with commensal bacteria 
from representative ready-to-consume deli and restaurant foods. J Food Prot 
73:1841–1848. 
 
23.  Wang Y, Wang GR, Shoemaker NB, Whitehead TR, Salyers AA (2005) Distribution 
of the ermG gene among bacterial isolates from porcine intestinal contents. Appl 
Environ Microbiol 71:4930–4934. 
 
24.  Ley RE, Lozupone CA, Hamady M, Knight R, Gordon JI (2008) Worlds within 
worlds: Evolution of the vertebrate gut microbiota. Nat Rev Microbiol 6:776–788. 
 
25.  Lamendella R, Domingo JW, Ghosh S, Martinson J, Oerther DB (2011) Comparative 
fecal metagenomics unveils unique functional capacity of the swine gut.BMC 
Microbiol 11:103. 
 
26.  Glass EM, Wilkening J, Wilke A, Antonopoulos D, Meyer F (2010) Using the 
metagenomics RAST server (MG-RAST) for analyzing shotgun metagenomes. Cold 
Spring Harb Protoc 2010:pdb prot5368. Available at http://cshprotocols.cshlp.org/. 
 
27.  Liu B, Pop M (2009) ARDB—Antibiotic Resistance Genes Database. Nucleic Acids 
Res 37 (Database issue):D443–D447. 
 
28.  MelvilleCM, ScottKP,Mercer DK, FlintHJ (2001)Novel tetracycline resistance gene, 
tet(32), in the Clostridium-related human colonic anaerobe K10 and its transmission 
in vitro to the rumen anaerobe Butyrivibrio fibrisolvens. Antimicrob Agents 
Chemother 45:3246–3249. 
 
29.  Martinez JL (2009) The role of natural environments in the evolution of resistance 
traits in pathogenic bacteria. Proc Biol Sci 276:2521–2530. 
 
30.  Barlow M (2009) What antimicrobial resistance has taught us about horizontal gene 
transfer. Methods Mol Biol 532:397–411. 
 
31.  Sauer FG, Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ (2000) Bacterial pili: 
Molecular mechanisms of pathogenesis. Curr Opin Microbiol 3:65–72. 
 
 
32.  Lupski JR (1987) Molecular mechanisms for transposition of drug-resistance genes 
and other movable genetic elements. Rev Infect Dis 9:357–368. 
 
33.  Antunes LC, et al. (2011) Effect of antibiotic treatment on the intestinal metabolome. 
Antimicrob Agents Chemother 55:1494–1503. 
 
34.  Turnbaugh PJ, et al. (2006) An obesity-associated gut microbiome with increased 
capacity for energy harvest. Nature 444:1027–1031. 
50 
 
 
 
 
 
35.  Antonopoulos DA, et al. (2009) Reproducible community dynamics of the 
gastrointestinal microbiota following antibiotic perturbation. Infect Immun 77:2367–
2375. 
 
36.  Pélissier MA, et al. (2010) Metronidazole effects on microbiota and mucus layer 
thickness in the rat gut. FEMS Microbiol Ecol 73:601–610. 
 
37.  Manichanh C, et al. (2010) Reshaping the gut microbiome with bacterial 
transplantation and antibiotic intake. Genome Res 20:1411–1419. 
 
38.  Thymann T, et al. (2007) Antimicrobial treatment reduces intestinal microflora and 
improves protein digestive capacity without changes in villous structure in weanling 
pigs. Br J Nutr 97:1128–1137. 
 
39.  Dethlefsen L, Huse S, SoginML, RelmanDA(2008) Thepervasive effects of an 
antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. 
PLoS Biol 6:e280. 
 
40.  Santacruz A, et al. (2010) Gut microbiota composition is associated with body 
weight, weight gain and biochemical parameters in pregnant women. Br J Nutr 
104:83–92. 
 
41.  Bik EM, et al. (2006) Molecular analysis of the bacterial microbiota in the human 
stomach. Proc Natl Acad Sci USA 103:732–737. 
 
42.  Rincon MT, et al. (2007) A novel cell surface-anchored cellulose-binding protein 
encoded by the sca gene cluster of Ruminococcus flavefaciens. J Bacteriol 189:4774–
4783. 
 
43.  Cole JR, et al. (2009) The Ribosomal Database Project: Improved alignments and 
new tools for rRNA analysis. Nucleic Acids Res 37(Database issue):D141–D145. 
 
44.  Schloss PD, et al. (2009) Introducing mothur: Open-source, platform-independent, 
community-supported software for describing and comparing microbial communities. 
Appl Environ Microbiol 75:7537–7541. 
 
45.  Hammer Ø, Harper DAT, Ryan PD (2001) PAST: Paleontological statistics software 
package for education and data analysis. Palaeontol Electronica 4:9. 
 
46.  Kristiansson E, Hugenholtz P, Dalevi D (2009) ShotgunFunctionalizeR: An R-
package for functional comparison of metagenomes. Bioinformatics 25:2737–2738. 
 
47.  Stedtfeld RD,etal. (2008)Developmentandexperimental validationofapredictive 
threshold cycle equation for quantification of virulence and marker genes by high-
51 
 
 
 
 
throughput nanoliter-volume PCR on the OpenArray platform. Appl Environ 
Microbiol 74:3831–3838. 
 
48.  Leigh MB, et al. (2007) Biphenyl-utilizing bacteria and their functional genes in a 
pine root zone contaminated with polychlorinated biphenyls (PCBs). ISME J 1:134–
148. 
 
49.  Srinivasan S, Aslan A, Xagoraraki I, Alocilja E, Rose JB (2011) Escherichia coli, 
enterococci, and Bacteroides thetaiotaomicron qPCR signals through wastewater and 
septage treatment. Water Res 45:2561–2572. 
 
50.  Anderson MJ, Ellingsen KE, McArdle BH (2006) Multivariate dispersion as a 
measure of beta diversity. Ecol Lett 9:683–693. 
 
  
52 
 
 
 
 
Figure 2.1.  Shifts in fecal bacterial community membership with antibiotic treatment. (A) 
NMDS analysis of Bray-Curtis similarity coefficients calculated from 16S rRNA gene 
sequence data from individual animals at days 0 and 14 shows the similarity among replicate 
pig fecal samples. (B) Phylum-level composition of fecal microbial communities. Data were 
pooled for a given treatment and time point and are shown as percentage of abundance. (C) 
Genus-level composition of Proteobacteria, shown as the total number of sequences 
(normalized to 50,000 total reads). (D) Predicted genera of COG3188 homologs found in the 
swine metagenomes based on BLASTx analysis. COG3188 was overrepresented in the 
medicated metagenome vs. the nonmedicated metagenomes.  
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Figure 2.2.  Changes in diversity and abundance of antibiotic resistance genes (ARG) in 
swine feces with antibiotic treatment. (A) Metagenomes were analyzed by BLASTx against 
the ARDB, and the number of reads were normalized to 100,000 total reads per metagenome. 
(B) Differences in the abundance of resistance genes were assessed by calculating the ratio of 
resistance gene copy number (ARG) to 16S rRNA gene copy number per sample as detected 
by qPCR. Columns denoted by the same letter are not statistically significant (P > 0.05) 
within each resistance type. Error bars represent the SEM. (C) Bray-Curtis similarity 
coefficients were calculated from qPCR-derived resistance gene abundance data and plotted 
in a multidimensional scaling graph. The distance between points indicates the degree of 
difference in the diversity of resistance genes between samples. The medicated sample 
outlier (square) is from one medicated pig on day 21. Measures for day 0 samples are not 
shown.  
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Table 2.1.  Antibiotic resistance genes differentially represented (P < 0.05) in the medicated vs. nonmedicated pig fecal samples as 
detected by metagenomics [number of sequences in the medicated (n = 1) vs. nonmedicated (n = 3) metagenomes per resistance 
gene] and qPCR (gene copy number/16S rRNA gene copy number) during the treatment period  
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CHAPTER 3. SWINE MICROBIAL COMMUNITIES SUBDIVIDED BY 
INTESTINAL LOCATIONS AND ANTIBIOTICS 
Looft T., Allen H.K., Stanton T. B. 
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Abstract 
Bacteria residing in the mammalian intestinal tract benefit from nutrient-rich feed and 
host-provided nutrients while assisting the host with digestion. Along the mucosa, bacteria 
are in close contact with the host and are important in the modulation of host health. 
Antibiotics are used to treat disease, prevent disease, and improve feed efficiency in swine, 
and have unknown effects on the spatial structure of bacterial communities on the mucosa 
and along intestinal tract. In this study, bacterial communities from specific gut locations 
were characterized to evaluate the effects of in-feed antibiotics on the bacterial spatial and 
functional diversity in the swine intestinal tract. Three-month-old swine were fed a diet 
containing performance-enhancing antibiotics (chlortetracycline, sulfamethazine, and 
penicillin [known as ASP250]), and after necropsies, tissue and lumen samples were 
collected from intestinal locations (ileum, cecum and colon) and feces. We used phylogenetic 
and metagenomic approaches to evaluate the spatial distribution of and the impact of 
antibiotics on the swine gut microbiota. Operational taxonomic unit (OTU) analysis revealed 
dramatic differences related to gut location and divergence of antibiotic-fed animals from 
those from control animals. While the ileum contents had minimal diversity (dominated by 
Firmicutes), the mucosa and other intestinal locations harbored diverse communities of 
microbes. A subset of organisms was found only on the tissue samples; these may be 
mucosal specialists. Antibiotic exposure lead to increased abundance of some antibiotic 
resistance genes, many which occur on plasmids, and genes associated with bacterial 
metabolism. Additionally, pigs receiving in-feed antibiotics had lower levels of many genera, 
but some did increased, including Escherichia and Erysipelothrix, both potential human and 
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animal pathogens. The results from this study demonstrate localized adaptations of microbial 
communities and function, and underscore the collateral effects of in-feed antibiotics. 
  
Introduction  
The mammalian gastrointestinal tract is a heterogeneous ecosystem with distinct, 
stratified environments. Along the length of the intestinal tract, resident bacteria benefit from 
nutrient-rich digesta, assisting the host in starch digestion and vitamin synthesis (Bird et al 
2010). Factors such as nutrient availability, pH, redox potential, and peristalsis strongly 
influence the composition of bacterial communities in the intestinal tract (Hao and Lee 
2004). Along the host mucosa, a subpopulation of bacteria thrive on host-provided nutrients, 
such as mucin and dead epithelial cells (Ashida et al 2012). Some of these bacteria are 
attached to the tissue while others burrow into the mucus layer. These mucosa-associated 
bacterial communities have been shown to differ from those in the intestinal contents 
(Zoetendal et al 2002), and those differences vary across the intestinal tract (Hill et al 2010). 
Because bacteria along the mucosa are in close contact with the host, it is important to define 
these bacteria, their functions, and their products. Key microbial features could be important 
in the modulation of host health, specifically regarding changes associated with diet, such as 
antibiotics or alternative “growth promotants”.   
The spatial distribution of intestinal bacteria can be thought of as existing along two 
axes, a longitudinal axis (proximal to distal) and a radial axis (lumen to the mucosa) 
(Takahashi and Sakaguchi 2006), both of which serve to differentiate the nutrient and 
bacterial distribution. The human colon may harbor as many as 1,000 bacterial species, with 
1011 cells per gram of feces (Whitman et al 1998), whereas studies of the small intestine 
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commensal bacterial showed much lower diversity (species richness and abundance) and cell 
densities (Booijink et al 2010). Previous studies looking at the radial organization in the 
mouse colon showed an enrichment of Firmicutes spp. on the mucosa, and an enrichment of 
Bacteroidaceae, Enterococcaceae and Lactobacillaceae spp. in the lumen (Nava et al 2011).  
In pigs with necrotizing entercolitis, more Clostridium spp. were associated with the ileal 
mucosa than in healthy pigs (Azcarate-Peril et al 2011). Observations like these illustrate the 
need to include spatial distribution when describing bacteria in the gut to better understand 
their niches and how they impact host health and performance.   
Antibiotics are used in livestock to treat disease, prevent disease, and improve feed 
efficiency (Cromwell 2002, Dibner and Richards 2005). Studies looking at shifts in microbial 
communities with in-feed antibiotics have detected shifts in bacterial membership and 
functions in swine feces (Allen et al 2011, Looft et al 2012), but don’t shed light on localized 
communities in the gut. While bacterial numbers are highest in the feces, they may not be 
representative of the upstream intestinal tract (Nielsen et al 2003). Feces often serve as a 
proxy for the gut microbiota because they can be harvested readily and frequently, but fecal 
bacteria are a mix of potentially discrete upstream populations. Direct sampling of specific 
gut locations allows for differentiation of sub-communities of the gut microbiota, potentially 
revealing how performance-enhancing antibiotics affect bacterial taxa in these micro-
habitats. Microscopic changes in the bacteria along the ileal, cecal, and colonic epithelium 
have been shown in chicks receiving in-feed antibiotics (Chichlowski et al 2007). 
Understanding how in-feed antibiotics affect the membership and functional distribution of 
mucosal bacteria may inform alternatives to antibiotics that mimic these changes.   
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In this study we examined the longitudinal and radial distribution of bacterial 
communities in the swine intestine. Within both axes there exists many micro-habitats and 
niches both in the lumen and mucosa, but for comparisons we present them here as distinct, 
singular communities. To this end, we characterized the bacterial membership and functions 
at three gut locations using phylotype and metagenomic analyses. Additionally, the effect of 
the in-feed antibiotic ASP250 was evaluated. The results show dramatic differences in the 
longitudinal and radial compositions of bacterial communities in the swine intestinal tract. 
The mucosa-associated communities were diverse, with as much species richness or greater 
than that found in the lumen. Pigs receiving in-feed antibiotics had higher levels of particular 
gut bacteria, including some that were specific to the mucosa. Additionally, antibiotic 
exposure lead to increased abundance of genes that confer resistance to certain antibiotics 
and of genes associated with bacterial metabolism.  
 
Methods  
Swine.   
Piglets were acquired and managed as previously described (Allen et al 2011).  
Briefly, piglets were divided into two groups of six at approximately three-months-old, with 
equal representation of littermates and gender. All pigs were fed the same diet (TechStart® 
17-25, Kent Feeds, Muscatine, IA) until the start of the experiment, at which point six control 
pigs continued to receive TechStart while the other group received TechStart containing 
ASP250 (chlortetracycline 100 g/ton, sulfamethazine 100 g/ton, penicillin 50 g/ton) ad 
libitum until euthanization.   
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Between 15 and 20 weeks of age, each animal was euthanized by intracardiac 
injection of sodium pentobarbital (26% solution containing 1 ml/4.5 kg Sleepaway; Fort 
Dodge Laboratories, Overland Park, KS) after being anesthetized with an intramuscular 
injection of a cocktail of ketamine (8 mg/kg), xylazine (4 mg/kg), and Telazol (6 mg/kg, Fort 
Dodge Animal Health, Fort Dodge, IA), in accordance with National Animal Disease Center 
Animal Care and Use Committee guidelines. Three sections of the GI tract (the ileum, the 
cecum, and the mid-colon) were harvested immediately after euthanasia. The sections were 
tied off by string ligatures and placed on ice for transport to the lab. With each intestinal 
sample, a both a tissue and a lumen-content sample was taken for DNA extraction. Tissues 
were washed by gently flowing sterile phosphate-buffered saline (PBS) across the tissue until 
no contents were visible but attached bacteria remained. A sterile glass microscope slide was 
used to scrape any attached bacteria off of the surface for DNA extractions. These tissue 
scrapings plus corresponding gut contents and feces were collected from each pig, and DNAs 
were extracted using the manufacturer’s protocol with the UltraClean Soil DNA Isolation Kit 
(Mo Bio Laboratories, Solana Beach, CA, USA).      
 
16S rRNA gene sequence analysis.  
Amplification of the V1-V3 region of bacterial 16S rRNA genes was carried out as 
previously described (Allen et al. 2011). Briefly, the conserved primers 8F (5′-
AGAGTTTGATCCTGGCTCAG) (Weisburg et al 1991) and 518R (5′-
ATTACCGCGGCTGCTGG) (Muyzer et al 1993) were designed with attached eight-
nucleotide unique sequence barcodes (Allen et al 2011, Hamady et al 2008). PCRs were 
performed with 22 cycles, and products were separated by gel electrophoresis and purified 
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using the MinElute kit (Qiagen Inc., Valencia, CA).  They were then sequenced on a 454 
Genome Sequencer (GS) FLX using the manufacturer’s protocol for Titanium chemistry 
(Roche Diagnostics, Branford, CT).    
 
Phylotype analysis.  
Sequence data were processed per Roche’s protocols, followed by AmpliconNoise 
(Quince et al 2011), mothur (Schloss et al 2009, Schloss et al 2011), and Uchime (Edgar et al 
2011) to remove barcodes and reduce sequence artifacts produced during PCR and 
sequencing.  Uchime was implemented in mothur (Schloss et al 2009). OTU-based 
phylogenetic analysis (97% similarity cutoff) and hypothesis testing were performed with 
normalized data in mothur (Schloss et al 2009).  To visualize changes in bacterial diversity, a 
nonmetric multidimensional scaling (NMDS) plot and dendogram of these data using the 
Bray-Curtis index of OTUs was calculated in PAST (Hammer et al 2001). The estimated 
total richness of operational taxonomic units was calculated by Catchall (Bunge 2011) within 
mothur. The bacterial richness estimate resulting from the best parametric model was 
reported for each sample. Taxonomic assignments of the 16S rRNA gene sequences were 
made using the Ribosomal Database project (RDP) web tools (Cole et al 2009). The 
Metastats statistical software was used for making comparisons between samples and 
identifying trends (White et al 2009). A p-value less than 0.05 with a q-value (false discovery 
rate) less than 0.05 was considered significant and R between 0-0.3 was considered a slight 
correlation while R greater than 0.3 was considered a correlation.                              
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Metagenomic analysis. 
  DNAs from feces and gut contents (of the ileum, cecum, and midcolon) were 
sequenced on Roche’s GS-FLX instrument (Roche Diagnostics) and processed as described 
previously (Allen et al 2011). Four samples from each of 12 pigs, minus samples from four 
pigs that were missing either ileal or fecal material, yielded 44 total DNA samples. These 
samples were divided across four regions of two Titanium plates.  DNA sequences were de-
replicated (Gomez-Alvarez et al 2009) and analyzed using the metagenomic and BLASTx 
pipelines in CAMERA (https://portal.camera.calit2.net, (Seshadri et al 2007)). Additionally, 
metagenomes were blasted in-house against the antibiotic resistance genes database (Liu and 
Pop 2009) as described previously (Looft et al 2012). Frequency counts of all functional data 
were normalized to the lowest total number of open reading frames (clusters of orthologous 
groups [COGs]), of assigned reads (SEED subsystems), or of bacterial reads (resistance 
genes) among the 44 metagenomes. Normalized datasets were tabulated and analyzed for 
patterns (e.g. cluster analyses and ANOSIM) in PAST (Hammer et al 2001). Additionally, 
STAMP (Parks and Beiko 2010) was used to make statistical comparisons between samples. 
Because the metagenomic samples might not be independent (e.g. the ileum contents move 
downstream to become the cecal contents), the Kruskal-Wallis H-test was used rather than 
ANOVA, followed by the Games-Howell post-hoc test and Storey’s FDR multiple 
comparison correction (Parks and Beiko 2010). Finally, COGs were further scrutinized by 
the Poisson distribution using the po.stat function in ShotgunFunctionalizeR (Kristiansson et 
al 2009). To draw statistical conclusions, the following cut-offs indicated:  0.5< P ≤0.1, 
trend; P≤0.05, significance; R=0-0.3, slight correlation; R=0.3-0.5, medium correlation.                             
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Results and discussion 
Swine intestinal bacterial diversity exhibits radial specificity.  
The overall bacterial diversity included common intestinal bacterial groups, 
dominated by Firmicutes (35%), Bacteroidetes (21%), Proteobacteria (3%), and 
Spirochaetes (2%), as shown previously in pigs (Allen et al 2011, Lamendella et al 2011, 
Looft et al 2012). Bacterial communities with either tissue or lumen association were 
different. Of the differences that were statistically significant, only three genera were found 
at higher levels in the lumen (Erysipelothrix, Anaerovorax, and Oxalobacter [p<0.01]) than 
on the mucosa (Figure 3.1). Erysipelothrix, includes E. rhusiopathiae, the etiological agent of 
swine erysipelas and causes opportunistic infections in humans, both resulting in major 
economic costs (Shimoji 2000). It is noteworthy that most intestinal bacteria identified from 
the lumen were also found on the mucosa, suggesting that the ability to occupy the mucosa is 
shared by most gut microbes.  
Although most lumen-associated microbes were also found on the mucosa, some 
notable organisms were found in greater abundance on the mucosa. Exclusive mucosa-
associated bacteria included Pseudomonas, Campylobacter, Bradyrhizobium, Weissella, and 
Sutterella (p<0.01) (Figure 3.1). Pseudomonas spp., for example, are well adapted to 
colonize the mucosa, including by degrading mucin (Aristoteli and Willcox 2003, Tsang et al 
1994). Pseudomonas spp. have been identified in human intestinal studies at low levels 
(Shinohara et al 2010), and colonize other mucosal surfaces in the human (Aristoteli and 
Willcox 2003). Campylobacter spp., which are common intestinal bacteria in the pig and 
common foodborne pathogens of humans, can effectively penetrate the mucus layer of the 
mucosa with its corkscrew motility to reach the epithelial layer (On 1996). The lactic acid 
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bacteria Weissella spp. and the bile-degrading Sutterella spp. have both been isolated from 
the human intestinal mucosa (Green et al 2006, Heilig et al 2002), suggesting that these 
genera are broadly specific to mucosal surfaces across mammals. Many of these mucosal 
colonizers are not dominant members of the gut community, but rather are part of a milieu of 
specialized intestinal bacteria that have adapted to colonize the mucosa. Studies that focus on 
fecal bacterial communities miss these subpopulations that were only captured by direct 
sampling of the mucosa.  
 
Distinct radial differences in the ileum.  
By additionally taking the gut location into account when examining radial diversity, 
the ileum in particular revealed striking differences between the bacterial communities of the 
lumen and mucosa. Only 15 OTUs (±5) were detected in the lumen compared to 252 OTUs 
(±115) associated with the host tissue at the same ileal location. This is likely in part because 
of both the low digesta retention time in the small intestine and the low bacterial diversity 
coming out of the stomach. The difference between the richness of the tissue and lumen 
communities at the other gut locations was not significant, and the luminal richness at these 
locations was higher than in the lumen of ileum (741 OTUs (±370)). Although the ileal 
lumen supported limited diversity, the bacterial richness of the mucosa reflected that seen in 
the other intestinal sections (Figure 3.2B). 
The elevated richness (membership) on the ileal mucosa compared to the lumen, and 
the high richness found on the other mucosal sites, may be important for intestinal function 
and health. In most cases, the mucosal samples contained a similar collection of genera as the 
corresponding lumen section. The richness of the ileum mucosa, however, more closely 
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resembled the mucosa at other locations than the adjacent lumen. By providing a rich 
environment for bacteria, the mucosa may provide the bacterial inoculum needed to aid in the 
breakdown of non-digested food substrates (Williams et al 2011). Savage (1987) proposed 
that the mucosal bacterial populations in the gut both stabilize the intestinal community and 
prevent pathogens by providing a constant, established inoculum for the lumen to complete 
digestion.  Our data show comparable richness on the mucosa and in the lumen, suggesting 
that Savage’s hypothesis is worth further investigation. Further research is needed to evaluate 
the importance of mucosal colonization as it relates to the gut ecosystem, intestinal function, 
and host health.         
 
Bacterial membership and functions exhibit longitudinal specificity.  
The small intestine and colon have considerably different physiological functions, 
and their respective bacterial communities reflect these differences. Analysis of the 
longitudinal differences of the bacterial phyla within each sampled intestinal section shows 
phylum-level differences between the ileum and the cecum, colon, and feces (Figure 3.2a). 
Finer resolution of the longitudinal + radial differences shows genus-level differences across 
lumen and mucosa of the sampled intestinal locations (Figure 3.2b). Members of the 
Synergistetes phylum were identified in each intestinal section, and increased in each 
subsequent section; ileum < cecum (P < 0.001, q= 0.001), cecum < mid-colon (P < 0.001, 
q=0.024). Synergistetes have been identified in a diverse range of anaerobic environments, 
but have few cultured representatives (Vartoukian et al 2007). Synergistetes have previously 
been identified in the intestinal tract of mammals, but their role in the gut is not known 
(Marchandin et al 2010). Additionally, species-level analyses of operational taxonomic units 
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(OTUs) revealed significant differences related to gut location (P<0.01, R=0.65). The ileal 
contents (both control and medicated) showed reduced diversity (richness and abundance) 
when compared to the rest of the intestinal tract communities (Figure 3.3a). Differences were 
driven by the dominance of members of the Firmicutes phylum (Clostridium and 
Turicibacter) in the ileum and various genera in the colon (Prevotella, Oscillibacter, and 
Succinivibrio).   
Analysis of the metagenomes further supported the longitudinal stratification of gut 
bacteria, showing the ileum metagenomes to be particularly different.  Indeed, more ileal 
contents sequences were annotated as eukaryotic (37 % ±19%) than in any of the other 
locations (remaining samples were < 1%) (Supplementary figure B1), reinforcing the limited 
bacterial richness detected in the ileum by the 16S rRNA sequence analysis. When all of the 
various COG data were reduced into single datapoints per metagenome, the richness of 
COGs in the ileum separated from those of the other gut locations in a pattern consistent with 
the bacterial membership (Figure 3.3b, Figure 3.3c). Significant drivers of the functional 
differences included increased abundance of respiration and amino acid SEED subsystems in 
the ileum.  Interestingly, the stress response subsystem increased in abundance from ileum to 
feces (R2=0.31, Supplementary figure B2), suggesting that the gut environment becomes less 
hospitable for bacteria towards its distal end.  
The effect of antibiotics on bacterial community structure and function.  
Many changes were detected in the membership and functions of the bacterial 
communities across all intestinal locations with antibiotic treatment. Analysis of the 
community structure at the 0.03 OTU level indicated divergence of the antibiotic-fed swine 
microbiota from the non-medicated swine microbiota (P < 0.01, R=0.21) (Figure 3.4). The 
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phyla that changed after exposure to antibiotics were the Spirochaetes, Synergistetes, 
Planctomycetes, Fibrobacteres, TM7, and Actinobacteria decreasing with antibiotic 
treatment (p<0.01) and Tenericutes increasing with treatment (p<0.01). Many genera 
decrease with exposure to antibiotics, including Treponema, Succinivibrio, Streptococcus, 
Parasporobacterium, and Anaerovorax (p<0.01). Certain genera increased with antibiotic 
treatment, such as Escherichia, Lachnobacterium, Tannerella, Anaeroplasma, and 
Erysipelothrix spp. (p<0.01) (Figure 3.5). Lachnobacterium spp. increase in both the lumen 
and mucosa with antibiotics and is known to produce bacteriocins (antimicrobial compounds) 
and butyrate, the latter of which is an energy source for colonic epithelial cells. For this 
reason, Lachnobacterium spp. have been considered as a potential direct-fed microbial for 
use in livestock production (McAllister et al 2011).   
Shifts in E. coli populations with ASP250 and other antibiotics have been previously 
shown (Allen et al 2011, Looft et al 2012). Erysipelothrix spp. isolated from swine have been 
identified harboring resistance genes, including tetracycline (Yamamoto et al 2001). 
Tannerella spp. have been associated with periodontal disease in humans and form biofilms 
in the presence of mucin, which may impart some resistance to antibiotics (Roy et al 2011).   
 Bacterial functions showed congruent separation by antibiotic treatment as was seen 
in phylotype analysis (Figure 3.3c). Among the COGs assigned to individual metagenomes, 
112 were differentially expressed with antibiotic treatment (83 higher in the medicated and 
29 higher in the non-medicated) (Figure 3.6). The COG categories C (energy production and 
conversion), G (carbohydrate transport and metabolism), M (cell wall/membrane/envelope 
biogenesis), P (inorganic ion transport and metabolism), and S (function unknown) were all 
overrepresented in the significant COGs of the medicated animals (Figure 3.6). The 
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prevalence of these COGs in the medicated animals suggests a more active microbiota, with 
more “tools” to exploit the available nutrients in the gut. Numerous studies have 
demonstrated the many host benefits of bacterial fermentation within the gut (Hooper et al 
2002, Sunkara et al 2011).  The COG category C genes are associated with in feed antibiotics 
in swine, and may indirectly benefit the host (Looft et al 2012).  Categories G and M are both 
associated with transport and metabolism and point to increased microbial activity.    
 
The effect of in-feed antibiotics is measurable at discrete gut regions.  
Some antibiotic effects are location specific. After antibiotic treatment, Helicobacter 
spp. were reduced to non-detectable levels in the cecum (p<0.01) while Holdemania spp. 
increased in the cecum (p<0.01) and along the mucosa (p<0.01). Helicobacter spp. have been 
associated with livestock disease (Dewhirst et al 2000, Kirkbride et al 1985) and cecal 
colonization of laboratory animals (Fox and Lee 1997). The reduction in Helicobacter spp. in 
the intestine may benefit the host by reducing inflammation along the mucosa. Holdemania is 
related to Erysipelothrix according to 16S rRNA gene analysis (Willems et al 1997) and was 
shown to be enriched on the chicken cecal mucosa (Gong et al 2002). Holdemania spp. have 
a unique murein type as part of their cell wall structure, which may contribute to insensitivity 
to penicillin (one of the antibiotics in ASP250) (Willems et al 1997).   
 
Antibiotic resistance gene diversity.  
Diverse antibiotic resistance genes were detected in both ASP250 treated and non-
treated animals, with 213 different resistance genes detected across all metagenomes. Among 
the antibiotic resistance genes found, 12 were higher in the medicated metagenomes and 
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eight were higher in the control metagenomes (Table 3.1) (p<0.05). Six genes were 
previously identified as increasing in abundance in a study of four metagenomes from swine 
receiving in-feed antibiotics (Looft et al 2012). Additional resistance genes that were higher 
in the medicated metagenomes included genes conferring resistance to chloramphenicol, 
cephalosporins, penicillins, and aminoglycosides. Penicillin antibiotics are part of the ASP 
250 cocktail, and the direct selection for penicillin resistance genes is a likely outcome. 
Chloramphenicol and aminoglycoside resistance in E. coli has been shown to be co-selected 
in swine (Rosengren et al 2007). Previous studies have also found cephalosporin resistance in 
swine intestinal bacteria, including E. coli and Salmonella (Kijima-Tanaka et al 2003, 
Winokur et al 2000). Cephalosporin use in agriculture has recently received attention. The 
FDA has proposed rules limiting the “off label” use of cephalosporin drugs in animal 
agriculture because it is used in human health, and drug resistance is a concern.  
 
Conclusions 
These results highlight the spatial distribution of bacterial communities in the mucosa 
and lumen of the intestinal tract. The spatial distribution of bacterial membership and 
function points to the localized adaptations of commensal bacteria. Although adjacent in the 
gut, the microbiota of the ileum differs drastically from that of the cecum and colon. All 
mucosa locations harbored diverse bacterial members, including some genera that were not 
found in the lumen. Several genera specific to the mucosa shifted with ASP250 use, and their 
impact on host health deserves additional research. Collateral effects of in-feed antibiotics 
include the increased Escherichia and Erysipelothrix populations with ASP250, which are 
concerning because these species represent potential human or animal pathogens. COGs 
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associated with energy conversion and metabolite transport in the microbiota of medicated 
swine suggest that antibiotics select for members of the community that could be more 
metabolically active. A transcriptomic analysis of the fecal microbiota would be ideal to test 
this hypothesis. ASP250 also selected for antibiotic resistance genes, 19 of which were 
higher in the medicated metagenomes. Several of these are relevant to animal and human 
health and are subject to ongoing debates in Congress. The controversy over the use of 
antibiotics in agriculture is likely to continue, but understanding how growth-promoting 
antibiotics affect intestinal bacterial communities, both along the mucosa and in the lumen, 
may inform alternative strategies that preserve the performance benefits while reducing 
potential risks to human and animal health.  
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Figure 3.1. Bacterial genera with significantly different representation between mucosa and lumen environments across all 
intestinal locations, based on taxonomic inference of bacteria (16S rRNA sequences) (P<0.01; q<0.05). 
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Figure 3.2. Swine intestinal bacterial communities differentiate along longitudinal and radial 
axes. (a) Phylum-level distribution of luminal bacterial through the intestinal tract;  (b) 
Spatial distribution of bacteria in the swine intestinal tract, based on taxonomic inference of 
bacteria (16S rRNA sequences). Tissue samples=T, Lumen contents=C. 
(a) 
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Figure 3.3. Bacterial community structure. (a) Heatmap of normalized OTU data (0.03 similarity cutoff) from medicated (med) 
and non-medicated (non-med) communities averaged by treatment and location.  Each column in the heatmap represents a 
different OTU, and the color of the OTU for each sample is scaled between black (low-abundance) and red (high-abundance) 
according to the relative abundance of that OTU within the group. (b) Cluster analysis of OTU data (bray-curtis similarity 
measure), averaged by treatment and location. (c) Cluster analysis of COG assignments from metagenomic data (dice similarity 
measure), averaged by treatment and location. L = lumen, M = mucosa, red = medicated, black = nonmedicated
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Figure 3.4. Nonmetric multidimensional scaling analysis of OTU-based bacterial 16S rRNA gene sequence abundances in 
individual pig intestinal samples. Environmental variables are plotted as vectors. The length of each vector is arbitrarily scaled, so 
only their directions and relative lengths should be considered. Mucosal and lumen samples are not differentiated.  
Ileum= diamond, cecum= triangle, mid colon= square, and feces= circle.  
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Figure 3.5. Bacterial genera that are differentially present due to antibiotic treatment, based on taxonomic inference of bacteria 
(16S rRNA sequences) from intestinal locations (P<0.01, q<0.05). Data are pooled across intestinal locations.  
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Figure 3.6.  Spindle diagram of COGs with differential representation (adjusted P<0.01) 
between the medicated and nonmedicated metagenomes, grouped by higher level COG 
category.  COG categories more frequently significant in the medicated metagenomes are 
highlighted in gray.   
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Table 3.1.  Antibiotic resistance of differential abundance in swine medicated versus nonmedicated metagenomes. 
Mechanism of 
resistance 
Genes 
detected Confers resistance to Found in genus
a,b Reported on 
mobile elements? 
Increased in medicated metagenomes 
Multidrug resistance 
efflux pumps 
cmlA  chloramphenicol 
Acinetobacter, Aeromonas, Enterobacter, Escherichia, Klebsiella, 
Proteobacteria, Pseudomonas, Salmonella, Serratia, Staphylococcus 
yes 
emrE  aminoglycoside Escherichia, Shigella no 
mdtH  deoxycholate, fosfomycin 
Citrobacter, Cronobacter, Enterobacter, Escherichia, Klebsiella, Salmonella, 
Shigella 
no 
mdtL  chloramphenicol Citrobacter, Escherichia, Salmonella, Shigella no 
mdtM 
acriflavin, chloramphenicol, 
norfloxacin 
Citrobacter, Escherichia, Salmonella, Shigella no 
mdtO, mdtP acriflavine, puromycin 
Escherichia, Salmonella, Shigella 
 
no 
tet(B) tetracycline 
Actinobacillus, Escherichia, Haemophilus, Neisseria, Pasteurella, 
Pseudomonas, Salmonella, Serratia, Shigella, Streptococcus 
yes 
Enzymes that deactivate 
the antibiotic 
aph(3'')-Ib streptomycin 
Acinetobacter, Actinobacillus, Aeromonas, Bordetella, Esherichia, 
Haemophilus, Klebsiella, Listeria, Pasteurella, Pseudomonas, Salmonella, 
Shigella 
yes 
blaampC cephalosporins Escherichia, Shigella yes 
Activities that protect 
from the antibiotic 
arnA polymixin Citrobacter, Esherichia, Salmonella, Shigella no 
vanWB vancomycin Clostridium, Enterococcus yes 
Decreased in medicated metagenomes 
Multidrug resistance 
efflux pumps 
macB macrolide Citrobacter, Enterobacter, Escherichia, Klebsiella, Salmonella, Shigella no 
msrA 
lincosamide, macrolide, 
streptogramin B 
Arcanobacterium, Corynebacterium, Enterococcus, Gemella, Pseudomonas, 
Staphylococcus, Streptococcus 
no 
tet(L) tetracycline 
Actinobacillus, Bacillus, Bifidobacterium, Enterococcus, Lactobacillus, 
Paenibacillus, Pseudomonas, Staphylococcus, Stenotrophomonas, 
Streptococcus 
yes 
Activities that protect 
from the antibiotic 
ermB erythromycin 
Bacillus, Bacteroides, Clostridium, Enterococcus, Escherichia, Lactobacillus, 
Lactococcus, Neisseria, Staphylococcus, Streptococcus 
yes 
ksgA kasugamycin 
Citrobacter, Cronobacter, Enterobacter, Escherichia, Klebsiella, 
Pectobacterium, Salmonella, Serratia, Shigella, Yersinia 
no 
tet(M) tetracycline 
Aeromonas, Clostridium, Enterococcus, Escherichia, Klebsiella, Lactobacillus, 
Lactococcus, Listeria, Pseudomonas, Streptococcus  
yes 
vanYA vancomycin Bacillus, Enterococcus, Paenibacillus, Staphylococcus yes 
vanYB vancomycin Clostridium, Eggerthella, Enterococcus yes 
aAccording to the ARDB 
bUp to 10 genera are listed 
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CHAPTER 4. CLOACIBACILLUS PORCORUM SP. NOV.,–A MUCIN-
DEGRADING BACTERIUM FROM THE SWINE INTESTINAL TRACT 
 
Looft T., Levine U. Y., Stanton T.B. 
 
 
 
 
 
 
 
 
 
 
 
 
 
I isolated CL-84T as part of a survey of mucin degraders in the swine gut. I also performed all 
experiments described in this manuscript, with the following exceptions: cellular fatty acid 
compositions were determined by Microbial ID Inc. (Newark, DE), Judy Stasko helped 
performed the electron microscopy work, and Uri Levine helped performed the butyryl-
CoA:acetate CoA-transferase assay. 
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Abstract: 
A novel anaerobic, mesophilic, amino-acid-fermenting bacterium, designated strain 
CL-84T, was isolated from the swine intestinal tract on mucin-based media. The bacterium 
had curved-rod cells (0.8-1.2 µm x 3.5-5.0 µm), stained Gram negative, and was non-motile 
with no evidence of spores. CL-84T produces acetate, propionate, formate and butyrate as the 
end products of metabolism when grown on serine. Optimum growth occurred at 39°C and 
pH 6.5. The major cellular fatty acids were iso-C15:0, iso-C15:0 3-OH, iso-C17:0, and C16:0, 
distinguishing CL-84T from closely related species. The G+C content of the DNA was 55.1 
mol%. 16S rRNA gene sequence analysis showed that CL-84T had sequence similarity with 
characterized genera within the Phylum Synergistetes, Family Synergistaceae. Phylogenetic 
analysis showed that CL-84T was related, but distinct from Cloacibacillus evryensis.  Based 
on these findings, we propose that strain CL-84T represents a new species of the genus 
Cloacibacillus. We further propose the name Cloacibacillus porcorum be designated for this 
species. The type strain is CL-84T (=DSM, =ATCC). 
 
Introduction 
Members of the recently described Synergistetes phylum have been identified in a 
diverse range of anaerobic environments, including anaerobic digesters (Ganesan et al., 
2008) and some infections in the human body (e.g. peritoneal fluid, soft tissues, blood and 
periodontal pockets) (Vartoukian et al., 2007). Despite Synergistetes’ culture-independent 
identification in a wide range of environments, there are few cultured representatives of this 
phylum.  Synergistes jonesii, the first characterized Synergistetes species, was isolated from a 
goat rumen. S. jonesii degrades toxic pyridinediols in the animals’ diet, and in turn the 
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animal’s gut provides required nutrients (Allison et al., 1992). In this paper we describe the 
isolation of a mucin-degrading bacterium, strain CL-84T, from the swine intestine and 
describe a new species of Cloacibacillus.  To our knowledge, this is the first description of a 
member of the Phylum Synergistetes that utilizes mucin as its sole source of carbon.    
 
Strain isolation.  
Strain CL-84T was one of eight Synergistetes strains isolated during the 
characterization of mucosa-associated and mucin-degrading microorganisms from the swine 
intestinal tract. The gently rinsed mucosal surface of a pig cecum was scraped with a sterile 
microscope slide and inoculated into minimal medium containing mucin. A series of three 
enrichments (10 days each) in broth, containing a basal medium, described below, and 1% 
wt/vol hog gastric mucin (HGM) (Sigma-Aldrich Corp., St Louis, MO), were used to 
improve the recovery of mucolytic bacteria before inoculation on solid media.  Mucin-
degrading bacteria were isolated on solid basal medium supplemented with 1% wt/vol HGM 
after incubation at 39°C for five days. Pure cultures were obtained after isolates were 
streaked for isolation three times. All cultures were inoculated and incubated (39°C) in a Coy 
anaerobic chamber inflated with an atmosphere of N2 (85%), CO2 (5%), and H2 (10%). The 
basal medium contained (per liter) 0.45 g of CaCl2, 0.45 g of MgSO4, 2.25 g of KH2PO4, 
2.25 g of K2HPO4, 4.5 g of NaCl, 4.5 g of (NH4)2SO4, 0.05% cysteine, 0.5 g hemin-1, 
0.0001% resazurin, and 1.6% noble agar.  
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Strain CL-84T cell morphology.  
Isolate CL-84T grew optimally on brain-heart infusion broth with 0.05% cysteine, 
0.0001% resazurin, and supplemented with 20 mM arginine and histidine (BHIAH). This 
medium was used to maintain cultures. After three days of growth at 39°C on BHIAH 
medium, CL-84T reached a terminal OD620, of 1.2, representing 1.5 x 109 CFU/ml. The 
calculated doubling time was 8 hrs. Isolate CL-84T cells cultured in BHIAH broth had a 
curved-rod shape, were non-motile, and spores were not seen (Figure 4.1a). On BHIAH 
plates after 5 days of growth CL-84T produced small semi-translucent brown colonies that 
were 1 mm in diameter. Gram strain was negative. Ultrathin sections were prepared for 
transmission electron microcopy (TEM) from four-day-old cultures, stained with uranyl 
acetate and lead citrate, and examined with a Tecnai 12 G2 Biotwin microscope (FEI, 
Hillsboro, OR). TEM micrographs showed a cell outer envelope structure consistent with 
gram negative cells with a thin peptidoglycan layer surrounded by an outer membrane 
(Figure 4.1b). No spores or inclusion bodies were seen. CL-84T was variable in size and 
ranged from 0.8-1.2 µm X 3.5-5.0 µm. The TEM appearance and Gram staining 
characteristics are consistent with the Gram negative envelope characteristics of other 
Synergistetes spp. 
16S rRNA gene sequence analysis.    
Genomic DNA was extracted from a cell pellet of the isolate following Dale and 
Greenway (1985). PCR amplification was carried out as described previously (Downes et al., 
2005), with the conserved bacterial primers 8F (Wilmotte et al., 1993) and 1492R 
(Stackebrandt & Goodfellow, 1991). Purified PCR products were sequenced yielding nearly 
full-length (1447 bp) sequences for the CL-84T 16S rRNA gene.  Taxonomic assessments of 
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the 16S rRNA gene sequences were made using the Ribosomal Database project (RDP) web 
tools (http://rdp.cme.msu.edu/) (Cole et al., 2009), which placed CL-84T within the 
Synergistetes phylum. The closest type strain matches to Cloacibacillus evryensis (95% 
sequence identity) and Synergistes jonesii (90% sequence identity). C. evryensis was isolated 
from a municipal anaerobic waste digester (Ganesan et al., 2008), and S. jonesii was isolated 
from a goat rumen (Allison et al., 1992). Support for other Synergistetes bacteria being 
associated with mucus and possibly utilizing mucin can be found from their identification 
from subgingival plaque samples, and optimized growth (in co-culture) by the addition of 
mucin to the media (Vartoukian et al., 2010).   
Neighbor-joining, maximum parsimony, and maximum likelihood phylogenetic 
analysis was performed based on the alignment of the 16S rRNA gene sequence from CL-84 
with Silva’s SINA web aligner (Pruesse et al., 2007) in the software package ARB (Ludwig 
et al., 2004). The methods used to construct the tree were ARB neighbor-joining (10,000 
bootstrap replicates), maximum parsimony with DNAPars v3.6 (1,000 bootstraps), and 
maximum likelihood with RAxML (‘advanced bootstrap + refinement of BS tree’ algorithm, 
GTRGAMMA model, 1,000 bootstraps). All three analyses produced trees with the same 
topology, and therefore only the neighbor-joining tree is presented (Figure 4.2). Isolate CL-
84T grouped with uncharacterized isolates from infected human blood (accession numbers 
GQ258969, EF551162, EF551160) (Marchandin et al., 2010) and peritoneal fluid samples 
(DQ412721) (Horz et al., 2006). These sequences were approximately 99% similar to each 
other, to CL-84T, and form a cluster previously designated OTU cluster 2 by Ganesan et al. 
(2008). In contrast, the 16S rRNA gene sequences from C. evryensis and S. jonesii were only 
95% and 90% similar to the sequences in OTU cluster 2, respectively. CL-84T, and related 
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sequences, form a distinct branch from C. evryensis (OTU cluster 1), within the 
Cloacibacillus genus. A previous study of the swine gut microbiota also identified a 
sequence from an uncultured Synergistetes sp. (AF371930) in the pig gut, which is distantly 
related to CL-84T and groups with the Pyramidobacter genus (Figure 4.2) (Leser et al., 
2002).     
As part of a larger survey of swine intestinal microbes, the genome of isolate CL-84T 
was sequenced using 454 titanium pyrosequencing platform (454 Life Sciences, Branford, 
CT). Preliminary sequence analysis revealed CL-84T to have a G+C content of 55.1 mol%.   
 
Substrate utilization.   
Mucins are glycoproteins with carbohydrate side chains connected to a protein 
backbone by O-glycosidic links (Nataro, 2005) and are the major component of mucus.  The 
carbohydrate side groups are made of the sugars galactose, fucose, N-acetylgalactosamine, 
N-acetylglucosamine, sialic acid, and mannose (Allen et al., 1998).  Mucolytic bacteria use 
proteases and glycosidases to degrade host mucin at polypeptide and glycosidic bonds, 
respectively (Bradshaw et al., 1994).  Growth on different mucin components was examined 
by preparing basal medium containing 0.2% w/v yeast extract with 0.5% w/v of each one of 
the following: chondroitin sulfate sodium salt, N-acetyl-D-glucosamine, N-acetyl-D-
galactosamine, hyaluronan biotin sodium salt, mannose, N-acetylneuraminic acid, D-
galactose, or fucose. CL-84T was further evaluated for its ability to degrade mucin O-linked 
glycans, purified from the HGM, as previously described (Martens et al., 2008). Growth on a 
variety of amino acids was examined by supplementing basal medium containing 0.2% w/v 
yeast extract with 10 mM of each one of the  following: arginine, histidine, lysine, serine, 
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tryptophan, alanine, glutamate, aspartate, proline, glycine, cysteine, phenylalanine, 
isoleucine, leucine, valine, threonine, methionine, glutamine, asparagine, or tyrosine. Growth 
results are summarized in Table 4.1 as OD620 values.    
 
Fermentation Products.   
The supernatants from cultures on each substrate were analyzed for fermentation 
acids by gas chromatography of butyl esters (Salanitro & Muirhead, 1975; Stanton & Lebo, 
1988). Major fermentation products were formate, acetate, or propionate; however, growth 
on serine, both alone and with threonine and proline, also produced buyrate (Table 4.1). CL-
84T contains butyryl-CoA:acetate CoA-transferase (E.C. 2.8.3.8) activity (Spec Act = 
9.88±0.45 µmol min-1 mg protein-1) as determined using cells cultured on basal medium with 
serine. The assay for transferase activity was performed on French press extracts of CL-84T 
according to Buckel et al. (1981) except that it was evaluated at 412 nm, 39°C, with 0.1 mM 
butyryl-CoA, and 0.5 units (8.8 nkat) of citrate synthase. The most prevalent amino acids in 
mucin are serine and threonine (Schrager, 1970) CL-84T’s ability to produce butyrate when 
grown on serine may reflect its role in the gut, as butyrate has been shown to stimulate mucin 
synthesis in human colonic cell lines and animal mucosa (Finnie et al., 1995; Hatayama et 
al., 2007).  
Additional biochemical characterizations were performed using Rapid ID 32 A and 
API ZYM test strips (bioMérieux, l'Etoile, France). CL-84T showed positive arginine 
dihydrolase and glutamic acid decarboxylase activities and weak alkaline phosphatase and 
proline arylamidase activities. Additionally, the API ZYM test showed that CL-84T had acid 
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phosphatase, naphthol-as-bi-phosphohydrolase, alkaline phosphatase, esterase (C 4), esterase 
lipase (C 8), and leucine arylamidase activities. CL-84T tested negative for catalase.     
 
Growth Tolerance.  
Heat, pH, and oxygen tolerance were tested in BHIAH medium (see above). The pH 
range for growth of CL-84T was between pH 4-8, with optimal growth (reaching OD620 >1.0) 
between pH 6-7. Growth was observed between 20ºC-45ºC. No viable cells remained after 
heating cultures to 80ºC for 30 min. Growth of CL-84T was inhibited by NaCl concentrations 
above 1.4% w/v, with optimal growth at 0.6-0.8% w/v. CL-84T cells were aerotolerant and 
still viable after 24hrs of exposure to oxygen. Growth of CL-84T was not observed on 
BHIAH plates, exposed to 1.0 % oxygen, after one week of incubation.  
 
Cellular fatty acid content.  
The closest related type strain to CL-84T, C. evryensis, was obtained from the DSM 
culture collection (No.19522, 158T).  Both CL-84T and C. evryensis were grown in BHIAH 
medium, and cell pellets were used for cellular fatty acid analysis. The cellular fatty acid 
composition was determined by Microbial ID Inc. (Newark, DE) with the GC-based MIDI 
Sherlock® Microbial Identification System.  The major cellular fatty acids for CL-84T were 
iso-C15:0 (27.1%), iso-C15:0 3-OH (15.0%), iso-C17:0 (11.7%), and C16:0 (9.7%). This profile 
differed from that of C. evryensis in both the fatty acid types and the proportions of each 
(Table 4.2).  
 
Resistance to antibiotics.   
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Antibiotic minimum inhibitory concentrations (MIC) assays were modified from 
Allen et al. (2009) by incubating anaerobically in BHIAH for one week. CL-84T was 
susceptible to tylosin, lincomycin, chlortetracycline, penicillin, florphenicol, ceftiofur and 
carbadox (MIC < 4 µg/µl) and resistant to kanamycin, vancomycin, and sulfathiazole (MIC 
is 512 µg/ µl each). Kanamycin (aminoglycoside) and sulfa-drug antibiotics are commonly 
added to swine feed for performance and disease prevention (Apley et al., 2012; Kobland et 
al., 1984). Genes encoding resistance for these antibiotics have been identified in swine 
metagenomes (Looft et al., 2012). Other Synergistetes spp. have also been shown to be 
resistant to vancomycin (Allison et al., 1992; Downes et al., 2009; Ganesan et al., 2008).  
Description of Cloacibacillus porcorum sp. nov.  
porcorum (por.co′rum. L. n. porcus swine, pig; L. masc. pl. n. porcorum of/from pigs). 
Cells are obligately anaerobic, non-motile, with a curved-rod shape. Cells ferment amino 
acids, some mucin sugars, and produce acetate, propionate, and formate but only produced 
butyrate when serine was supplied, as the end products of metabolism. Cells have Gram-
negative cell wall structure and range in size from 0.8-1.2 µm wide to 3.5-5.0 µm long. 
Strong growth is obtained in brain-heart infusion medium, and growth is enhanced by the 
addition of histidine, arginine, but not glucose. After 7 days incubation, colonies are 1 mm in 
diameter, circular, shiny, brown, and semi-translucent. The main cellular fatty acids are: iso-
C15:0, iso-C15:0 3-OH, iso-C17:0, and C16:0. Cells are resistant to kanamycin, vancomycin, and 
sulfathiazole and are susceptible to tylosin, lincomycin, chlortetracycline, penicillin, 
florphenicol, ceftiofur and carbadox. Optimal growth is at 39°C at pH 6.5.  
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The type strain, strain CL-84T (=DSM, =ATCC ), was isolated from the mucosal lining of a 
pig cecum in Ames, Iowa, USA. The DNA G+C content of the type strain is 55.1 mol%. 
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Figure 4.1. (A) Phase contrast micrograph of CL-84T cells grown in BHIAH medium. (B) 
Transmission electron micrographs of ultra-thin sections of CL-84T, showing a loose outer 
cell membrane consistent a Gram-negative outer cell envelope. 
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Figure 4.2.  Neighbor-joining phyogentic tree of proposed species Cloacibacillus porcorum CL-84T and selected reference 
sequences’ partial 16S rRNA genes (all sequences ≥1334 bp). The tree is rooted by Aminiphilus circumscriptus strain, numbers by 
the branches of the tree represent the percentage bootstrap values of 10,000 resamplings, and are only noted if the percentage was 
greater than 50%. The scale bar represents 10 nucleotide substitutions per 100 nucleotides.   
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Table 4.1. Fermentation products from substrates that support growth of strain CL-84T in 
basal meduim. 
  
Substrate 
Formic Acetic Propionic Butyric 
OD620‡ acid* acid* acid* acid* 
BHIAH - ++ + - +++ 
Histidine + + + - ++ 
Arginine + + + - ++ 
Tryptophan - + - - + 
Cysteine + ++ + - ++ 
Threonine - + - - + 
Serine + + - + + 
Serine, threonine, proline + ++ + + ++ 
(-)-N-acetylneuraminic acid + - + - + 
Hyaluronan biotin sodium salt + + + - ++ 
Mannose + + - - ++ 
Chondroitin sulfate sodium salt + + + - + 
Fucose - + + - + 
D-Galactose - + - - + 
N-acetyl-D-galactosamine - - + - + 
N-acetyl-D-glucosamine - - - - + 
Mucin + + + - + 
Mucin O-linked glycans + ++ + - + 
 
 *Measure by gas chromatography. All values were corrected for the small amount of short 
chain fatty acids formed in the control tubes. Experiments were conducted in triplicate and 
mean values are given. + =1.0-5.0 mM, ++ =5.1-10.0 mM 
 
†No growth was observed on the following substrates: Methionine, Aspartate, Valine, 
Proline, Isoleucine, Lysine, Alanine, Phenylalanine, Leucine, Glucose, Glutamine, Arginine, 
Glycine, Asparagine, Glutamate, and Tyrosine  
 
‡ OD620  + =0.05-0.1 
++ =0.2-0.5 
+++ =0.6-1.2  
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Table 4.2. Cellular fatty acid profiles (%) of strain CL-84T and C. evryensis, grown on 
BHIAH medium.    
 
 
% of total fatty acids 
 
CL-84T C. evryensis  
iso-C15:0             27.1 14.2 
iso-C15:0 3-OH        15 14 
iso-C17:0             11.7 2.4 
C16:0                 9.7 1.8 
iso-C13:0             7.6 5.8 
C17:0                 4.2 12 
iso-C17:1 at 10       3.9 2.7 
C16:1 w7c            3.7 1.6 
C18:0                 2.8 0 
C18:1 w11c            2.6 0 
C17:1 w11c           2.3 12.4 
C15:0                 1.9 4.8 
C16:1 w11c           1.7 0 
iso-C17:1 at 9       1.6 0 
C13:0                 0 3.4 
C15:0 3-OH            0 7.7 
C15:1 w6c            0 4.3 
C16:1 w5c            0 1.8 
C17:1 w3c             0 1.3 
C17:1 w6c             0 5.3 
Summed Feature 2* 3.2 2.2 
Summed Feature 6* 0 1.8 
 
*Summed features represent two fatty acids that cannot be separated with the MIDI system. 
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Table 4.3. Differential characteristics of the species Cloacibacillus porcorum and related species in the phylum Synergistetes 
 
Characteristic Cloacibacillus porcorum  
strain CL-84
T
 
Cloacibacillus evryensis 
strain 158
T
* 
Synergistes jonesii  
Strain 78-1
T† 
Habitat Swine intestinal tract Anaerobic digester  Goat rumen 
Cell morphology Slightly curved rods Straight rods Rods 
size 0.8-1.2 x 3.5-5.0 µm 0.8 - 1.0 x 2.0 - 3.0 µm 0.6-0.8 x 1.2-1.8 µm 
16S rRNA similarity to CL-84
T
 (%) 100 95 90 
Optimum growth temperature (°C) 39 35–40 39 
DNA G+C content (mol%) 55.1 55.8 58 
Metabolism Fermentative Fermentative Fermentative 
Fermentation Proteolytic, some 
carbohydrates 
Proteolytic Proteolytic 
Short chain fatty acids produced  
during fermentation 
Acetate, propionate, and 
formate. Butyrate, only 
when serine is supplied 
acetate, propionate, 
butyrate, and valerate  
Acetate and propionate. 
Formate only when 
histidine is supplied 
Major cellular fatty acids 
iso-C15:0, iso-C15:0 3-OH,  
iso-C17:0, and C16:0 
iso-C15:0, iso-C15:0 3-OH,  
C17:1 ω11c,  C17:0   
C17 : 0, C20 cyc,  
C17 : 1ω6c, C15:0 
Additional features Degrades mucin Some species of this 
genus detected in 
human clinical 
infections 
Degrades 3,4-dihydroxy 
pyridine 
*(Ganesan et al., 2008)  
†(Allison et al., 1992)  
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CHAPTER 5. GENERAL CONCLUSIONS 
 
Collateral impacts of in-feed antibiotics on the swine microbiota 
The data in this dissertation describe the shifts in swine intestinal bacterial 
communities with in-feed antibiotics using phylotype- and functional-based approaches. The 
design of these studies featured a single inoculum source (the mother), no exposure of the 
sow or piglets to antibiotics except for the treatment, and identical diets except for the 
inclusion of ASP250 for the medicated animals. Used for disease prevention, disease 
treatment, and growth promotion, ASP250 (chlortetracycline, sulfamethazine, and penicillin) 
caused significant community-wide changes in bacterial membership and functions.  
 
Community Shifts  
Many bacterial taxa decreased with antibiotic treatment, but a few increased. The 
shift in E. coli populations was particularly striking, increasing 10-fold with antibiotic 
treatment. E coli has been previously reported as increasing with other antibiotics such as 
amoxicillin, metronidazole, and bismuth (Antonopoulos et al 2009), metronidazole (Pelissier 
et al 2010), and vancomycin and imipenem (Manichanh et al 2010). While E. coli is a known 
intestinal commensal, it is also a potential human pathogen. Increasing E. coli numbers so 
dramatically with antibiotic exposure could be troublesome in the event that a pathogenic E. 
coli are part of this population. 
Other notable shifts in microbial membership were detected. Members of the 
Bacteroidetes phylum decreased in the treated animals, which may relate to the growth-
promoting benefits obtained from feeding ASP250 as part of their diets. Obese mice have 
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lower levels of Bacteroidetes relative to Firmicutes in their feces compared with lean mice, 
and this balance is associated with improved energy-harvesting capacity (Ley et al 2006, 
Turnbaugh et al 2006). In-fact, analysis of the metagenomes showed that bacterial functions 
associated to energy production and conversion were increased in the antibiotic-fed pigs. Our 
data suggest that the gut microbiota relates to the improved feed conversion obtained with in-
feed antibiotics. Further studies are needed to confirm our results and define the mechanisms 
involved.  
 
Resistance  
Antibiotic resistance genes were pervasive in the swine intestinal microbiome, even 
in the absence of selective pressure. Antibiotic resistance genes were identified by 
metagenomic and qPCR analyses, and all genetically encoded mechanisms of resistance were 
detected: efflux pumps, antibiotic-modifying enzymes, and modified or protected targets of 
the antibiotic. The constant selective pressure of decades of in-feed antibiotics has lead to a 
high background level of resistance in the swine microbiome that persists even without 
antibiotics. 
Even low, short-term exposure to in-feed antibiotics increased the abundance and 
diversity of antibiotic resistance genes, despite the high background. Some resistance genes 
associated with antibiotics not administered increased in abundance with in-feed ASP250. 
Many of the other antibiotic resistance genes matched genes that are known to occur on 
plasmids. This suggests an indirect mechanism of selection, perhaps by co-occurrence on 
mobile genetic elements conferring resistance to ASP250 antibiotics. The clustering of 
resistance genes on mobile elements, such as plasmids, may offer a fitness advantage to a 
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bacterium living in the presence of antibiotics. Antibiotic resistance genes occurring on 
plasmids is concerning because of the potential for transfer to pathogens, pointing to another 
undesirable collateral effect of in-feed antibiotics. 
  
The importance of spatial distribution of bacteria in the gut 
The longitudinal and radial distribution of bacterial communities in the swine 
intestine reflects interesting differences along both axes. The most dramatic differences were 
seen between the ileum and the rest of the intestinal tract. Bacterial communities from 
contents from the ileum were dominated by only a handful of species from the Firmicutes 
phylum, while the cecum and colon had several hundred across many phyla. Dramatic 
differences were also seen between the ileal lumen and mucosa, the latter of which had 10-
fold more species than the former. A small subset of organisms was found only on the tissue, 
indicating potential mucosal specialists. While feces is easy to obtain and is a suitable 
material to characterize intestinal microbes for many studies, the spatial distribution of the 
microbes is lost when looking at feces alone. Defining the habitat in the gut provide insights 
on how microbes contribute to digestion in each intestinal section, on which microbes are in 
direct contact with the host, and on how the bacteria relate back to animal health.  
 
Characterizing bacterial specialists in gut 
The functional niche of mucin degradation was used to selectively culture bacteria 
that were adapted to a physical GI niche (mucosal colonization). Mucin-degrading activities 
have been linked to pathogenesis in some microbes (Campieri and Gionchetti 2001), but it 
may simply reflect an adaptation for mucosal colonization by commensal, beneficial 
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microbes. I described isolate Cloacibacillus porcorum, a new species of the Synergistetes 
phylum that was isolated from a pig cecal mucosa on mucin-based media. Synergistetes 
species have been identified in a diverse range of anaerobic environments (Vartoukian et al 
2007), including in the culture-independent and -dependent studies in this dissertation. As a 
member of an understudied phylum, the significance of Cloacibacillus porcorum in the gut in 
unclear, but its in vitro phenotypes of mucin degradation and butyrate production suggest that 
it benefits from and provides benefit to host tissue.    
 
Future directions 
Much is still unknown about the role of intestinal bacteria in host health and how 
antibiotics affect the interaction between bacterial communities and their animal host. In 
order to develop viable alternatives to antibiotics, we need to know how the in-feed 
antibiotics are functioning to improve feed efficiency. In-feed ASP250 is only one of many 
antibiotics used for disease prevention and growth performance. Studies of the effects on the 
microbiota with other in-feed antibiotics are needed to identify common changes to the 
bacterial community with improved growth performance. Quantitative PCR should be used 
to confirm shifts identified with sequencing-based studies. 
 Community-wide transcription analysis (metatranscriptomics) may provide insights 
over metagenomic studies because it examines the activity of the community, not just the 
metabolic potential. This would be useful in identifying the mechanisms bacterial 
communities use to deal with the stress of antibiotics, and how energy-harvesting functions 
benefit the host. Additionally, analysis of host gene expression along the intestinal tract will 
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allow us to detect host responses to bacteria along the mucosa, thus defining the mechanisms 
of the mutualism between a host and its microbiota. 
Bacteria that interact with the host are important, and the data in this dissertation 
suggest that there is much more to the story. In particular, it was surprising to find much 
higher diversity on the ileal mucosa relative to the ileal lumen. The colon is often the focus of 
gastrointestinal microbial studies, but many intestinal infections happen in the small 
intestine, which is an underexplored ecosystem. Studies characterizing bacterial communities 
further up the intestinal tract (small intestine through stomach) will help define their role in 
animal health.    
While culture-independent studies have greatly expanded our understanding of GI 
bacterial communities, having isolates in pure cultures is invaluable for defining their 
characteristics and relating them back to their role in the ecosystem. After isolating mucin 
degraders and butyrate producers from the intestinal tract, characterizing their niche in the 
intestinal tract will help us understand the role of these functions in the gut. Designing qPCR 
or FISH probes specific to these bacteria (e.g. using their 16S rRNA gene and specific 
functional genes), will allow us to evaluate the role of these functions on niche specificity 
within the gut.  
Bacterial communities within the pig intestine are both complex and dynamic, and by 
understanding how they adapt to niches or respond to perturbations, we hope to predict how 
bacterial communities behave in relation to host health and performance. Predicting 
microbial outcomes will inform potential mitigation strategies, thus leading to the ultimate 
objective of identifying viable alternatives to in-feed antibiotics.    
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APPENDIX A. SUPPORTING INFORMATION FOR CHAPTER 2: IN-
FEED ANTIBIOTIC EFFECTS ON THE SWINE INTESTINAL 
MICROBIOME 
 
DNA Extractions.  
Feces were processed as follows for phylotype and metagenomic analysis. Ten grams 
of fresh feces per sample were collected and blended in 300 ml sterile PBS. After suspension, 
the feces were centrifuged at 250 × g for 5 min to remove the large particles (such as 
insoluble food) from the sample. The supernatant was retained and centrifuged at 10,000 × g 
for 30 min at 4 °C to pellet the bacterial cells. The supernatant was poured off and the pellet 
was washed by suspending it in PBS and spinning it again at 10,000 × g for 30 min at 4 °C. 
Two grams of the washed pellet were used for DNA extractions using the Power Max Soil 
DNA Isolation Kit following the manufacturer’s protocol (MO BIO Laboratories). DNA 
samples were quantified on a Nanodrop ND-1000 UV-Vis spectrophotometer (Nanodrop 
Technologies). DNA integrity was determined by gel electrophoresis. Extracted DNA was 
stored at −20 °C. 
 
16S rRNA Gene Amplification.  
Amplification of the V1-V3 region of bacterial 16S rRNA genes was carried out with 
the conserved primers 8F (5′-AGAGTTTGATCCTGGCTCAG) (1) and 518R (5′-
ATTACCGCGGCTGCTGG) (2) with attached unique eight nucleotide sequence barcodes 
(3). The V3 region was chosen because it was shown to be highly informative (4). PCR 
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reactions contained 200 µM of each deoxyribonucleotide triphosphate, 2.0 µM of each 
primer, 2.0 U Ampligold Taq polymerase (Applied Biosystems), 2.5 mM MgCl2, 50 ng 
template DNA, Ampligold Taq buffer (Applied Biosystems), and water to 50 µL. PCRs were 
performed in a PTC-225 thermal cycler (MJ Research) with the following protocol: 3 min at 
95 °C, 21 cycles of (1 min at 95 °C, 30 s at 56 °C, 45 s 72 °C), and a final elongation step for 
3 min at 72 °C. PCR products were separated by gel electrophoresis and purified using 
MinElute kit (Qiagen). 
 
Metagenomic Analysis.  
Sequence replicate artifacts were removed using a local version of the 454 Replicate 
Filter (5) and specifying a sequence identity cutoff of 0.9, a length difference requirement of 
0, and a check for a three-base identical sequence at the beginning of each cluster. The 
clustered sequences were assigned to clusters of orthologous groups (COGs) by using 
BLASTx to compare the nucleic acid sequences to the database of proteins that was 
originally used to identify COGs. The BLAST reports were parsed to extract COG 
information, and COG frequencies were calculated and tabulated using SAS (SAS Institute). 
COG frequencies were subsequently analyzed in ShotgunFunctionalizeR (6) using the 
testGeneFamilies.dircomp function and Poisson group statistics to perform gene-centric 
analysis between two groups [nonmedicated (n = 3) and medicated (n = 1) swine 
metagenomes]. Differences with P < 0.05 were significant, and the significant COGs were 
labeled with their respective COG category to visualize trends. Metagenomic sequences 
belonging to select significantly different COGs were analyzed to infer phylogeny. 
Phylogeny assignments were made by extracting sequences belonging to the COGs of 
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interest, BLASTx comparison of those sequences to the GenBank nonredundant protein 
database, extraction of the top-hit accession, and retrieval of the phylogeny for that 
accession. COG counts were also corrected for differences in the estimated average genome 
size of each metagenome and reanalyzed as above, invoking the eff.nseq adjustment using 
the testGeneFamilies2.dircomp function (7). Because different methods of average genome 
size calculations could affect the outcome, COG counts were also corrected with the average 
genome sizes that were calculated by GAAS (8). These adjustments did not dramatically 
affect the results, and therefore only the results of the original ShotgunFunctionalizeR 
calculations are reported.  
Swine metagenomes were also examined for the presence of known antibiotic 
resistance genes. MG-RAST (9) was used to bin sequences by subsystems. In addition, 
sequences were locally analyzed by BLASTx comparison of the sequences against the 
Antibiotic Resistance Gene Database (ARDB) (10), which was kindly provided by the 
ARDB authors. The BLASTx parameters were optimized for short reads and diversity by 
using a bitscore cutoff of ≥60 and an identity cutoff of 35%. Antibiotic resistance gene-
centric analysis was carried out in R using the testGene-Families function as described 
above. Differences with P < 0.05 were significant. For ecological analyses, the number of 
hits was normalized to 100,000 submitted reads and analyzed using multidimensional scaling 
(MDS) and cluster analyses with the Bray-Curtis similarity measurement in PAST (11).  
Design of Primers for Quantitative PCR Targeting Antibiotic Resistance Genes in Biotrove 
Array  
Antibiotic resistance-gene reference sequences were collected using: (i) the Antibiotic 
Resistance Genes Online database, which contained 555 β-lactamase and 115 vancomycin 
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resistance-gene sequences at the time of collection (12); (ii) a National Center for 
Biotechnology Information (NCBI) search for resistance-gene sequences; and (iii) literature 
search. Reference sequence protein IDs were used as seeds to harvest all closely related 
alleles from GenBank using the Fun-Gene pipeline and repository (FGPR) 
(http://fungene.cme.msu.edu/index.spr). Aligned sequences from the FGPR were used to 
create consensus sequences using BioEdit (13). Primer sets were designed from consensus 
sequences and then selected or rejected following criteria previously described (14). Overall, 
174 antibiotic resistance genes were targeted with 272 primer sets designed from 5,241 
sequences. Primer sets were grouped into 18 resistance types by subjecting all primer sets to 
the ARDB (10) BLAST tool (Table A4), or by the BLAST tool in the NCBI when no results 
were obtained by the ARDB BLAST (Table A5). Abundance of the resistance type was the 
sum of individual genes within the resistance type. Antibiotic resistance gene categories used 
to group the results include (family: type): beta-lactamase: (i) class A, (ii) class B, and (iii) 
class C; tetracycline resistance: (iv) ribosome protection protein and (v) tetracycline efflux; 
(vi) sulfonamide resistance; macrolide-lincosamide-streptogramin B resistance: (vii) erm 
rRNA methylases, (viii) ATP-binding transporters, (ix) major facilitator family transporters, 
(x) hydrolases, and (xi) transferases; aminoglycoside resistance: (xii) acetylation, (xiii) 
adenylylation, and (xiv) phosphorylation; multidrug transporters: (xv) multidrug and toxic 
compound extrusion family, (xvi) major facilitator superfamily transporter, (xvii) resistance- 
nodulation-cell division transporter, and (xviii) small multidrug resistance transporter. 
 
Validation of the BioTrove System for Quantitative PCR of Antibiotic Resistance Genes. 
 Randomly-selected genes were tested in parallel with published PCR primers that 
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target the same gene (Table A6). If no amplification curve was observed using the previously 
published primer set or if the threshold cycle was high (greater than 35), the results were 
confirmed further by running the quantitative PCR (qPCR) product on a 1% agarose gel and 
confirming presence or absence of the gene by visualization of a band of the correct length. 
 
Validation of the BioTrove Antibiotic Resistance Genes Primer Set.  
Results obtained using the BioTrove platform were validated by probing samples in 
parallel with primers that were previously published. Antibiotic resistance genes were 
randomly selected for this validation insofar as a published qPCR primer set using SYBR as 
the dye could be obtained. Samples were probed by qPCR and in some cases by traditional 
PCR and gel imaging. The result obtained using the BioTrove platform was considered 
“true” if the previously published primer set confirmed the result. In validation of the results, 
in total, there were 29 instances of true positives, 46 instances of true negatives, 2 instances 
of false-positives, and 7 instances of false-negatives; these results translate to an 89% success 
rate, which we consider satisfactory. We used strict interpretation of the PCR to determine if 
the BioTrove platform result was accurate or not. For example, three of the false-negative 
instances resulted in a very faint band on a gel, or a high threshold cycle (14). It is possible 
that the BioTrove primers did not fail in these instances but were simply less sensitive than 
other PCR reactions because of the small reaction volume. We also observed that some of the 
BioTrove individual primer sets may be much more broad than previously published primer 
sets.  
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Culturing Escherichia coli.  
The antibiotic feed trial was repeated with an independent set of pigs. Twelve pigs 
(offspring from three sows) were housed and maintained as described above. Six pigs 
received antibiotics (ASP250) and six receive no antibiotics continuously for 21 d before 
being sampled. E. coli was cultured from fresh pig intestinal contents at necropsy, from both 
medicated and nonmedicated animals, after 21 d of feed. Serial dilutions were plated on 
MacConkey plates with lactose and incubated overnight at 39 °C. Colony forming units were 
enumerated for each animal (Figure A2). 
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Figure A1.  E. coli enumerations from swine gut contents in a repeated ASP250 study.  E. 
coli was cultured on MacConkey’s agar from fresh gut contents, from both medicated and 
control animals after 21 days of feed.  Wide black horizontal bars show the average cfu per 
treatment group, which are significantly different (p=0.04). 
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Figure  A2. Microbial functions encoded by the swine metagenomes. (A) COGs in the 
metagenomes. The following COGs were less than 0.02% of the total number of COGs per 
metagenome and therefore cannot be visualized on the graph: A, RNA processing and 
modification; B, chromatin structure and dynamics; W, extracellular structures; Y, nuclear 
structure; Z, cytoskeleton. (B) SEED subsystems in the metagenomes. 
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Figure A3. Tetracycline efflux abundance trends for each treatment animal. This is a 
representative figure; similar trends were observed for each of the six treatment-enriched 
gene types. Black lines are medicated animals and gray dashed lines are nonmedicated 
animals. 
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Table A1.  Phylotypes based on 16S analysis, by treatment.  Genus assignments were made using RDP’s sequence classifier. 
 medicated_0  medicated_14  control_0   control_14  
Genera No. of hits (%) No. of hits (%) No. of hits (%) No. of hits (%) 
Prevotella 7479 21.7 8724 29.6 10490 26.8 7659 21.4 
Succinivibrio 2901 8.4 1789 6.1 4211 10.7 772 2.2 
Escherichia 256 0.7 3253 11.0 186 0.5 18 0.1 
Anaerovibrio 3071 8.9 256 0.9 334 0.9 470 1.3 
Selenomonas 17 0.0 17 0.1 4273 10.9 8 0.0 
Coprococcus 450 1.3 929 3.1 681 1.7 713 2.0 
Oscillibacter 824 2.4 610 2.1 634 1.6 752 2.1 
Parabacteroides 802 2.3 442 1.5 523 1.3 322 0.9 
Anaerobacter 374 1.1 127 0.4 380 1.0 728 2.0 
Hallella 625 1.8 127 0.4 446 1.1 281 0.8 
Roseburia 157 0.5 365 1.2 255 0.7 271 0.8 
Barnesiella 136 0.4 135 0.5 316 0.8 473 1.3 
Papillibacter 52 0.2 75 0.3 344 0.9 444 1.2 
Treponema 203 0.6 137 0.5 165 0.4 286 0.8 
Ruminococcus 91 0.3 204 0.7 83 0.2 64 0.2 
Butyricicoccus 43 0.1 239 0.8 47 0.1 66 0.2 
Tannerella 74 0.2 40 0.1 181 0.5 99 0.3 
Paraprevotella 124 0.4 98 0.3 66 0.2 50 0.1 
Subdoligranulum 59 0.2 131 0.4 135 0.3 13 0.0 
Streptococcus 64 0.2 29 0.1 90 0.2 172 0.5 
Phascolarctobacterium 92 0.3 45 0.2 132 0.3 69 0.2 
Lactobacillus 1 0.0 253 0.9 10 0.0 19 0.1 
Faecalibacterium 15 0.0 20 0.1 298 0.8 4 0.0 
Bacteroides 42 0.1 90 0.3 62 0.2 42 0.1 
Blautia 21 0.1 115 0.4 63 0.2 18 0.1 
Butyricimonas 22 0.1 31 0.1 79 0.2 89 0.2 
Akkermansia 158 0.5 0 0.0 60 0.2 1 0.0 
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Dorea 
 
 
17 
 
 
0.0 
 
 
88 
 
 
0.3 
 
 
49 
 
 
0.1 
 
 
46 
 
 
0.1 
Acetanaerobacterium 11 0.0 104 0.4 43 0.1 24 0.1 
Sporacetigenium 67 0.2 6 0.0 56 0.1 54 0.2 
Turicibacter 41 0.1 8 0.0 40 0.1 75 0.2 
Clostridium 14 0.0 24 0.1 40 0.1 77 0.2 
Anaerotruncus 12 0.0 50 0.2 16 0.0 69 0.2 
Xylanibacter 35 0.1 26 0.1 72 0.2 9 0.0 
Schwartzia 23 0.1 23 0.1 85 0.2 12 0.0 
TM7_genera_incertae_sedis 2 0.0 61 0.2 3 0.0 32 0.1 
Anaerostipes 12 0.0 61 0.2 16 0.0 8 0.0 
Lachnobacterium 46 0.1 29 0.1 21 0.1 2 0.0 
Parasporobacterium 12 0.0 25 0.1 1 0.0 54 0.2 
Catenibacterium 7 0.0 50 0.2 22 0.1 3 0.0 
Acetivibrio 11 0.0 16 0.1 44 0.1 14 0.0 
Eubacterium 8 0.0 22 0.1 20 0.1 22 0.1 
Anaerofilum 4 0.0 18 0.1 27 0.1 16 0.0 
Peptostreptococcus 11 0.0 16 0.1 7 0.0 29 0.1 
Campylobacter 1 0.0 9 0.0 2 0.0 48 0.1 
Fibrobacter 35 0.1 3 0.0 3 0.0 18 0.1 
Sarcina 4 0.0 0 0.0 20 0.1 34 0.1 
Desulfovibrio 7 0.0 31 0.1 1 0.0 7 0.0 
Pyramidobacter 16 0.0 5 0.0 25 0.1 5 0.0 
Mitsuokella 0 0.0 30 0.1 12 0.0 1 0.0 
Pseudobutyrivibrio 4 0.0 19 0.1 9 0.0 7 0.0 
Spirochaeta 2 0.0 16 0.1 10 0.0 11 0.0 
Rhodopirellula 2 0.0 9 0.0 0 0.0 25 0.1 
Oribacterium 7 0.0 3 0.0 17 0.0 11 0.0 
Anaeroglobus 0 0.0 0 0.0 1 0.0 35 0.1 
118 
 
 
 
 
Table A2.  Clusters of orthologous groups (COGs) that are differentially represented in the 
ASP250 (n=1) vs. unmedicated (n=3) swine fecal metagenomes.  
Gene 
Family  
Adjusted P-
valuea 
Annotation 
More prevalent in medicated metagenome 
COG3188 0.000 P pilus assembly protein, porin PapC 
COG3539 0.000 P pilus assembly protein, pilin FimA 
COG0243 0.000 Anaerobic dehydrogenases, typically selenocysteine-
containing 
COG0814 0.000 Amino acid permeases 
COG1289b 0.000 Predicted membrane protein 
COG0675 0.000 Transposase and inactivated derivatives 
COG2909 0.000 ATP-dependent transcriptional regulator 
COG1662 0.000 Transposase and inactivated derivatives, IS1 family 
COG4644 0.000 Transposase and inactivated derivatives, TnpA family 
COG3121 0.000 P pilus assembly protein, chaperone PapD 
COG3468 0.000 Type V secretory pathway, adhesin AidA 
COG3570b 0.000 Streptomycin 6-kinase 
COG3164 0.000 Predicted membrane protein 
COG0430 0.000 RNA 3'-terminal phosphate cyclase 
COG5013 0.000 Nitrate reductase alpha subunit 
COG3596 0.000 Predicted GTPase 
COG3765 0.000 Chain length determinant protein 
COG0786 0.000 Na+/glutamate symporter 
COG3203 0.000 Outer membrane protein (porin) 
COG0583 0.000 Transcriptional regulator 
COG1735 0.000 Predicted metal-dependent hydrolase with the TIM-barrel fold 
COG1012 0.000 NAD-dependent aldehyde dehydrogenases 
COG3623 0.000 Putative L-xylulose-5-phosphate 3-epimerase 
COG2225 0.000 Malate synthase 
COG4533 0.000 ABC-type uncharacterized transport system, periplasmic 
component 
COG3019 0.000 Predicted metal-binding protein 
COG3272 0.000 Uncharacterized conserved protein 
COG1113 0.000 Gamma-aminobutyrate permease and related permeases 
COG4943 0.000 Predicted signal transduction protein containing sensor and 
EAL domains 
COG3131 0.000 Periplasmic glucans biosynthesis protein 
COG5518 0.000 Bacteriophage capsid portal protein 
COG1961 0.000 Site-specific recombinases, DNA invertase Pin homolog 
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COG3850 
 
 
0.000 
 
 
Signal transduction histidine kinase, nitrate/nitrite-specific 
COG1494 0.000 Fructose-1,6-bisphosphatase/sedoheptulose 1,7-bisphosphatase 
and related proteins 
COG1659 0.000 Uncharacterized protein, linocin/CFP29 homolog 
COG3228 0.000 Uncharacterized protein conserved in bacteria 
COG1475 0.001 Predicted transcriptional regulators 
COG1018 0.001 Flavodoxin reductases (ferredoxin-NADPH reductases) family 
1 
COG1288 0.001 Predicted membrane protein 
COG2959 0.001 Uncharacterized enzyme of heme biosynthesis 
COG3302 0.001 DMSO reductase anchor subunit 
COG3634 0.001 Alkyl hydroperoxide reductase, large subunit 
COG0654 0.001 2-polyprenyl-6-methoxyphenol hydroxylase and related FAD-
dependent oxidoreductases 
COG1986 0.002 Uncharacterized conserved protein 
COG2352 0.002 Phosphoenolpyruvate carboxylase 
COG1140 0.002 Nitrate reductase beta subunit 
COG2116 0.002 Formate/nitrite family of transporters 
COG1298 0.003 Flagellar biosynthesis pathway, component FlhA 
COG1391 0.003 Glutamine synthetase adenylyltransferase 
COG0064 0.004 Asp-tRNAAsn/Glu-tRNAGln amidotransferase B subunit 
(PET112 homolog) 
COG0754 0.004 Glutathionylspermidine synthase 
COG5339 0.004 Uncharacterized protein conserved in bacteria 
COG2837 0.004 Predicted iron-dependent peroxidase 
COG3477 0.005 Predicted periplasmic/secreted protein 
COG5404 0.005 SOS-response cell division inhibitor, blocks FtsZ ring 
formation 
COG5463 0.005 Predicted integral membrane protein 
COG5562 0.005 Phage envelope protein 
COG1172 0.005 Ribose/xylose/arabinose/galactoside ABC-type transport 
systems, permease components 
COG2186 0.005 Transcriptional regulators 
COG2844 0.005 UTP:GlnB (protein PII) uridylyltransferase 
COG4509 0.005 Uncharacterized protein conserved in bacteria 
COG1887 0.005 Putative glycosyl/glycerophosphate transferases involved in 
teichoic acid biosynthesis TagF/TagB/EpsJ/RodC 
COG1276 0.005 Putative copper export protein 
COG3626 0.005 Uncharacterized enzyme of phosphonate metabolism 
OG2375 0.005 Siderophore-interacting protein 
Table A2 continued. 
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COG3414 
 
 
0.005 
 
 
Phosphotransferase system, galactitol-specific IIB component 
COG5532 0.005 Uncharacterized conserved protein 
COG1199 0.005 Rad3-related DNA helicases 
COG2937 0.006 Glycerol-3-phosphate O-acyltransferase 
COG0531 0.006 Amino acid transporters 
COG3264 0.007 Small-conductance mechanosensitive channel 
COG1454 0.007 Alcohol dehydrogenase, class IV 
COG2515 0.007 1-aminocyclopropane-1-carboxylate deaminase 
COG3768 0.007 Predicted membrane protein 
COG2513 0.008 PEP phosphonomutase and related enzymes 
COG0709 0.008 Selenophosphate synthase 
COG0477b 0.008 Permeases of the major facilitator superfamily 
COG1988 0.008 Predicted membrane-bound metal-dependent hydrolases 
COG3449 0.008 DNA gyrase inhibitor 
COG2224 0.008 Isocitrate lyase 
COG2943 0.008 Membrane glycosyltransferase 
COG0321 0.008 Lipoate-protein ligase B 
COG3209 0.009 Rhs family protein 
COG2336 0.009 Growth regulator 
COG4573 0.009 Predicted tagatose 6-phosphate kinase 
COG2813 0.009 16S RNA G1207 methylase RsmC 
COG3316 0.010 Transposase and inactivated derivatives 
COG1131 0.011 ABC-type multidrug transport system, ATPase component 
COG4172 0.011 ABC-type uncharacterized transport system, duplicated 
ATPase component 
COG1982 0.011 Arginine/lysine/ornithine decarboxylases 
COG1832 0.011 Predicted CoA-binding protein 
COG3078 0.011 Uncharacterized protein conserved in bacteria 
COG3685 0.011 Uncharacterized protein conserved in bacteria 
COG3700 0.011 Acid phosphatase (class B) 
COG4700 0.011 Uncharacterized protein conserved in bacteria containing a 
divergent form of TPR repeats 
COG0666 0.012 FOG: Ankyrin repeat 
COG3691 0.012 Uncharacterized protein conserved in bacteria 
COG3971 0.012 2-keto-4-pentenoate hydratase 
COG2963 0.012 Transposase and inactivated derivatives 
COG3293 0.012 Transposase and inactivated derivatives 
COG0031 0.013 Cysteine synthase 
OG3605 0.013 Signal transduction protein containing GAF and PtsI domains 
COG2182 0.016 Maltose-binding periplasmic proteins/domains 
Table A2 continued 
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COG4580 
 
 
0.016 
 
 
Maltoporin (phage lambda and maltose receptor) 
COG3954 0.017 Phosphoribulokinase 
COG3054 0.017 Predicted transcriptional regulator 
COG1686 0.017 D-alanyl-D-alanine carboxypeptidase 
COG4579 0.018 Isocitrate dehydrogenase kinase/phosphatase 
COG4134 0.018 ABC-type uncharacterized transport system, periplasmic 
component 
COG0745 0.018 Response regulators consisting of a CheY-like receiver domain 
and a winged-helix DNA-binding domain 
COG2933 0.018 Predicted SAM-dependent methyltransferase 
COG3025 0.018 Uncharacterized conserved protein 
COG5410 0.018 Uncharacterized protein conserved in bacteria 
COG2205 0.019 Osmosensitive K+ channel histidine kinase 
COG0449 0.021 Glucosamine 6-phosphate synthetase, contains 
amidotransferase and phosphosugar isomerase domains 
COG2080 0.021 Aerobic-type carbon monoxide dehydrogenase, small subunit 
CoxS/CutS homologs 
COG1201 0.023 Lhr-like helicases 
COG2961 0.023 Protein involved in catabolism of external DNA 
COG4565 0.023 Response regulator of citrate/malate metabolism 
COG1263 0.023 Phosphotransferase system IIC components, 
glucose/maltose/N-acetylglucosamine-specific 
COG3096 0.023 Uncharacterized protein involved in chromosome partitioning 
COG2739 0.023 Uncharacterized protein conserved in bacteria 
COG1882 0.025 Pyruvate-formate lyase 
COG2088 0.025 Uncharacterized protein, involved in the regulation of septum 
location 
COG1357 0.026 Uncharacterized low-complexity proteins 
COG1250 0.026 3-hydroxyacyl-CoA dehydrogenase 
COG0825 0.028 Acetyl-CoA carboxylase alpha subunit 
COG1972 0.028 Nucleoside permease 
COG0818 0.029 Diacylglycerol kinase 
COG1732 0.029 Periplasmic glycine betaine/choline-binding (lipo)protein of an 
ABC-type transport system (osmoprotectant binding protein) 
COG2918 0.029 Gamma-glutamylcysteine synthetase 
COG3261 0.030 Ni,Fe-hydrogenase III large subunit 
OG2223 0.030 Nitrate/nitrite transporter 
COG4776 0.030 Exoribonuclease II 
COG3061 0.030 Cell envelope opacity-associated protein A 
COG3840 0.030 ABC-type thiamine transport system, ATPase component 
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COG1780 
 
 
0.030 
 
 
Protein involved in ribonucleotide reduction 
COG2862 0.030 Predicted membrane protein 
COG2924 0.030 Fe-S cluster protector protein 
COG3076 0.030 Uncharacterized protein conserved in bacteria 
COG3097 0.030 Uncharacterized protein conserved in bacteria 
COG3257 0.030 Uncharacterized protein, possibly involved in glyoxylate 
utilization 
COG3592 0.030 Uncharacterized conserved protein 
COG3783 0.030 Soluble cytochrome b562 
COG4135 0.030 ABC-type uncharacterized transport system, permease 
component 
COG0702 0.030 Predicted nucleoside-diphosphate-sugar epimerases 
COG2995 0.031 Uncharacterized paraquat-inducible protein A 
COG0148 0.031 Enolase 
COG0641 0.036 Arylsulfatase regulator (Fe-S oxidoreductase) 
COG2180 0.036 Nitrate reductase delta subunit 
COG2717 0.036 Predicted membrane protein 
COG4685 0.036 Uncharacterized protein conserved in bacteria 
COG0364 0.037 Glucose-6-phosphate 1-dehydrogenase 
COG1076 0.037 DnaJ-domain-containing proteins 1 
COG2915 0.037 Uncharacterized protein involved in purine metabolism 
COG3775 0.037 Phosphotransferase system, galactitol-specific IIC component 
COG2704 0.038 Anaerobic C4-dicarboxylate transporter 
COG2864 0.038 Cytochrome b subunit of formate dehydrogenase 
COG0121 0.038 Predicted glutamine amidotransferase 
COG2269 0.038 Truncated, possibly inactive, lysyl-tRNA synthetase (class II) 
COG2161 0.038 Antitoxin of toxin-antitoxin stability system 
COG2895 0.039 GTPases - Sulfate adenylate transferase subunit 1 
COG1064 0.040 Zn-dependent alcohol dehydrogenases 
COG0433 0.042 Predicted ATPase 
COG0815 0.042 Apolipoprotein N-acyltransferase 
COG4932 0.042 Predicted outer membrane protein 
COG1593 0.045 TRAP-type C4-dicarboxylate transport system, large permease 
component 
OG0695 0.045 Glutaredoxin and related proteins 
COG1636 0.045 Uncharacterized protein conserved in bacteria 
 
 
More prevalent in control metagenomes 
COG1629 0.000 Outer membrane receptor proteins, mostly Fe transport 
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COG1672 
 
 
0.000 
 
 
Predicted ATPase (AAA+ superfamily) 
COG1506 0.000 Dipeptidyl aminopeptidases/acylaminoacyl-peptidases 
COG0457 0.000 FOG: TPR repeat 
COG1373 0.000 Predicted ATPase (AAA+ superfamily) 
COG3385 0.000 FOG: Transposase and inactivated derivatives 
COG0438 0.000 Glycosyltransferase 
COG3292 0.000 Predicted periplasmic ligand-binding sensor domain 
COG0463 0.000 Glycosyltransferases involved in cell wall biogenesis 
COG1216 0.000 Predicted glycosyltransferases 
COG3210 0.000 Large exoproteins involved in heme utilization or adhesion 
COG3344 0.000 Retron-type reverse transcriptase 
COG0514 0.000 Superfamily II DNA helicase 
COG0614 0.001 ABC-type Fe3+-hydroxamate transport system, periplasmic 
component 
COG1260 0.001 Myo-inositol-1-phosphate synthase 
COG1205 0.001 Distinct helicase family with a unique C-terminal domain 
including a metal-binding cysteine cluster 
COG1649 0.001 Uncharacterized protein conserved in bacteria 
COG3666 0.002 Transposase and inactivated derivatives 
COG3876 0.002 Uncharacterized protein conserved in bacteria 
COG2148 0.003 Sugar transferases involved in lipopolysaccharide synthesis 
COG1086 0.003 Predicted nucleoside-diphosphate sugar epimerases 
COG3039 0.004 Transposase and inactivated derivatives, IS5 family 
COG2875 0.004 Precorrin-4 methylase 
COG0732 0.005 Restriction endonuclease S subunits 
COG3589 0.006 Uncharacterized conserved protein 
COG1522 0.007 Transcriptional regulators 
COG1595 0.007 DNA-directed RNA polymerase specialized sigma subunit, 
sigma24 homolog 
COG1453 0.008 Predicted oxidoreductases of the aldo/keto reductase family 
COG1479 0.008 Uncharacterized conserved protein 
COG4412 0.010 Uncharacterized protein conserved in bacteria 
COG0153 0.011 Galactokinase 
COG1472 0.011 Beta-glucosidase-related glycosidases 
COG0526 0.011 Thiol-disulfide isomerase and thioredoxins 
COG3177 0.013 Uncharacterized conserved protein 
COG4823 0.013 Abortive infection bacteriophage resistance protein 
COG1055 0.013 Na+/H+ antiporter NhaD and related arsenite permeases 
COG1404 0.014 Subtilisin-like serine proteases 
COG2319 0.015 FOG: WD40 repeat 
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COG3914 
 
 
0.017 
 
 
Predicted O-linked N-acetylglucosamine transferase, 
SPINDLY family 
COG4463 0.019 Transcriptional repressor of class III stress genes 
COG0615 0.019 Cytidylyltransferase 
COG3882 0.023 Predicted enzyme involved in methoxymalonyl-ACP 
biosynthesis 
COG2865 0.024 Predicted transcriptional regulator containing an HTH domain 
and an uncharacterized domain shared with the mammalian 
protein Schlafen 
COG4898 0.025 Uncharacterized protein conserved in bacteria 
COG4372 0.027 Uncharacterized protein conserved in bacteria with the myosin-
like domain 
COG0840 0.028 Methyl-accepting chemotaxis protein 
COG3590 0.028 Predicted metalloendopeptidase 
COG3600 0.028 Uncharacterized phage-associated protein 
COG5368 0.029 Uncharacterized protein conserved in bacteria 
COG4690 0.030 Dipeptidase 
COG1508 0.032 DNA-directed RNA polymerase specialized sigma subunit, 
sigma54 homolog 
COG0302 0.032 GTP cyclohydrolase I 
COG2189 0.032 Adenine specific DNA methylase Mod 
COG1188 0.036 Ribosome-associated heat shock protein implicated in the 
recycling of the 50S subunit (S4 paralog) 
COG3176 0.038 Putative hemolysin 
COG0535 0.038 Predicted Fe-S oxidoreductases 
COG4206 0.038 Outer membrane cobalamin receptor protein 
COG3878 0.038 Uncharacterized protein conserved in bacteria 
COG3527 0.038 Alpha-acetolactate decarboxylase 
COG3560 0.038 Predicted oxidoreductase related to nitroreductase 
COG1088 0.041 dTDP-D-glucose 4,6-dehydratase 
COG3291 0.042 FOG: PKD repeat 
COG1022 0.044 Long-chain acyl-CoA synthetases (AMP-forming) 
 
a. The P-value cut-off was <0.05.  P-values are adjusted for multiple testing.  See Kristiansson et al. 
2010 for more details. 
b. These COGs contain genes that were also identified in the antibiotic resistance gene database (Liu 
and Pop 2009) (Table 2.2). 
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Table A3.  Individual COGs of the energy production and conversion COG category that were significantly more prevalent in the 
medicated metagenome (n = 1) than the nonmedicated metagenomes (n = 3)  
 
  
Gene family Description 
COG0243 Anaerobic dehydrogenases, typically selenocysteine-containing 
COG1012 NAD-dependent aldehyde dehydrogenases 
COG1018 Flavodoxin reductases (ferredoxin-NADPH reductases) family 1 
COG1140 Nitrate reductase beta subunit 
COG1454 Alcohol dehydrogenase, class IV 
COG1882 Pyruvate-formate lyase 
COG2080 
Aerobic-type carbon monoxide dehydrogenase, small subunit CoxS/CutS 
homologs 
COG2180 Nitrate reductase delta subunit 
COG2224 Isocitrate lyase 
COG2225 Malate synthase 
COG2352 Phosphoenolpyruvate carboxylase 
COG2864 Cytochrome b subunit of formate dehydrogenase 
COG2924 Fe-S cluster protector protein 
COG3261 Ni,Fe-hydrogenase III large subunit 
COG3783 Soluble cytochrome b562 
COG3954 Phosphoribulokinase 
COG5013 Nitrate reductase alpha subunit 
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Table A4.  Primer sets targeting antibiotic resistance genes (specificity classified by ARDB) 
 
Forward Primer Reverse Primer ARG name 
CGTCACTTATTCGATGCCCTTAC GTCGGGCGCGGCATA aac3vi 
GTTTGAGAGGCAAGGTACCGTAA GAATGCCTGGCGTGTTTGA aac6ib 
ACACTGCGCCTCATGACTGA GTCGGGCGTGCTTCTTCTC aac6ib 
AGAAGCACGCCCGACACTT GCTCTCCATTCAGCATTGCA aac6ib 
CCGACAACATTTCTACCATCCTT ACCGAAGCGCTCGTCGTATA aadd 
GGTCTATCACCCTACGCGCTATC GCGCGCACGAACATACC acra 
CAACGATCGGACGGGTTTC TGGCGATGCCACCGTACT acra 
TACTTTGCGCGCCATCTTC CGTGCGCGAACGAACAT acra 
ACGGCTCCGCAGTGGAT GGCCACAGTAACCAACAAATCA ant2ia 
CTTGTCGTGCATGACGACATC TCGAAGATACCCGCAAGAATG ant2ia 
AGCTAAGCGCGAACTGCAAT TGGCTCGAAGATACCTGCAA ant3ia 
GTTGTGCACGACGACATCATT GGCTCGAAGATACCTGCAAGAA ant3ia 
CAATGACATTCTTGCGGGTATC GACCTACCAAGGCAACGCTATG ant3ia 
CGAGATTCTCCGCGCTGTA GCTGCCATTCTCCAAATTGC ant3ia 
TTGTGCACGACGACATCATTC TGGCTCGAAGATACCTGCAA ant3ia 
TGAACAAGTCTGGAAAGAAATGCA CCTATTAATTTCCCCTCGTCAAAAA aph3ia 
CGGAATTGAAAAAACTGATCGAA ATACCGGCTGTCCGTCATTT aph3iiia 
GCTCGGTCGTGAGAACAATCT CAATTTCGGTCGCCTGGTAGT aph6id 
TTTTGGGTGTGGTCGAAGGA GGCCGTATCGCCTTCAAAC baca 
TTCCACGACACGATTAAGTCATTG CGGCTCTTTCGGCTTCAG baca 
CCGGATGAGGTCACGGATAC ATGCTGGCGTTAGCGTAAAGA bl1_ampc 
CCGCTCAAGCTGGACCATAC CCATATCCTGCACGTTGGTTT bl1_ampc 
CTGTTCGAGCTGGGTTCTATAAGTAAA CAGTATCTGGTCACCGGATCGT bl1_ampc 
AAAGCCTCATGGGTGCATAAA ATAGCTTTTGTTTGCCAGCATCA bl1_cmy2 
CAGCCGCTGATGAAAAAATATG CAGCGAGCCCACTTCGA bl1_sm 
GCAATGTGCTCAACGTTCAAG GTGCCTGAGTCAATTCTTTCAAAG bl2_ges 
GGAGATAAAGTAACAAATCCAGTTAGATATGA TGCTTAATTTTCCATTTGCGATAAG bl2a_pc 
TTGACGCCGGGCAAGA TGCTTTTCTGTGACTGGTGAGTACT bl2b_tem1 
AGCATCTTACGGATGGCATGA TCCTCCGATCGTTGTCAGAAGT bl2b_tem1 
CTGATTGACACCGCCGATAAC GGTGCTGCACATGGCAAAG bl2be_ctxm 
CCGCCATGAACAAATTGATTG TTCAGTGCGATCCAGACGAA bl2be_ctxm 
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Table A4 continued 
   
GCGATAACGTGGCGATGAAT GTCGAGACGGAACGTTTCGT bl2be_ctxm 
CACAGTTGGTGACGTGGCTTAA CTCCGCTGCCGGTTTTATC bl2be_ctxm 
TGCTGGTTGCTGTTTTTGTGA CCTGCGCAATGATAGCTTCAT bl2be_per 
GGCGCGCCGATGAAC TCCTGCTGGCGATAGTGGAT bl2be_shv2 
CTTTCCCATGATGAGCACCTTT TCCTGCTGGCGATAGTGGAT bl2be_shv2 
CGGATGGTTTGAAGGGTTTATTAT TCTTGGCTTTTATGCTTGATGTTAA bl2d_oxa1 
AGTTGCGCAGAACAGTCCTCTT TCGTATCTTGCCCGTCGATAAT bl2e_cepa 
TCATTCCTCGTTCAAGTTTTCAGA TGCAGCACCAAGAGGAGATGT bl2e_cfxa 
CCGCCAAATTATTAATGTCCAAAT CAAGAGTGATGCGTCTCCAACTT bl3_imp 
AACACGGTTTGGTGGTTCTTGTA GCGCTCCACAAACCAATTG bl3_imp 
AAGGCAGCATTTCCTCTCATTTT GGATAGATCGAGAATTAAGCCACTCT bl3_imp 
GCACTTCTCGCGGAGATTG CGACGGTGATGCGTACGTT bl3_vim 
GGGTGAGTTTCACCAGTTTTGATT CACCTTGTCGCCTTGCGTATA cata1 
TAGGAAGCATCGGAACGTTGAT CAGACCGAGCACGACTGTTG cml_e1 
AGGAAGCATCGGAACGTTGA ACAGACCGAGCACGACTGTTG cml_e1 
CCTGTGGTACGGAGAATTCATGT ACCGCATTCGCTTTGCTT erea 
CGGATCAGGAAAAGGACATTTT AGCCTCCATCAATTTCTATAGCAGTAA erma 
CATTTTACCAAGGAACTTGTGGAA TGGCATGACATAAACCTTCATCA erma 
AAATCGGATCAGGAAAAGGACAT CCTCCATCAATTTCTATAGCAGTAACTG erma 
TTGAGAAGGGATTTGCGAAAAG ATATCCATCTCCACCATTAATAGTAAACC erma 
ACATTTTACCAAGGAACTTGTGGAA GTGGCATGACATAAACCTTCATCA erma 
TGAAAGCCATGCGTCTGACA CCCTAGTGTTCGGTGAATATCCA ermb 
ATTCACCGAACACTAGGGTTGCT CATTCCGCTGGCAGCTTAA ermb 
TAAAGGGCATTTAACGACGAAACT TTTATACCTCTGTTTGTTAGGGAATTGAA ermb 
GTCATCTATTCAACTTATCGTCAGAAAAAT ACCTCTGTTTGTTAGGGAATTGAAA ermb 
CGTGGAATACGGGTTTGCTAA TAGGATGAAAATATTCTCTTGGAACCAT ermc 
ATATCTTTGAAATCGGCTCAGGAA ATGGTCTATTTCAATGGCAGTTACG ermc 
AATACAAAACGCTCATTGGCATT TAGGATGAAAATATTCTCTTGGAACCATA ermc 
TTTGAAATCGGCTCAGGAAAA ATGGTCTATTTCAATGGCAGTTACG ermc 
TTTCAAAGTGGTGTCAAATATTCCTT GGACAATGGAACCTCCCAGAA ermf 
ATTCCTTATGGCATTACTTCCGATATT AATGGAACCTCCCAGAAAATTTC ermf 
CAGCTTTGGTTGAACATTTACGAA AAATTCCTAAAATCACAACCGACAA ermf 
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Table A4 continued 
 
GTGTCAAATATTCCTTATGGCATTACTT GACAATGGAACCTCCCAGAAAAT ermf 
GTTCACTAGCACTATTTTTAATGACAGAAGT GAAGGGTGTCTTTTTAATACAATTAACGA ermt 
GTAAAATCCCTAGAGAATACTTTCATCCA TGAGTGATATTTTTGAAGGGTGTCTT ermt 
GCTCAGTGGTCCCCATGGT ATCCCCCCGTCAACGTTT ermx 
CTCGGGTACCAAGGTCTGCTT CACTAAGATCCCCCCGTCAA ermx 
TTGTCTTTGAAAGTGAAGCAACAGT TAACGCTAGAGAACGATTTGTATTGAG ermy 
TCGACGTGACCGTAGTGAACA CGTGACTACCCAGGTGAGTTGA lmra 
TGACGCTCAACACACTCAAAAA TTCATGCTTAAGTTCCATACGTGAA lnua 
AGAATGAAAAAGAAGCTGAGCTTCTT AAGGTGGCAATTACGTTTTTCAAA lnua 
TGAACATAATCCCCTCGTTTAAAGAT TAATTGCCCTGTTTCATCGTAAATAA lnub 
AAAGGAGAAGGTGACCAATACTCTGA GGAGCTACGTCAAACAACCAGTT lnub 
GGTTACGGACAAGGTGAAATACTGAT TGTCTTTTAATAAGTGAGGTGCGTTAATA meca 
CCGTAGCATTGGAACAGCTTTT AAACGGAGTATAAGAGTGCTGCAA mefa 
CGGTTACACCACTTTTAGTACCAGAAG TGCAACTGCCGGACTAACAA mefa 
TTGCATCTATTACGGTAGCAATTGTA GTCTCAATGCGACAATTCCTTCTT mefa 
TGCGGTTACGCCACTTTTAGTA CAACCGCCGGACTAACAATATAG mefa 
ATGAACGGGATCGACAATCTG GCCAGTTGCAGCTTGTTCTG mexb 
GGTCAGCACCGACAAGGTCTAC AGCTCGACGTACTTGAGGAACAC mexe 
CCGCGAGAAGGCCAAGA TTGAGTTCGGCGGTGATGA mexf 
CGCAGCGCTTGATCTTGTAG TTACTGCATCCATACGCTGCTT mphb 
CGTTTGAAGTACCGAATTGGAAA GCTGCGGGTTTGCCTGTA mphc 
CTGCTAACACAAGTACGATTCCAAAT TCAAGTAAAGTTGTCTTACCTACACCATT msra 
AACGAAATCAAGCGCAACAA CAACCGTGCCTTTTTCTTTTG msra 
TGGCAATAGGAGCTATGGTGTTT AAGGTAACACTATTTTCGGTCCAAATC qaca 
AATGAGTTTTGGAGTGTCTCAACGTA AATCAAAACCCCTATTAAAGCCAAT str 
TCATCTGCCAAACTCGTCGTTA GTCAAAGAACGCCGCAATGT sul2 
GCTGTTTGTTCTGCCGGAAA GGTTAAGTTCCTTGAACGCAAACT tet30 
CCATTACTTCGGACAACGGTAGA CAATCTCTGTGAGGGCATTTAACA tet32 
CTTAGCGCAAACAGCAATCAGT CGGTGATACAGCGCGTAAACT tet34 
AGAATACTCAGCAGAGGTCAGTTCCT TGGTAGGTCGATAACCCGAAAAT tet36 
TGCAGGAAAGACCTCCATTACAG CTTTGTCCACACTTCCACGTACTATG tet36 
TTAATGTGGCGGTATCTGTAGGTATT TTGCCTGGGAAATTTAATGCTTT tet38 
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Table A4 continued 
 
CTCACCAGCCTGACCTCGAT CACGTTGTTATAGAAGCCGCATAG teta 
AGTGCGCTTTGGATGCTGTA AGCCCCAGTAGCTCCTGTGA tetb 
GCCCAGTGCTGTTGTTGTCAT TGAAAGCAAACGGCCTAAATACA tetb 
TGCCGCGTTTGATTACACA CACCAGTGATCCCGGAGATAA tetd 
TGTCATCGCGCTGGTGATT CATCCGCTTCCGGGAGAT tetd 
TCAACCATTGCCGATTCGA TGGCCCGGCAATCATG tetg 
CATCAGCGCCGGTCTTATG CCCCATGTAGCCGAACCA tetg 
TTTGGGTCATCTTACCAGCATTAA TTGCGCATTATCATCGACAGA teth 
GGGTGCCGCATTAGATTACCT TCGTCCAATGTAGAGCATCCATA tetj 
CAGCAGTCATTGGAAAATTATCTGATTATA CCTTGTACTAACCTACCAAAAATCAAAATA tetk 
AGCCCGATTTATTCAAGGAATTG CAAATGCTTTCCCCCTGTTCT tetl 
ATGGTTGTAGTTGCGCGCTATAT ATCGCTGGACCGACTCCTT tetl 
CATCATAGACACGCCAGGACATAT CGCCATCTTTTGCAGAAATCA tetm 
TAATATTGGAGTTTTAGCTCATGTTGATG CCTCTCTGACGTTCTAAAAGCGTATTAT tetm 
TTTTAGAACGTCAGAGAGGAATTACAAT CGTGTCTATGATGTTCACCTTCGT tetm 
ATAAAGGCACAACAAGAACGGATT CGGCAGCCTGAATGGTAATT tetm 
ATGTGGATACTACAACGCATGAGATT TGCCTCCACATGATATTTTTCCT teto 
AGTTGCAGATGTGTATAGTCGTAAACTATCTATT TGCTACAAGTACGAAAACAAAACTAGAA tetpa 
CGCCTCAGAAGTAAGTTCATACACTAAG TCGTTCATGCGGATATTATCAGAAT tetq 
TTAAGGACAAACTTTCTGACGACATC TGTCTCCCATTGTTCTGGTTCA tets 
GCGGGAACGACGATGTATATC CCGCTATCTCACGACCATGAT tetv 
TCCTTCCAGTGGCACAGATGT GCCCCATCTAAAACAGCCAAA tetw 
TTGCAGAACTAGGGAGCGTAGAT AAAAGATGTCACTGCTGTCTGGATA tetw 
ATGAACATTCCCACCGTTATCTTT ATATCGGCGGAGAGCTTATCC tetw 
CAACATTAACGGAAAGTTTATTGTATACCA TTGACGCTCCAAATTCATTGTATC tetw 
AAATTTGTTACCGACACGGAAGTT CATAGCTGAAAAAATCCAGGACAGTT tetx 
AAAAGGCTCTGAAAACGCAGTTAT CGGCCGTTATCTTGTAAAAACAT vana 
TTGTCGGCGAAGTGGATCA AGCCTTTTTCCGGCTCGTT vanb 
CCGGTCGAGGAACGAAATC TCCTCCTGCAAAAAAAGATCAAC vanb 
CAGAGGAACATAATGTTTCGATAAAATCT GCCGGATTTTGTGATTCCAA vand 
GAGGTTTCCGAGGCGACAA CTCTCGGCGGCAGTCGTAT vanhb 
GTGGCCGATTATACCGTCATG CGCAGGTCATTCAGGCAAT vanhd 
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Table A4 continued 
 
CCCTTACTCCCACCGAGTTTT TTCGTCGCCCCATATCTCAT vanra 
CCACTCCGGCCTTGTCATT GCTAACCACATTCCCCTTGTTTT vanra 
CGCGTCATGCTTTCAAAATTC TCCGCAGAAAGCTCAATTTGTT vansa 
CGGACAAAGATACCCCCTATAAAG AAATAGTAAATTGCTCATCTGGCACAT vanwb 
ACATTTTCATTTTGGCAGCTTGTAC CCGCCATAAGAGCCTACAATCT vanwg 
CGCTAAATATGCCACTTGGGATA TCAAAAGCGATTCAGCCAACT vanxa 
AGGCACAAAATCGAAGATGCTT GGGTATGGCTCATCAATCAACTT vanxb 
TAAACCGTGTTATGGGAACGAA GCGATAGCCGTCCCATAAGA vanxd 
TGCAATAGTAGCTGCTAATTCTGTTGTT TGTTTTATTTCGTTAGCAGGATTTCC vatd 
GGTGCCATTATCGGAGCAAAT TTGGATTGCCACCGACAAT vate 
GACCGTCCTACCAGGCGTAA TTGGATTGCCACCGACAATT vate 
CGAGTATTGTGGAAAGCAGCTAGTT CCCGTACCGTTAGAGCCGATA vgaa 
GACGGGTATTGTGGAAAGCAA TTTCCTGTACCATTAGATCCGATAATT vgaa 
ATACGAGCTGCCTAATAAAGGATCTT TGTGAACCACAGGGCATTATCA vgba 
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Table A5.  Primer sets targeting antibiotic resistance genes (specificity classified by NCBI) 
Forward Primer Reverse Primer ARG name 
CGTCGCCGAGCAACTTG CGGTACCTTGCCTCTCAAACC aac 
CGCGGCAAGCCTATCTTG CAAATCAGCGACCGCAGACT aad9 
GGATGCACGCTTGGATGAA CCTCTAGCGGCCGGAGTATT aad9 
ATCACGATCTTGCGATTTTGCT CTGCGGATGGGCCTAGAAG aadA5 
GTTCTTGCTCTTGCTCGCATT GATGCTCGGCAGGCAAAC aadA5 
GTTCTTGCTCTTGCTCGCATT GATGCTCGGCAGGCAAAC aadA5 
GAATGGGCAAAGCATAAAAACTTG CCGATTTTGAAACCACAATTATGATA aadE 
CGTGCGCGAACGAACA ACTTTGCGCGCCATCTTC acrA 
GATGATACCCCCTGCTGTGAGA ACCAAACAAGAAGCGCAAGAA acrA 
GCGCTGGAGACACGACAAC GCCTTGCTGCGAGAACAAA acrA 
CAGACCCGCATCGCATATT CGACAATTTCGCGCTCATG acrA 
TTCTTGCTCTTGCTCGCATTT GATGCTCGGCAGGCAAAC ant4IIa 
TACCTTATTGCCCTTGGAAGAGTTA GGAACTATGTCCCTTTTAATTCTACAATCT ant6ia 
TAAGGATATACCGACAGTTTTGGAAA TTTAATCCCTCTTCATACCAATCCATA aph2 
TGAGCAGTATCATAAGTTGAGTGAAAAG GACAGAACAATCAATCTCTATGGAATG aph2 
CCGGTGGCATTTGAGAAAAA GTGGCTCAACCTGCGAAAAG aph33ib 
ATACAGCAGTGGATATTGGTTTAATTGT TGCATAAGGTGAATGTTCCATGA araJ 
CGGCTTCGTGACCTCGTT ACAATGCGATACCAGGCAAAT bacA 
CTGCGTGTCGATGGTGTCAT GCCGTTCCCGCCATATG bcr 
GCGGATCTCTGGTCAGCAA TGATTGATGGTTCCCCGTACA bexA 
GGTTTGCCGCTGCAGTTC GCGGCCAGGTGACCAA bl1_ampc 
CCGCCCAGAGCAAGGACTA GCTCGACTTCACGCCGTAAG bl1_ampc 
GCGAGCAGCCTGAAGCA CGGATGGGCTTGTCCTCTT bl1_cmy2 
GCAGCGAAGCGTCAGTCA AGATCCGTGGCCGCATAA blaBES 
GGAGGCGTGACGGCTTTT TTCAGTGCGATCCAGACGAA blaCTX 
CGATACCACCACGCCGTTA GCATTGCCCAACGTCAGATT blaCTX 
GCCGCGGTGCTGAAGA ATCGGATTATAGTTAACCAGGTCAGATTT blaCTX 
CTTGGCGTTGCGCTGAT CGTTCATCGGCACGGTAGA blaCTX 
CCGCCGCCATCCAGTA GGGCCGCCAAGATGCT blaSFO 
ACACTTTGCCATTGCTGTTTATGT TGCAAATTTCGGCAATAATCTTT blaTLA 
CGCAACTAGCTCTGCATGACAT CTCGCCCGGCTTGATG carA 
GGAGTGAGGCTGACCGTAGAAG ATCGGCGAAACGCACAAA carB 
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Table A5 contiued  
GCAGCGTTGCTGGACACA GTTCGGGATAAACGTGGTGACT cfiA 
GCAGCGTTGCTGGACACA TTCGGGATAAACGTGGTGACTT cfiA 
AGGTTCGGACTCAATGCAACA TTCAGCACATACCGCCTTGAT cfiA 
GGAAATCAACGGCATCCAGTT CATCCATGCGCTTTTGTCTCT cfiA 
GCAAAATTCAGAGCAAGTTACGAA AAAATGACTCCCAACCTGCTTTAT cfr 
GCAGCAAAGAAGAAGCACCAA AGCAGGGTAAGTAAAACTAAGTGGTAAATCT cme 
CGGCATCGTCAGTGGAATT CGGTTCCGAAAAAGATGGAA cmr 
TGGCCGCAGCAGAAAGA CCGTTTTATGCACCCAGGAA dha 
GCTTTATTTCAGGAGGCGGAAT TTTTAAATGCCACAGCACAGAATC ereB 
TCGACATGCGTGACGAGATT CCGCGAATTAGGCCAGAA erm30 
TCGTGGGCCAGGTGAAGA TTCCCCTTGCCGGTGAA erm30 
GCGCGTTGACGACGATTT TGGTCATACTCGACGGCTAGAAC erm34 
TTGAAAACGATGTTGCATTAAGTCA TCTATAATCACAACTAACCACTTGAACGT erm35 
GGCGGACCGACTTGCAT TCTGCGTTGACGACGGTTAC erm36 
CTCTCAGAGGCTCATAGACGAAGA TTTACGAAGTTACCAGACGTTTGTTTA ermC 
GGACTCGGCAATGGTCAGAA CCCCGAAACGCAATATAATGTT ermJ,D 
GTTTGATATTGGCATTGTCAGAGAAA ACCATTGCCGAGTCCACTTT ermJ,D,K 
GAGCCGCAAGCCCCTTT GTGTTTCATTTGACGCGGAGTAA ermK 
TTTCAGCTCAGCACTTTGGTCAT AAGGCATCTTTTTCAGCCAGTTC fab 
CGAGCAGTTCCTGCCAAAG CCCAGTCATCCGGTTCATAATC folA 
TCACTGTAACTAATGAAGCATTAGACCAT CCATCTGGATCTGTAAAGTAAAGAGATC fosB 
CCGGACTAGAGCTTCATGTAAGC CCCACGCGGTACTCTTGTAAA imiR 
TTCAGATGCAATGGCGTTTG ATAATCGGGAACATAATGAGCATAACTAC lmrA 
TGGTCAATATAACAGATGTAAACCAGATTT CACCCCAGCCACCATCAA lnuC 
TCTGGCGTTAGCTTCACCAGTAC GTGCAAAGGCTGGATCGAA marA 
GCGGCGTACTGGTGAAGCTA TGCCCTGGTCGTTGATGA marA 
CCTAACGGGCGTGACTTCA TTCACCTGTTTCAAGGGTCAAA mdtA 
ATCGGTCGCTCTTCGTTCAC ATAAATAGGATCGAGCTGCTGGAT mepA 
TCACGACCGCCGATACCT GCCCAAGCTCATTGACAGTCA mphA 
CTGACGCGCTCCGTGTT GGTGGTGCATGGCGATCT mphA 
TGATGACCCTGCCATCGA TTCGCGAGCCCCTCTTC mphA 
GAATCACTTGTCCGCAGTTTGTT CGTACACAACGGTTTCGTCAGA msrC 
TCAGACCGGATCGGTTGTC CCTATTTTTTGGAGTCTTCTCTCTAATGTT msrC 
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GCAAGAGCCAAGCTGCAAA TCCGCAGCCCTTTCCAA msrD 
TAGTAGGCAAGCTCGGTGTTGA CCTGTGCTATTTTAAGCCTTGTTTCT msrD 
GGACGGGAAGATGGTCCAA CGTAGCGTTCCGGTTCGAT mtrC 
CGGAGTCCATCGACCATTTG ATCGTCGGCAAGGAGAATCA mtrC 
TGCGCGTAGTCGTTCATCTC CGTTCCAATTTCCTGATGATTG mtrD 
CCGCCAAGCCGATATAGACA GGCCGGGTTGCCAAA mtrD 
GGTCGGCACGCTCTTGTC TGAAGAATTTGCGCACCACTAC mtrE 
CGATGTGTCGTTTTGGAAGGT CCTGCACCATGATTCCTCAATA mtrE 
AGCGTCAATGGCACCTTCA AATCGAGCTGGCTGGAGTTG mtrE 
AATTTTGCCGATTATTGCTGAAA GATTGTCATCATTCGTTTATCACCAA multidrug 
TGCGCCAAGATAGGGCATA GTCGTGAATTCGGCAGGTTTA nimE 
GGGAGAGTTGCCGATGTTGTA AGCCACTCGTTAAAGGGCAAT nisB 
CCCGGAGTCGATGTTCGA GCCGAAGACGTACACGAACAG oleC 
CCGGTGCCATTGGTTTAGA AAAATAGCCGCCCCAAGATT pbp 
GGCGAACTTCTAATTAATCCTATCCA CGCCGATGACATTCTTCTTATCTT Pbp5 
CTTTTCTCTAACCGTACATTATCTACGATAAA AGAACGTAGCGACTGATAAAATGCT Protein B 
TTTAGGCAGCCTCGCTTCA CCGAATCCAAATAAAACCCAATAA protein D 
CAATAATAACCGAAATAATAGGGACAAGTT AATAAGTGTTCCTAGTGTTGGCCATAG qac 
CATCGTGCTTGTGGCAGCTA TGAACGCCCAGAAGTCTAGTTTT qac 
GTGGCAGCTATCGCTTGGAT CCAACGAACGCCCACAA qac 
TCGCAACATCCGCATTAAAA ATGGATTTCAGAACCAGAGAAAGAAA qac 
CCCCTTCCGCCGTTGT CGACCAGACTGCATAAGCAACA qacEdelta1 
GCGGGTGTGGTCACTACGAT AGCGTTGGGCCGATATACTG rarD 
TGACGCATCGCGTGATCT AAATTTTCTGTGGCGTCTGAATC rarD 
CACTACCGCTTCCGCACTTAA TGAAAAAACGGGAAAAGTCCAT sdeAB 
CAGAATCTTCCTGAAAAGTTTGATGAA CGCAGACACGCCGAATC spcN 
AAAAGTTCGATGAAACACGCCTAT TCCAGTGGTAGTCCCCGAATC spcN 
GCAAGAGGTATTTGCTCAACAAGA CAGGGTCACCCTCATAAAGAAAA speA 
TTTCAGCAAGTGGATCATGTTAAAAT CCAAGCTGTTTCCACTGTTTTTC spec-aph 
CAGCGCTATGCGCTCAAG ATCCCGCTGCGCTGAGT sul1 
GCGATTCGCAAGGAAAGTGA CACATGGGCCATTTTTTCATC sulA 
CAGGCTCGTAAATTGATAGCAGAAG CTTTCCTTGCGAATCGCTTT sulA 
CACGGCTTCGGCTCATGT TGCCATCCTGTGACTAGCTACGT sulA 
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ACCCCATGACGTACCTGTAGAGA CAACCCACACTGGCTACCAGTT tet35 
GAGAACGTTGAAAAGGTGGTGAA AACCAAGCCTGGATCAGTCTCA tet37 
CATATCGCAATACATGCGAAAAA AAAGCCGCGGTAAATAGCAA tetC 
ACTGGTAAGGTAAACGCCATTGTC ATGCATAAACCAGCCATTGAGTAAG tetC 
ATGAGTTCGGCCAGAATTTCC GGTTGTGCGCGAAATGATT tetR 
CGCGATAGACGCCTTCGA TCCTGACAACGAGCCTCCTT tetR 
CGCGATGGAGCAAAAGTACAT AGTGAAAAACCTTGTTGGCATAAAA tetR 
GTGGCAAAGCAACGGATTG TGCGGGCTTGCAAAACTATC tetU 
AACAGCGGGTTAAGTGTGCAA ATGGTATCATTCAGTTTTCCGACAAT tetU 
GTGGCAAAGCAACGGATTG AATGCGGGCTTGCAAAACT tetU 
CATCATCGGACGGACAGAATT GTCGGAGATGTGGGTGTAGAAAGT Tn21 
GGGCGGGTCGATTGAAA GTGGGCGGGATCTGCTT Tn22 
GAAACCGATGCTACAATATCCAATTT CAGCACCGTTTGCAGTGTAAG Tn23 
GCCGCACTGTCGATTTTTATC GCGGGATCTGCCACTTCTT Tn24 
CCGATCACGGAAAGCTCAAG GGCTCGCATGACTTCGAATC Tn25 
ACGCCAATGCCAAACGATT GTCACGGCGCAGCTTGA ttgA 
TCGCCCTGGATGTACACCTT ACCATTGCCGACATCAACAAC ttgB 
ACAGGGATTGGCTATGAACCAT TGACTGGCGATGATTTGACTATG vanC 
CCTGCCACAATCGATCGTT CGGCTTCATTCGGCTTGATA vanC 
AAATCAATACTATGCCGGGCTTT CCGACCGCTGCCATCA vanC 
CACACGCATTTTTTCCCATCTAG CAGCCAACAGATCATCAAAACAA vanC-3 
TGAACAATTTTACAGGTTGGATACATCT TCCCGTTATGAAGCTCCACTATTT vanS 
GGAAAAAGCAACTCCATCTCTTGA TCCTGGCATAACAGTAACATTCTGA vatB 
TTGGGAAAAAGCAACTCCATCT CAATCCACACATCATTTCCAACA vatB 
CGGAAATTGGGAACGATGTT GCAATAATAGCCCCGTTTCCTA vatC 
TAAAAGAGAATAAGGCGCAAGGA TGTTTAGTAGCATGTTGCATTTTCC vgaB 
GAATGATTAAGCCCCCTTCAAAA ATTCGTGTTTCCAACGATTTCG vgaB 
AGGGAGGGTATCCATGCAGAT ACCAAATGCGCCCGTTT vgb 
CCACGATGGCTGCCTTTG GGCCATGCAGGACGGATAT vgb 
CGATGTTTGGATTGGACGAGAT GCTGCAATAATAGCCCCGTTT vgbB 
CAGCCGGATTCTGGTCCTT TACGATCTCCATTCAATTGGGTAAA vgbB 
CCGTTGCAAGAAGATTATAGAAAAAA CAAGCATAAGACCGCATAAATGAT yyaR 
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Table A6.  Quantitative PCR primers used in validation of the antibiotic resistance primer set 
 
Target 
Gene Forward Sequence (5'-3') Reverse Sequence (5'-3') Size Use 
Annealing 
Temp Reference 
blaSHV TGCTTGGCCCGAATAACAA GCGTATCCCGCAGATAAATCA N/A qPCR 60 Hammond (19) 
cfiA GTCGCAGTTATGGCACAGAA TCATTGATCGGTGTGTCCAG N/A qPCR 55 Pumbwe (20) 
ermA TATCTTATCGTTGAGAAGGGATT CTACACTTGGCTTAGGATGAAA 138 qPCR 60 Diaz (21) 
ermB GATACCGTTTACGAAATTGG GAATCGAGACTTGAGTGTGC 364 qPCR 58 Chen (22) 
mexE CCAGGACCAGCACGAACTTCTTGC CGACAACGCCAAGGGCGAGTTCACC 114 qPCR 60 Dumas (23) 
sul(I) CGCACCGGAAACATCGCTGCAC TGAAGTTCCGCCGCAAGGCTCG 163 qPCR 65 Pei (24) 
tetA GATATTCTGAGCACTGTCGC CTGCCTGGACAACATTGCTT 950 PCR 55 Cabrera (25) 
tetB CTAATCTAGACATCATTAATTCC TTTGAAGCTAAATCTTCTTTAT 1,397 PCR 50 Furushita (26) 
tetC ATGAAATCTAACAATGCGC TCAGGTCGAGGTGGCCCGG 1,191 PCR 50 Furushita (26) 
tetD GAATGCCTGCACCTTTCTGATG GGCAATAAATCCGGCGAAAA 346 qPCR 62 Fan (27) 
tetG GCTCGGTGGTATCTCTGCTC AGCAACAGAATCGGGAACAC 468 qPCR 62 Fan (27) 
tetH GTGATGTGACTCCCGCTAAAAAT CCAGAACCGCCAAAGACATACC 407 qPCR 62 Fan (27) 
tetM GAGGTCCGTCTGAACTTTGCG AGAAAGGATTTGGCGGCACT 900 PCR 54 Zhang, 2008(28) 
tetO TTGTTTTGGGGCTATTGGAG TATATGACTTTTGCAAGCTG 2,037 PCR 60 Patterson,2007(29) 
tetS CATAGACAAGCCGTTGACC ATGTTTTTGGAACGCCAGAG 667 PCR 55 Ng, 2001(30) 
tetW TTGGGGCTGTAAAGGGAGGAC CTTTACATTACCTTCTGA 1,949 PCR 52.5 Patterson (29) 
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APPENDIX B. SUPPORTING INFORMATION FOR CHAPTER 3: 
SWINE MICROBIAL COMMUNITIES, SUBDIVIDED BY 
INTESTINAL LOCATIONS AND ANTIBIOTICS  
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Figure B1.  Total assigned reads from metagenomes from lumen samples, averaged by 
intestinal location and treatment.  
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Figure B2. Stress Response assignments among the locations (non-medicated). Comparison 
of the number of SEED subsystem reads revealed differences among gut locations.  Thirteen 
subsystems were significantly differently represented among the four gut locations. 
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Table B1.  Most abundant bacteria from the intestinal samples of swine fed ASP250 and their nonmedicated counterparts. 
Phylotype summary table includes top genera, normalized and averaged by treatment and intestinal site.  
non=nonmedicated, med=medicated 
Genera 
Ileum 
lumen 
non 
leum 
lumen 
med 
Cecum 
lumen 
non 
Cecum 
lumen 
med 
Colon 
lumen 
non 
Colon 
lumen 
med 
Feces 
lumen 
non 
Feces 
lumen 
med 
leum 
Tissue 
non 
I leum 
Tissue 
med 
Cecum 
Tissue 
non 
Cecum 
Tissue 
med 
Colon 
Tissue 
non 
Colon 
Tissue 
med 
Prevotella 0 0 971 1047 470 601 443 512 132 208 784 1049 550 956 
Anaerobacter 851 1079 82 174 59 178 135 415 348 444 38 71 41 65 
Turicibacter 633 310 35 18 29 10 38 15 440 341 28 16 26 8 
Coprococcus 0 0 126 211 162 145 77 123 9 35 109 202 112 151 
Papillibacter 0 0 37 78 109 219 209 158 5 33 42 62 94 82 
Treponema 0 0 116 31 220 18 195 71 10 20 103 36 228 63 
Oscillibacter 0 0 59 41 109 188 112 124 3 13 42 46 85 109 
Roseburia 0 0 131 65 46 53 14 17 5 24 217 112 35 75 
Bacteroides 0 0 48 69 132 146 49 40 5 17 61 85 57 77 
Lactobacillus 74 153 13 48 17 29 23 18 54 148 15 91 19 29 
Anaerovibrio 0 0 135 50 89 82 8 18 13 12 181 101 69 55 
Escherichia 3 351 0 22 0 27 1 13 7 246 0 31 0 66 
Clostridium 49 39 11 9 23 19 12 13 69 213 6 7 5 6 
Succinivibrio 0 0 143 20 60 1 59 15 11 7 153 31 73 59 
Streptococcus 54 0 21 0 75 0 65 0 154 21 20 1 87 1 
Parabacteroides 0 0 59 56 37 43 26 52 7 14 67 63 47 66 
Sporacetigenium 52 37 3 8 3 4 6 6 43 33 2 4 2 2 
Ruminococcus 0 0 39 29 28 18 12 11 2 5 18 10 23 14 
Butyricicoccus 0 0 5 9 18 12 29 10 2 7 9 11 23 16 
Parasporobacterium 0 0 16 2 26 1 17 1 1 5 24 7 29 3 
Hallella 0 0 10 16 6 22 6 8 4 5 19 19 13 18 
Phascolarctobacterium 0 0 15 12 11 24 6 6 1 1 14 10 11 16 
Tannerella 0 0 5 18 5 14 3 26 1 2 6 26 4 18 
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Pseudomonas 0 0 0 0 0 0 0 0 27 29 1 0 1 0 
Anaerostipes 0 0 7 6 9 17 4 1 0 2 6 3 7 10 
Anaeroplasma 0 0 2 17 0 3 0 9 1 2 2 22 1 24 
Faecalibacterium 0 0 12 5 8 2 2 1 1 3 15 11 7 6 
Blautia 0 0 4 4 14 5 10 3 1 4 4 4 13 4 
Campylobacter 0 0 0 0 0 0 0 0 25 1 8 1 2 1 
Dorea 0 0 6 11 4 10 1 10 0 1 4 5 3 6 
Barnesiella 0 0 3 6 4 6 5 8 1 2 3 8 5 9 
Bradyrhizobium 0 0 0 0 0 0 0 0 18 10 0 0 0 0 
Anaerotruncus 0 0 3 1 14 6 4 3 0 1 4 0 7 3 
Fibrobacter 0 0 16 0 5 1 6 3 6 0 11 0 4 2 
TM7_genera_ 
incertae_sedis 0 0 6 1 11 1 7 0 0 1 4 1 10 1 
Salsuginibacillus 0 0 0 9 0 11 0 6 0 2 0 5 0 11 
Hespellia 0 0 6 4 5 3 2 2 0 1 4 4 4 4 
Subdoligranulum 0 0 4 2 5 3 4 3 1 1 4 4 5 3 
Spirochaeta 0 0 2 2 3 1 5 6 0 1 3 2 7 5 
Mitsuokella 0 0 4 0 5 2 5 0 1 1 2 2 10 4 
Alistipes 0 0 4 1 4 7 2 0 0 2 4 3 5 5 
Eubacterium 0 0 0 1 4 5 3 2 0 1 1 1 5 3 
Sutterella 0 0 4 1 0 0 0 1 1 1 9 4 2 3 
Lachnobacterium 0 0 0 4 0 10 0 3 0 0 0 2 0 5 
Acetivibrio 0 0 2 1 5 2 3 3 0 1 2 0 3 1 
Peptostreptococcus 0 0 1 1 3 2 1 3 0 1 1 2 3 3 
Catenibacterium 0 0 1 3 1 4 1 0 0 1 2 2 1 2 
Eggerthella 0 0 2 0 5 2 1 0 0 0 2 1 3 1 
Peptococcus 0 0 0 1 2 2 1 0 0 1 2 3 3 1 
Butyricimonas 0 0 1 1 2 1 3 2 0 0 1 2 1 3 
Pyramidobacter 0 0 2 1 2 1 1 0 0 0 2 1 3 2 
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Coprobacillus 0 0 1 2 0 6 0 3 0 0 0 0 1 3 
Paraprevotella 0 0 0 6 0 1 0 2 0 1 0 4 0 2 
Subdivision5_ 
genera_incertae_sedis 0 0 0 0 1 0 2 4 0 0 1 0 2 2 
Lentisphaera 0 0 0 0 2 0 4 1 0 0 0 0 3 1 
Oribacterium 0 0 3 1 1 1 0 2 0 0 1 0 1 1 
Anaerofilum 0 0 1 0 3 0 1 1 0 0 0 0 1 1 
Pseudobutyrivibrio 0 0 2 1 1 0 1 0 0 0 2 0 0 0 
Enterobacter 0 1 0 0 0 0 0 0 3 1 0 0 0 0 
Akkermansia 0 0 0 0 0 1 0 1 0 0 3 0 0 1 
Weissella 0 0 0 0 0 0 0 0 4 0 0 0 0 0 
Acetanaerobacterium 0 0 0 0 0 1 0 3 0 0 0 0 0 1 
Jonquetella 0 0 0 0 1 0 3 0 0 0 0 0 2 0 
Mogibacterium 0 0 0 0 1 0 1 2 0 1 0 0 1 1 
Robinsoniella 0 0 1 1 0 1 0 0 0 0 0 1 0 1 
Rhodopirellula 0 0 0 0 2 0 1 0 0 0 0 0 1 0 
Allobaculum 0 0 0 1 1 1 0 1 0 0 0 1 0 1 
Helicobacter 0 0 0 0 0 0 0 0 0 0 5 0 0 0 
Anaerovorax 0 0 1 0 1 0 1 1 0 0 0 0 1 0 
Cronobacter 0 0 0 0 0 0 0 0 3 0 0 0 0 0 
Actinobacillus 1 0 0 0 0 0 0 0 3 0 0 0 0 0 
Anaerosporobacter 0 0 1 0 0 0 0 0 0 0 1 0 0 0 
Xylanibacter 0 0 1 0 0 0 0 1 0 0 0 0 0 2 
Acholeplasma 0 0 0 0 0 0 0 0 0 1 0 1 0 1 
Erysipelothrix 0 0 0 0 0 1 0 1 0 0 0 0 0 0 
Megasphaera 0 0 0 0 0 0 0 0 0 0 0 0 1 0 
Solobacterium 0 0 0 0 1 1 0 0 0 0 0 0 0 0 
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APPENDIX C. ANTIBIOTICS IN FEED INDUCE PROPHAGES IN 
SWINE FECAL MICROBIOMES 
Heather K. Allen, Torey Looft, Darrell O. Bayles, Samuel Humphrey, Uri Y. Levine, 
David Alt, and Thaddeus B. Stanton 
 
 
 
 
 
 
 
 
 
 
 
 
 
This work has been published elsewhere. 
Allen HK, Looft T, Bayles DO, Humphrey S, Levine UY, Alt D et al (2011). Antibiotics in 
Feed Induce Prophages in Swine Fecal Microbiomes. mBio 2. I designed this experiment 
with the listed coauthors. Additionally, I collected samples, extracted DNA, performed the 
16S rRNA gene PCR reactions, analyzed 16S rRNA data, and wrote the methods, results and 
discussions sections that relate to the phylotype analysis.   
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Abstract 
Antibiotics are a cost-effective tool for improving feed efficiency and preventing 
disease in agricultural animals, but the full scope of their collateral effects is not understood. 
Antibiotics have been shown to mediate gene transfer by inducing prophages in certain 
bacterial strains; therefore, one collateral effect could be prophage induction in the gut 
microbiome at large. Here we used metagenomics to evaluate the effect of two antibiotics in 
feed (carbadox and ASP250 [chlortetracycline, sulfamethazine, and penicillin]) on swine 
intestinal phage metagenomes (viromes). We also monitored the bacterial communities using 
16S rRNA gene sequencing. ASP250, but not carbadox, caused significant population shifts 
in both the phage and bacterial communities. Antibiotic resistance genes, such as multidrug 
resistance efflux pumps, were identified in the viromes, but in-feed antibiotics caused no 
significant changes in their abundance. The abundance of phage integrase-encoding genes 
was significantly increased in the viromes of medicated swine over that in the viromes of 
nonmedicated swine, demonstrating the induction of prophages with antibiotic treatment. 
Phage-bacterium population dynamics were also examined. We observed a decrease in the 
relative abundance of Streptococcus bacteria (prey) when Streptococcus phages (predators) 
were abundant, supporting the “kill-the-winner” ecological model of population dynamics in 
the swine fecal microbiome. The data show that gut ecosystem dynamics are influenced by 
phages and that prophage induction is a collateral effect of in-feed antibiotics.  
 
Importance 
This study advances our knowledge of the collateral effects of in-feed antibiotics at a 
time in which the widespread use of “growth-promoting” antibiotics in agriculture is under 
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scrutiny. Using comparative metagenomics, we show that prophages are induced by in-feed 
antibiotics in swine fecal microbiomes and that antibiotic resistance genes were detected in 
most viromes. This suggests that in-feed antibiotics are contributing to phage-mediated gene 
transfer, potentially of antibiotic resistance genes, in the swine gut. Additionally, the so-
called “kill-the-winner” model of phage-bacterium population dynamics has been shown in 
aquatic ecosystems but met with conflicting evidence in gut ecosystems. The data support the 
idea that swine fecal Streptococcus bacteria and their phages follow the kill-the-winner 
model. Understanding the role of phages in gut microbial ecology is an essential component 
of the antibiotic resistance problem and of developing potential mitigation strategies. 
 
Introduction 
The Infectious Diseases Society of America is among the organizations that have 
recommended that the U.S. government limit the use of antibiotics in agriculture (1, 2). The 
European Union has banned the use of all agricultural antibiotics that are used for growth 
promotion (3, 4). However, various factors, notably the cost-effectiveness of antibiotic use 
for performance benefits in modern, conventional agricultural practices (5), have forestalled 
similar measures in the United States. Partly driving the ongoing debate on the prudence of 
the widespread use of antibiotics to improve feed efficiency in agricultural animals (6, 7) is a 
growing body of research on the collateral effects of these antibiotics, ranging from an 
increased abundance of antibiotic resistance genes in pigs fed antibiotics (T. P. Looft, T. 
Johnson, H. K. Allen, D. O. Bayles, D. P. Alt, R. D. Stedtfeld, W.-J. Sul, T. M. Stedtfeld, B. 
Chai, S. A. Hashsham, J. M. Tiedje, and T. B. Stanton, submitted for publication) to the 
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modulation of bacterial gene expression by subinhibitory concentrations of antibiotics (8). 
Another collateral effect could be the induction of gene transfer among bacteria.  
Horizontal gene transfer is a mechanism by which bacteria exchange genetic material 
and is known to occur among gut bacteria (9). One type of horizontal gene transfer is 
mediated by phages. Some antibiotics are known to affect prophage-mediated gene transfer 
in certain bacteria in vitro. The virus-like gene transfer agent VSH-1 is induced by carbadox 
in the swine pathogen Brachyspira hyodysenteriae and transfers antibiotic resistance genes 
(10, 11). Also, beta-lactam antibiotics and fluoroquinolones induce prophages in 
Staphylococcus aureus, some of which package pathogenicity islands and therefore transfer 
virulence traits (12, 13). However, the in vivo effects of antibiotics on phages in the gut are 
unknown.  
Phage diversity and function have been studied in water, soil, and animal-associated 
environments, but only a small fraction of phages have been characterized (14). 
Metagenomic analyses enable the study of phages without isolating them (15). The phage 
metagenome, or virome, is the sequenced assemblage of the total phages of a microbial 
community. Recently, phage metagenomic analyses have launched studies comparing phage 
ecology between environments. In such studies, phage diversity and functions can be 
elucidated despite a limited understanding of specific phages in a given community, such as 
the demonstrated increase in phage diversity in the lungs of cystic fibrosis patients (16).  
Our goal was to examine the fecal viromes over time in swine that were fed the 
common antibiotics carbadox and ASP250. The viromes were compared to those of 
nonmedicated swine and to the corresponding bacterial communities. The data show that in-
feed antibiotics induce prophages in the swine intestine and cause significant shifts in both 
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phage and bacterial community structures. Additionally, analysis of the relative abundance of 
Firmicutes bacteria and phages, specifically the Streptococcus spp., unexpectedly revealed 
that the predator-prey population dynamics model called “kill-the-winner” might apply to the 
swine microbiome.  
 
Results 
Diverse phages in swine feces. 
Phages in each sample were visualized by electron microscopy, revealing members of 
the Siphoviridae, Myoviridae, and Podoviridae phage families based on morphology 
(Fig. C1a to C1d). Several enveloped viruses were also seen (Fig. C1e). Frequently, many 
phages could be visualized in a field of view (Fig. C1f). No bacterial cells were seen by 
electron microscopy. Lack of bacterial cell contamination of phage preparations was further 
confirmed by the inability to amplify the 16S rRNA gene from virome samples.  
 
ASP250 causes shifts in phage membership. 
Viromes were analyzed by MG-RAST (17) and GAAS (18) to classify the sequences 
based on their putative origins. Out of nearly 1 million phage metagenomic sequence reads, 
44% of the sequences (average across viromes) had no hits in the databases according to 
MG-RAST (Fig. C2a). Few virome sequences were solely assignable to phage or virus 
origins, while considerably more virome sequences were attributed to bacterial origins 
(Fig. C2a). GAAS was used to infer phage taxonomy based on the best match according to 
BLASTx. Only phages that occurred at ≥0.1% abundance in at least one virome were 
analyzed. Approximately 90% of assignable phages were attributed to phages of canonical 
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gut bacteria, and the vast majority of assignments were to bacteria of the Firmicutes phylum 
(Fig. C2b; Supplemental Fig. C1). ASP250 but not carbadox caused considerable shifts in the 
phage community compared to control and pre-ASP250-fed animals (R = 0.72, P < 0.10). 
 
Phage community shifts are paralleled in the bacterial community. 
We compared phage diversity to bacterial diversity by amplifying and analyzing 16S 
rRNA gene sequences from the swine fecal samples. Sequencing the V1-to-V3 region of the 
16S rRNA gene of fecal DNAs yielded 1,077,133 sequences from 86 bar-coded samples. All 
samples were dominated by four phyla: Bacteroidetes, Firmicutes, Spirochaetes, and 
Proteobacteria (Fig. C3a), and the identified genera are typical for a mammalian gut 
environment (Fig. C3b). Specific genera detected at lower levels (P < 0.01) in ASP250-
treated animals than in corresponding nonmedicated animals (day 0 and nonmedicated 
control animals) were Coprococcus, Succinivibrio, Streptococcus, Treponema, and 
Turicibacter spp. (Fig. C3b; Supplemental Table C1). Additionally, Escherichia sp. 
increased with in-feed ASP250, although the overall abundance of this genus remained 
relatively low (Fig. C3b). 
To visualize changes in bacterial diversity, a principal component analysis of 
operational taxonomic units (OTUs) was performed. The bacterial community shifted in 
animals medicated with ASP250 compared to that in nonmedicated animals (both ASP250 on 
day 0 and all corresponding control animals; P < 0.01, R = 0.43; Fig. C3c), mirroring the 
results shown for the phage communities. The shift was driven in part by total bacterial OTU 
diversity decreases in the day 14 ASP250-treated samples compared to the control animals 
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(see Table S2 in the supplemental material). No significant changes in bacterial diversity 
were detected with in-feed carbadox treatment (Table S2). 
 
Kill-the-winner population dynamics are displayed in the swine fecal microbiome. 
Predator-prey relationships between swine fecal phages and bacteria were examined. 
Firmicutes bacteria and their associated phages were analyzed because they made up a large 
proportion of the assignable virome data (Fig. C2b). Even at the phylum level, the dynamic 
relationship between phages and bacteria was apparent in the nonmedicated swine viromes 
over time (Fig. C4a). A regression analysis of all viromes revealed that when the Firmicutes 
phages were present in relatively high abundance, the abundance of Firmicutes bacteria 
tended to be lower (r2 = 0.21, P < 0.1; Fig. 4b). Of the Firmicutes, the Streptococcus genus 
was analyzed because its members were relatively abundant in both the phage and bacterial 
data sets. As with the Firmicutes, Streptococcus bacteria decreased as Streptococcus phages 
increased (r2 = 0.23, P < 0.1; Fig. 4c and 4d). Only three other genera were present in both 
the phage and bacterial relative abundance data, and they all showed the same trend to 
various degrees (Escherichia, r2 = 0.45; Lactobacillus, r2 = 0.13; Clostridium, r2 = 0.03). 
These data suggest that the kill-the-winner model of population dynamics applies to swine 
gut microbial communities. 
 
Functional analysis of swine viromes reveals fitness genes. 
Putative functions of coding sequences were collated by CAMERA (19) and 
analyzed. Clusters of orthologous groups (COGs) revealed an emphasis on DNA replication 
and transcription in the viromes (Supplemental Fig. C3). Multivariate analyses, in addition to 
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statistical analyses of the COG assignments using ShotgunFunctionalizeR (20), revealed no 
significant patterns of COGs based on time or treatment.  
We hypothesized that antibiotic resistance would be one type of bacterial fitness trait 
encoded by phages; therefore, we searched for antibiotic resistance functions in all viromes. 
Sequences encoding resistance to antibiotics and toxins were annotated by MG-RAST (see 
Table S3 in the supplemental material) (17), and further details were acquired by comparing 
the viromes to the antibiotic resistance gene database (ARDB [21]) (Table 1). According to 
the ARDB, most viromes harbored few antibiotic resistance genes (107 genes out of 
1,036,084 total reads [0.01%]), and two viromes had no detectable resistance genes. Eight 
resistance genes occurred more than twice across all viromes, and most of these encoded 
efflux pumps (Table 1). Normalized resistance gene frequencies were analyzed in 
multivariate analyses but showed no discernable pattern based on time or treatment.  
 
In-feed antibiotics induce prophages in the swine gut. 
A potential indicator of the effect of antibiotics on prophages could be genes 
encoding phage integrases (S. Casjens, personal communication). Genes annotated as 
encoding an integrase were enumerated by MG-RAST and normalized by the total number of 
reads per virome. To gain statistical power, both carbadox- and ASP250-treated swine 
viromes were grouped as “medicated.” The viromes of medicated pigs (n = 5) harbored more 
integrase genes than did the viromes of nonmedicated pigs (n = 10, P < 0.01) (Fig. C5). This 
indicates that in-feed antibiotics induced prophages from gut bacteria, with a surge in the 
abundance of integrase-encoding genes in the ASP250-treated swine virome at day 8. 
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Discussion 
This is the first report of the effect of antibiotics on total phage diversity in a 
microbial community. The results show that a collateral effect of antibiotic treatment is 
increased abundance of phage integrase-encoding genes, reflecting the induction of 
prophages from gut bacteria. Integrases are an appropriate marker for prophage induction 
because they are required for temperate phages transitioning from lysis to lysogeny (22). 
Integrases are also associated with pathogenicity islands, which are often mobilized by 
prophages (23). A greater abundance of integrases with antibiotic treatment, therefore, 
indicates that antibiotics are inducing phage-mediated bacterial lysis in the gut. Integrase 
abundance increased regardless of the type of in-feed antibiotic; further research is required 
to determine the specificity of perturbations that result in increased integrase abundance.  
Additional consequences of in-feed antibiotic-mediated phage induction could be 
increased abundance of bacterial fitness or virulence genes, such as those encoding antibiotic 
resistance. Various homologues of antibiotic resistance genes were detected in the swine 
viromes at a frequency corresponding to approximately 1/50 of the frequency of antibiotic 
resistance genes in an Escherichia coli genome. Particularly in the context of no detection of 
16S rRNA genes by PCR in the viromes, the apparent low number of resistance-encoding 
virome reads seems surprisingly frequent. Resistance genes were identified slightly more 
frequently in human fecal viromes (0.1% [24]). With selective pressure, any phage-
transferred resistance genes could accelerate the evolution of resistance in the gut 
microbiome. Despite the potential relevance of the transduction of resistance genes in an 
antibiotic-containing environment, the swine viromes provided no evidence of a treatment 
effect. Increased sequencing depth may be required to detect differences among the viromes, 
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such as the effect of generalized transduction on a virome. Additionally, transcriptomic 
analyses would demonstrate which phage genes have altered expression as a result of 
antibiotic treatment, revealing those genes important for fitness in an antibiotic environment.  
Phages have been shown to play an important role in ecosystem dynamics (25), and 
one dynamic is the relationship between phages and bacteria. A widely investigated model 
for this relationship is called kill-the-winner (26). This model predicts that an increase in a 
given bacterial host population (winning prey) results in an increase in its phages (predators) 
and subsequent predation of the winner. Kill-the-winner population dynamics have been 
supported in marine ecosystems (27), but it is unclear if the model holds true for gut 
ecosystems. The extended sampling (seven viromes over time) of nonmedicated animals’ 
viromes presented a ripe data set for investigating phage-bacterial population dynamics. 
Overall, the nonmedicated swine viromes showed taxonomic and functional stability over 
time, as seen in aquatic microbiomes (27). Despite this apparent stability, examination of the 
relative abundances of Streptococcus phages compared to Streptococcus bacterial 
abundances over time revealed a dynamic process resembling kill-the-winner. Indeed, the 
swine viromes suggest that the kill-the-winner process might be detectable at the phylum 
level. This is consistent with other work that has shown kill-the-winner dynamics at the strain 
level in aquatic microbiomes (27) and horse feces (28). However, a fecal phage metagenomic 
study from pairs of twins and their mothers revealed little intravirome change across three 
sampling dates, and the authors refuted the model (29). Two major differences between the 
present study and the twin study are that we isolated phages from fresh (not frozen) feces and 
that we did not employ a DNA amplification step prior to sequencing. These protocol 
improvements were designed to reduce bias in analyses of phage diversity (30), enabling us 
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to view population dynamics even in complex ecosystems such as the swine microbiome. 
The results tentatively support kill-the-winner dynamics in swine microbiomes, but more 
research is required to resolve the applicability of the kill-the-winner model across 
mammalian gut ecosystems.  
Analysis of the in-feed ASP250 viromes suggests that there is an antibiotic effect on 
the relative abundance of fecal phages. The only component of ASP250 known to have an 
effect on phage lysis is penicillin. Subinhibitory concentrations of penicillin were shown to 
weaken Streptococcus spp. such that even so-called phage-resistant strains in mixed cultures 
were susceptible to phage lysis by exogenous phages (31). This could account for the 
significant decrease in Streptococcus spp. with ASP250, although it provides no evidence for 
the concomitant increase in Streptococcus phages. A related phenomenon is called phage-
antibiotic synergy (PAS) and has been demonstrated with diverse phages of E. coli in the 
presence of subinhibitory concentrations of various cephalosporin-type beta-lactam 
antibiotics (32). The result of PAS is phage induction, and it is independent of an SOS 
response and dependent on a filamentation phenotype resulting from certain antibiotic 
treatments (32). Taken together, these data suggest that penicillin is the active component of 
ASP250 that is affecting the phage population, perhaps by numerous and complex 
mechanisms in the bacterial milieu.  
Analysis of the structure of the bacterial communities shows that a small, important 
fraction of the data is driving the shift in diversity with ASP250 treatment. The decrease in 
the lactic acid bacterium (LAB) Streptococcus is particularly intriguing and agrees with the 
reported decrease in the abundance of LABs with certain oral antibiotic treatments (33–35). 
This decrease is often accompanied by an increase in Proteobacteria, specifically in 
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Escherichia populations as shown here and elsewhere (33; Looft et al., submitted). In 
addition to the immediate effects on the microbiota, oral antibiotic treatment was shown to 
decrease the immune response in mice, even in distant locations such as the lungs (34, 35). 
The interaction of LABs with the gut mucosa is thought to be immunomodulatory (36), so 
perhaps there is a connection between the abundance of LABs and immune function. 
Interestingly, a recent study evaluating in-feed fumaric and formic acids showed a trend 
towards increased abundance of coliforms and decreased lactobacilli in plate counts (37), 
mirroring the effect of ASP250 on the microbiota. Fumaric acid has been demonstrated to 
improve weight gain despite no changes in available energy in the gut (38). Furthermore, in a 
study of irritable bowel syndrome, subjects with a higher body mass index than that of 
normal subjects had fewer lactobacilli (a type of LAB) (39). Considering that one mechanism 
of antibiotic-mediated growth promotion could be suppressed immune response due to 
decreased bacterial load (40), a decrease in immunomodulatory LABs might also decrease 
the energy spent on immunity and allow for increased feed efficiency.  
The fecal bacterial diversity in the current study supports what has been shown 
previously: the swine gut is dominated by Firmicutes (~30%), Bacteroidetes (~50%), and 
Proteobacteria (~10%). However, the proportion of assignable phage sequences does not 
mirror this distribution, with nearly 80% of reads called from phages of bacteria of the 
Firmicutes phylum. Their inflation in our data set could result from the overrepresentation of 
phages of Firmicutes in public databases compared to those of Bacteroidetes, perhaps 
because of increased research interest due to their potential biotechnological applications 
(41). Additionally, phage sequences are simply lacking in the databases compared to 
bacterial sequences, limiting the pool of potential homologues for the swine viromes.  
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A relatively large proportion of assignable virome sequences were of bacterial origin 
despite no detectable bacterial contamination of the viromes. Phages harbor more bacterial 
genes than previously appreciated (42), making it reasonable that the assignable sequences of 
the swine viromes have 46% bacterial genes even in the absence of bacterial contamination. 
Also, generalized transducing phages package host bacterial DNA, contributing an unknown 
proportion to the counted bacterial genes.  
No statistically significant effect of carbadox was detected on swine fecal phages or 
bacteria. Different sampling intervals and minor protocol improvements between the 
carbadox and ASP250 experiments (see Materials and Methods) may have affected the 
results. Our results suggest that 1 week following the commencement of in-feed antibiotics is 
an appropriate time to detect changes in the fecal microbiome.  
This study provides evidence that a collateral effect of some in-feed antibiotics, such 
as ASP250, is the induction of prophages. Additionally, antibiotic resistance genes were 
detected in the phage metagenomes. Further work is required to determine the implications of 
prophage induction on the transfer of antibiotic resistance genes. Surprisingly, the data also 
support the kill-the-winner model for phage-bacterium population dynamics. Taken together, 
the data underscore the importance of phages in complex microbial communities.  
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Materials and Methods 
Swine. 
Three rooms that would house pigs were decontaminated prior to the beginning of the 
study. All animals were managed in accordance with National Animal Disease Center 
Animal Care and Use Committee guidelines. Three pregnant sows farrowed on site, and 
piglets were weaned after 14 days. Weaned pigs were divided into three groups with 
approximately equal representation of littermates and gender, with two groups of six pigs 
housed in their own clean rooms and the remaining pigs housed in a third room 
(Supplemental Fig. C2). All pigs were fed the same diet (TechStart 17-25; Kent Feeds, 
Muscatine, IA) for 1 week after weaning and until the start of their respective study, at which 
point six control pigs continued to receive TechStart while three groups of six experimental 
pigs received one of the following in-feed supplements: subtherapeutic carbadox, 10 g/ton; 
therapeutic carbadox, 50 g/ton; or ASP250 (chlortetracycline, 100 g/ton; sulfamethazine, 
100 g/ton; penicillin, 50 g/ton). For a 4.5-kg pig, this equaled the following concentrations of 
antibiotic per gram of pig per day: 8.2 µg therapeutic carbadox; 1.6 µg subtherapeutic 
carbadox; and 16.4 µg chlortetracycline, 16.4 µg sulfamethazine, and 8.2 µg penicillin 
(ASP250). Note that these concentrations decreased as the pigs increased in size. Freshly 
voided fecal samples were collected from control and medicated animals just before 
treatment (day 0) and 3, 8, 14, or 28 days after continued treatment (Supplemental Fig. C2). 
Feces were transported on ice from the barn to the lab and were immediately processed for 
phage isolation and stored at −20°C for bulk DNA extraction.  
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Phage isolation. 
The following protocol was adapted from previous reports (43–45). Approximately 
equal amounts of feces from each of the six animals in a treatment group were pooled to 
roughly 10 g. Feces were pooled because of the low biomass of phages and to avoid biasing 
the samples by amplifying the DNA in a later step (30). Pooled feces were blended in 50 ml 
SM buffer (8 mM MgSO4, 100 mM NaCl, 50 mM Tris-Cl, and 0.002% [wt/vol] gelatin) in a 
Waring blender (Torrington, CT) for 30 s. Fecal slurries were poured through a Nitex mesh 
(~118-µm pore size; Wildlife Supply, Yulee, FL) into a sterile centrifuge bottle. Samples 
were centrifuged three times at 4°C, first at 3,000 × g for 10 min and then twice at 10,000 × g 
for 10 min. The supernatants were carefully transferred to sterile centrifuge bottles between 
spins or to 50-ml Falcon tubes following the final spin. CsCl was added to the final 
supernatant to a density of 1.15 g/ml.  
Meanwhile, two CsCl gradients were prepared per fecal sample (44, 45). Gradients 
were ultracentrifuged at 37,946 × g for 2 h at 4°C in a Beckman SW28 rotor. A 20-gauge 
needle on a 1-ml syringe was used to draw off 1 ml containing concentrated virions from the 
interface between the 1.35- and 1.5-g/ml layers. To improve DNA yield, the needle was 
inserted in the middle of the 1.5-g/ml layer and the volume of virions extracted was increased 
to 5 ml for the six samples taken during the ASP250 experiment. Because of a brown, stringy 
substance suspended vertically through the gradient, all virions were gently filtered through a 
0.45-µm syringe filter into an Ultracel 3K regenerated cellulose concentrator (Millipore, 
Billerica, MA). Samples were gently centrifuged (<3,000 × g) until the sample volume was 
~1 ml.  
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TEM visualization of phage particles. 
An aliquot of virions was washed and concentrated for transmission electron 
microscopy (TEM) visualization. Briefly, 50 µl of virion-containing CsCl was applied to a 
Microcon YM-100 filter tube (Millipore) and washed twice with 500 µl SM buffer. Virions 
were resuspended in 10 µl SM buffer and stored at 4°C until TEM. On the day of TEM, 10 µl 
of virions was mixed with 10 µl of fresh 2% phosphotungstic acid (pH 7.0) and incubated at 
room temperature for 3 minutes. A Formvar- and carbon-coated 200-mesh copper grid 
(Electron Microscopy Sciences, Hatfield, PA) was introduced into this mixture for 1 min. 
The excess fluid was wicked away with filter paper. Grids were viewed on a Tecnai G2 
Biotwin transmission electron microscope (FEI, Hillsboro, OR).  
 
Phage DNA isolation.  
Phage DNAs were isolated as described previously (45). Briefly, intact virions were 
treated with DNase to eliminate free DNA. Following DNase inactivation, virions were lysed 
with formamide and the DNA was precipitated. DNA was extracted by sequential SDS, 
cetyltrimethylammonium bromide (CTAB), and chloroform treatments.  
 
Metagenomic sequencing and analysis.  
Individual preparations of phage DNA were quantified using Quant-iT PicoGreen 
(Invitrogen, Carlsbad, CA). Five hundred nanograms of DNA from each preparation was 
used in the Rapid Library Preparation method (454 Life Sciences, Branford, CT). Libraries 
were created with Roche multiplex identifier (MID)-labeled adaptors. Individual libraries 
were pooled into one of two groups in an equimolar fashion. Pooled preparations were used 
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to prepare DNA beads for sequencing using a two-region picotiter plate on a Roche GS-FLX 
instrument using Titanium chemistry (454 Life Sciences).  
The metagenome sequences were processed with the 454 Replicate Filter, 
extract_replicates.py script, to remove artificially replicated sequences (46). Sequences in a 
cluster were removed as artificial replicates if the first three bases were identical and there 
was greater than 90% identity over the length of the shortest sequence in a cluster (see 
Table S3 in the supplemental material). Dereplicated reads were uploaded to CAMERA 
(https://portal.camera.calit2.net [19]), and the RAMMCAP pipeline sorted the reads for 
encoded functions, including separation by clusters of orthologous groups (COGs). Domain 
taxonomy and integrases were determined by MG-RAST (http://metagenomics.anl.gov/ 
[17]). The dereplicated virome reads were analyzed with GAAS to obtain estimates of the 
viral genome sizes as well as confidence intervals of the estimates (18). PAST (47) was used 
to perform one-way ANOSIM and principal component analyses on the normalized 
(percentage of the total number of assigned reads per virome) phage relative abundance data 
from GAAS. ShotgunFunctionalizeR was used to make statistical comparisons of COG 
assignments among viromes (20). To draw statistical conclusions, the following cutoffs were 
indicated: P < 0.1, trend; P < 0.01, significance; R = 0 to 0.3, slight correlation; R = 0.3 to 
0.5, medium correlation.  
 
16S rRNA gene sequence analysis.  
16S rRNA gene sequences were amplified from the fecal samples of individual pigs. 
PCR amplification of the V1-to-V3 region of bacterial 16S rRNA genes was carried out with 
the conserved primers 8F (5′-AGAGTTTGATCCTGGCTCAG [48]) and 518R (5′-
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ATTACCGCGGCTGCTGG [49]) with sequence tags (bar codes) and sequencing primers 
incorporated into each PCR primer (see Table S4 in the supplemental material). PCR 
mixtures contained 200 µM (each) deoxyribonucleotide triphosphate, 2.0 µM (each) primer, 
2.0 U Ampligold Taq polymerase (Applied Biosystems, Foster City, CA), 2.5 mM MgCl2, 50 
ng template DNA, Ampligold Taq buffer (Applied Biosystems), and water to 50 µl. PCRs 
were performed in a PTC-225 thermal cycler (MJ Research, Watertown, MA) with the 
following protocol: 3 min at 95°C; 21 cycles of 1 min at 95°C, 30 s at 56°C, and 45 s at 
72°C; and a final elongation step for 3 min at 72°C. PCR for the 16S rRNA gene was also 
performed on purified phage metagenomic DNAs, but the number of cycles was increased to 
40. PCR products were separated by gel electrophoresis and purified using the MinElute kit 
(Qiagen Inc., Valencia, CA). They were then sequenced on a 454 Genome Sequencer FLX, 
using the manufacturer’s protocol for Titanium chemistry (Roche Diagnostics, Branford, 
CT). Data were processed per manufacturer’s protocols, and AmpliconNoise (50) was used 
to reduce sequence artifacts produced during PCR and sequencing.  
 
Phylotype analysis. 
After binning the samples by bar code, phylogenetic analysis and taxonomic 
assignments of the 16S rRNA gene sequences were made using the Ribosomal Database 
Project (RDP) web tools (51). Additional phylotype comparisons and hypothesis testing were 
performed with the software package mothur (52). OTU abundances (97% similarity) were 
normalized to the total number of OTUs per sample, and these data were subjected to 
principal component analyses in mothur (52). PAST (47) was used to plot the data, allowing 
for the visualization of the relationships between samples. The estimated total diversity of 
162 
 
 
 
  
 
 
operational taxonomic units was calculated with Catchall (53). Regression analyses were 
performed in Excel (P < 0.1, trend; P < 0.01, significance).  
Nucleotide sequence accession numbers.  
All sequences (phage metagenomes and 16S rRNA gene sequences) were deposited 
in NCBI (BioProject PRJNA72355; Sequence Read Archive accession number SRA045429) 
and are additionally available through CAMERA and MG-RAST.  
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Figure C1.  Electron micrographs of virions isolated from swine feces. (A to D) 
Representative phages of the Myoviridae (A), Siphoviridae (B [no arrow] and C), and 
Podoviridae (B [arrow] and D) families. (E) An enveloped virus as seen in numerous fecal 
samples of young pigs. (F) Ten Siphoviridae (arrows) were visualized in a single field.  
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Figure C2.  Community structure based on taxonomic inference of phages from swine feces. 
(A) Phage metagenomic sequence origins. “No hits” is the percentage of reads with no 
similar sequences in the database, and “unassigned or unclassified” is the percentage of reads 
with a database hit that has no associated taxonomic information. The values on the graph are 
the medians, and the values in parentheses are the ranges. (B) Genus-level phylogenetic 
origins of the phage-derived sequences from the ASP250 experiment. Phage taxa occurring 
at roughly <0.5% abundance were grouped as “Other phages.” Asterisks denote those of the 
Firmicutes phylum.  
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Figure C3.  Community structure based on taxonomic inference of bacteria (16S rRNA 
sequences) from swine feces. (A) Phylum-level assignments of assignable 16S rRNA gene 
sequences from swine feces, averaged across all 86 individual samples. The values on the 
graph are the medians among treatment groups, and the values in parentheses are the ranges. 
(B) Average percent abundance of genus-level assignments of 16S rRNA gene sequences 
from the feces of six swine fed ASP250 and the corresponding nonmedicated animals. 
Values were normalized to the total number of assignments within a sample. Taxa occurring 
at roughly <0.3% abundance were grouped as “Others.” Asterisks denote those of the 
Firmicutes phylum. See Table S1 in the supplemental material for the values of the means 
and the standard errors. (C) Principal component analysis of OTU-based bacterial 16S rRNA 
gene sequence abundances in individual pig samples (P < 0.01, R = 0.43). The percent 
variance accounted for by each component is in parentheses. An ellipse is drawn around the 
data sets of pigs that did not receive ASP250. Black, day 0 (just prior to treatment); blue, day 
8; pink, day 14. Circles, nonmedicated pigs; squares, medicated pigs.  
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Figure C4.  Population dynamics of bacteria and phages in swine fecal microbiomes. (A and 
C) Abundances of Firmicutes (A) and Streptococcus (C) bacteria and phages in the 
nonmedicated swine are plotted against time. (B and D) Regression analyses of the 
abundances of Firmicutes (B) and Streptococcus (D) phages against the respective bacterial 
abundances in all treatments and time points (r2 = 0.21 and 0.23, respectively; P < 0.1 for 
both). In all figures, the bacterial abundances are pooled data from six animals.  
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Figure C5.  Box plot of integrase-encoding gene abundance in nonmedicated (n = 10) and 
medicated (n = 5) swine viromes (P < 0.01). Asterisks denote the means. The number of 
integrase-encoding genes was normalized by the total number of reads per virome.  
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Table C1.  Antibiotic resistance genes detected more than twice across all viromes, as annotated by the antibiotic resistance gene 
database (21)  
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Supplemental Figure C1.  GAAS was used to infer phylogeny of the phage-derived sequences from the subtherapeutic (A) and 
therapeutic (B) carbadox experiments. Phage taxa occurring at roughly <0.5% abundance are grouped as “Other phages.” 
Asterisks denote those of the Firmicutes phylum. Note that because of the experimental design, nonmedicated day 14 in panel A is 
the same virome as nonmedicated day 0 in panel B. 
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Supplemental Figure C2.  Schematic of swine fecal phage metagenomic study. Phages were 
isolated from fecal samples that were pooled from 6 pigs at each sampling point per 
treatment. Bacterial 16S rRNA genes were amplified and sequenced from individual pigs at 
each sampling point  
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Supplemental Figure C3.  Clusters of orthologous groups (COGs) identified by CAMERA in assignable virome reads. 
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Supplemental Table C1.  Mean and standard error (SE) of the most abundant bacteria in the feces of swine fed ASP250 and their 
nonmedicated counterparts.  
 Non-medicated Medicated 
 
day 0 day 8 day 14 day 0 day 8 day 14 
Genus mean s.e. mean s.e. mean s.e. mean s.e. mean s.e. mean s.e. 
Prevotella 30.02 3.90 44.01 5.21 39.36 5.07 32.10 4.16 52.76 5.59 46.78 5.13 
Oscillibacter 13.37 1.80 12.51 1.25 17.46 3.49 13.09 1.98 12.58 5.20 9.54 0.86 
Treponema 15.55 3.18 11.29 2.63 8.68 2.61 11.63 3.08 2.05 0.74 7.49 1.36 
Clostridium 6.90 1.42 2.52 0.66 4.80 1.35 7.77 2.48 5.67 1.34 15.21 2.98 
Streptococcus 7.99 2.68 4.88 1.33 2.49 0.72 3.28 1.64 0.28 0.19 0.08 0.06 
Succinivibrio 2.74 1.11 3.86 1.19 4.56 2.26 5.25 1.41 1.11 0.29 0.64 0.25 
Coprococcus 3.46 1.13 2.52 0.55 2.03 0.64 5.83 1.69 1.91 0.33 0.88 0.10 
Ruminococcus 3.16 0.42 1.90 0.50 2.65 0.75 3.43 1.28 4.26 2.05 2.07 0.57 
Butyricicoccus 3.50 0.56 2.47 0.61 1.78 0.38 2.40 0.68 1.46 0.50 1.70 0.41 
Parabacteroides 0.81 0.11 1.91 0.50 2.47 0.52 1.84 0.66 2.61 0.96 3.29 1.01 
Anaerovibrio 0.49 0.13 1.61 0.60 3.84 0.76 1.95 0.90 1.12 0.23 0.65 0.15 
Turicibacter 2.42 0.64 0.82 0.11 0.80 0.13 2.23 0.49 0.06 0.03 0.05 0.02 
Lactobacillus 0.15 0.06 1.37 0.35 1.64 0.66 0.23 0.10 1.10 0.15 1.41 0.40 
Escherichia 0.07 0.02 0.01 0.01 0.00 0.00 0.12 0.02 1.11 0.47 0.32 0.16 
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Supplemental Table C2.  Estimated operational taxonomic unit (OTU) diversity (± standard error) of 16S rRNA gene sequences in 
the ASP250 experiment, averaged within each sampling date and treatment.  
Experimental group Sampling day # 
0 14 17 42 56 64 70 
Non-medicated  599 ±165 238 ±25 394 ±44 275 ±27 848 ±234 671 ±107 636 ±134 
Subtherapeutic carbadox  663 ±85a 648 ±238           
Therapeutic carbadox   307 ±27 497 ±121 336 ±23       
ASP250          1116 ±115 531 ±71 881 ±184 
 
aGray boxes indicate pre-medication sampling. 
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Supplemental Table C3.  Summary of swine fecal phage metagenomic (virome) data. 
 non-
med 
day 0 
subther 
day 0 
non-med 
day 14 
subther 
day 14 
ther day 
0 
non-
med day 
3 
ther 
day 3 
non-
med 
day 28 
ther 
day 28 
non-
med 
day 0 
ASP250 
day 0 
non-med 
day 8 
ASP250 
day 8 
non-med 
day 14 
ASP250 
day 14 
#reads (pre 
QC)b 25,980 91,801 122,762 13,971 60,047 97,408 38,480 65,791 53,872 64,264 102,989 84,947 101,259 176,197 118,923 
#reads (post 
QC) 22,403 65,994 103,043 11,916 48,342 80,838 33,037 52,927 45,116 53,161 83,589 70,601 68,315 140,276 93,718 
Average 
read length 358 385 359 374 378 375 363 366 363 344 345 335 356 375 357 
#ARGc (%) 
4 (.02) 3 (.005) 16 (.02) 0 (0) 12 (.02) 17 (.02) 13 (.04) 
10 
(.02) 7 (.02) 
47 
(.09) 56 (.07) 64 (.09) 7 (.01) 53 (.04) 28 (.03) 
 
a
 Non-med, non-medicated; ther, therapeutic carbadox; subther, subtherapeutic carbadox.   
bQC (quality control) was done using the 454 dereplicate filter (16). 
cARG, reads annotated as conferring resistance to antibiotics and toxic compounds, identified in the virulence, disease, and 
defense SEED subsystem (14). 
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Supplemental Table C4.  Barcodes used in this study for parallel 16S rRNA gene 
sequencing.a     
Barcode name  Sequence Barcode name  Sequence 
Wilmington-1 CACACACA  KingstonCA-31 TGCCGACA 
BowlingGreen-2 CACAGTCA  AmmanCA-32 TAGGAACA 
Munich-3 CACTCTCA  NairobiCA-33 CCGGCCCA 
Fagaras-4 CACTGACA  SeoulCA-34 AACCTGCA 
Cincinnati-5 CAGACTCA  RigaCA-35 TTCGTGCA 
Cleveland-6 CAGAGACA  BeirutCA-36 AACACACA 
Dayton-7 CAGTCACA  MaseruCA-37 TTCTTGCA 
Bucharest-8 CAGTGTCA  VilniusCA-38 ACCTGACA 
Brasov-9 CTCACTCA  BamakoCA-39 TTGACACA 
Memphis-10 CTCAGACA  VallettaCA-40 TCCAGACA 
Columbus-11 CTCTGTCA  MonacoCA-41 AAGGCCCA 
Chatham -13 CTGACACA  WellingtonCA-42 ACGAGACA 
Louisville-14 CTGAGTCA  ManaguaCA-43 TGGTGACA 
St.Louis-15 CTGTCTCA  WarsawCA-44 TTCTCACA 
Earlham-16 CTGTGACA  RiyadhCA-45 TTGAACCA 
Desmoines-17 GACACTCA  BelgradeCA-46 CCGTTCCA 
Iowacity-18 GACAGACA  SofiaCA-47 AAGCCCA 
Albuquerque-19 GACTCACA  OttawaCA-48 CAAGACA 
Houston-20 GACTGTCA  SantiagoCA-49 TATCACA 
Madison-21 GAGACACA  BogotaCA-50 CGGTACA 
Jacksonville-22 GAGAGTCA  ZagrebCA-51 AGACCCA 
Chapelhill-23 GAGTCTCA  CopenhagenCA-52 AACCACA 
Mankato-24 GAGTGACA  DjiboutiCA-53 TTCGACA 
Siouxfalls-25 GTCACACA  SuvaCA-54 TAATCCA 
Sandiego-26 GTCAGTCA  HelsinkiCA-55 TCACCCA 
Hana-27 GTCTCTCA  ParisCA-56 TCCGCCA 
Honolulu-28 GTCTGACA  AthensCA-57 ACGGCCA 
Denver-29 GTGACTCA  DublinCA-58 AAGGCCA 
Minneapolis-30 GTGAGACA     
 
aBarcodes 31-58 are derived from those of the Broad Institute  
(http://www.hmpdacc.org/doc/HMP_MDG_454_16S_Protocol_V4_2_102109.pdf).   
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APPENDIX D. TABLE OF MUCIN DEGRADERS ISOLATED  
FROM THE SWINE INTESTINAL TRACT. 
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Table D1. Identities of mucin-degrading bacteria, isolated from the swine intestinal tract. 
Taxonomic assignments of partial 16S rRNA gene sequences (V1-V3 region) were made 
using the Ribosomal Database project sequence classifier. 
 
 
 
 
Mucosa Lumen Total 
Proteobacteria 67 37 104 
Firmicutes 58 32 90 
Bacteroidetes 26 64 89 
Actinobacteria 24 16 40 
Synergistetes 5 3 8 
Total  180 145 325 
Bacteroides 23 47 70 
Escherichia 42 17 59 
Enterococcus 28 14 42 
Actinomyces 17 11 28 
Eubacterium 8 6 14 
Klebsiella 9 5 14 
Parabacteroides 3 10 13 
Clostridium 8 2 10 
Enterobacter 8 0 8 
Proteus 2 6 8 
Cloacibacillus 5 3 8 
Streptococcus 5 2 7 
Citrobacter 4 3 7 
Paraeggerthella 2 4 6 
Desulfovibrio 0 5 5 
Arcanobacterium 3 0 3 
Finegoldia 2 0 2 
Butyricicoccus 2 0 2 
Atopobium 1 0 1 
Collinsella 1 0 1 
Lactococcus 1 0 1 
Sharpea 0 1 1 
Peptoniphilus 1 0 1 
Peptostreptococcus 0 1 1 
Sutterella 1 0 1 
unclassified Lachnospiraceae 0 4 4 
unclassified Ruminococcaceae 2 1 3 
unclassified Enterobacteriaceae 1 1 2 
unclassified Coriobacteriaceae 0 1 1 
unclassified Clostridiales 0 1 1 
unclassified Eubacteriaceae 1 0 1 
